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ABSTRACT 
Previous studies of autism spectrum disorder (ASD) have shown 
abnormalities in brain development, synaptic plasticity, and social and learning 
behavior. Our previous study has identified the X-linked gene KIAA2022, and its 
protein product KIDLIA, as the etiological factor in a particular group of patients 
with intellectual disability and ASD phenotypes. I found that KIDLIA is neuron 
specific and localized exclusively in the nucleus, indicating a possible role for 
KIDLIA in neuronal gene regulation. Using rat hippocampal neurons, I found that 
shRNA-mediated knockdown of KIDLIA resulted in a marked impairment of 
neurite outgrowth via the disruption of the N-cadherin/δ-catenin/RhoA signaling 
pathway. Additionally, I showed that loss of KIDLIA expression decreases 
synapse formation and synaptic transmission. To investigate the role of KIDLIA in 
vivo, I generated and characterized KIDLIA knockout (KO) mice. KIDLIA KO mice 
demonstrated significant impairments in social interactions, increased repetitive 
  
behaviors and deficits in learning and memory, consistent with symptoms 
observed in human ASD patients and validate this mouse line as a valuable new 
model for ASD. The KIDLIA KO mice showed reduced synapse formation and 
abnormal expression of synaptic components such as the GluA1 subunit of 
AMPA receptors. To understand the potential role of KIDLIA in gene regulation, I 
used RNAseq to identify major candidates involved in synapse formation and 
function and discovered the synapse-enriched Ca2+-mediated protein, 
neurogranin, as the most down-regulated synaptic transcript. I showed that over-
expression of neurogranin can rescue KIDLIA-dependent structural and 
functional synaptic deficits. This study provides valuable insight into the cellular 
and molecular mechanisms underlying KIDLIA-dependent autism and intellectual 
disability phenotypes. 
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CHAPTER ONE: 
INTRODUCTION 
  
2 
 
 
1.1 Fundamental elements in ASD 
Autism spectrum disorder (ASD) comprises a heterogeneous class of 
neurodevelopmental disorders characterized by impaired social interactions, 
restrictive interests and repetitive behaviors (Landa, 2008). ASD typically 
presents with other psychiatric and medical conditions such as intellectual 
disability (ID), epilepsy, motor coordination problems, anxiety, gastrointestinal 
issues and attention-deficit/ hyperactivity disorder (ADHD). In up to 25% of 
individuals diagnosed with ASD, an identifiable or genetic variant can be 
identified, providing valuable insights into the mechanisms involved in proper 
neurodevelopment (Huguet et al, 2013). A large number of ASD-linked genes are 
also associated with broad processes such as metabolism, chromatin 
remodeling, mRNA regulation, protein synthesis, and synaptic function.  
 The human brain contains about 86 billion neurons making trillions of 
connections (Azevedo et al, 2009). Most neurons are produced in the ventricular 
zone (VZ) and migrate radially out into the developing neocortex, and it is 
estimated that about 75% of rodent, and up to 90% of human neurons use glial-
guided migration (Letinic et al, 2002). The movement of neurons along migratory 
routes is guided by a number of guidance molecules that direct their movement 
into the cortex and the formation of an organized 6-layered structure (Huang, 
2009; Marin and Rubenstein, 2001; Valiente and Marin, 2010). 
3 
 
 
 After neuronal migration, neurons must undergo extensive morphological 
changes. Long axonal processes are extended and are required to connect to 
target neurons with precision, while complex dendritic arbors must grow and 
branch to occupy specified dendritic field volumes. These processes take place 
during prenatal and early postnatal periods and lay the foundations for neuronal 
connectivity within and across brain regions. Ultimately, with activity-dependent 
structural remodeling, neurons form synaptic connections and incorporate into 
functional neuronal networks for proper brain function. It’s of no surprise that 
disruptions in any of these intricate processes would cause abnormalities in brain 
development and function, leading to neurodevelopmental disorders including 
ASD. 
 While ASD shares characteristic features at the behavioral level, its 
underlying causes are highly heterogeneous. Developmental dysregulation in 
ASD may affect processes ranging from progenitor cell proliferation and neuronal 
differentiation to neuron migration, axon guidance, dendrite outgrowth, 
synaptogenesis, synaptic function and neural circuitry. 
A study of ASD-related brain pathologies provides evidence that abnormal 
acceleration of brain growth in early childhood (Wegiel et al, 2010) accompanied 
with impaired neuron morphological development and brain cytoarchitecture are 
common underlying features (Bailey et al, 1998; Bauman and Kemper, 1985; van 
Kooten et al, 2008). Additionally, impairments in synapse formation and synaptic 
4 
 
 
plasticity (Bourgeron, 2007, 2009), which ultimately lead to functional and 
cognitive impairments, are fundamental causative factors underlying ASD 
pathology. 
Analysis of the Simmons Foundation Autism Research Initiative (SFARI) 
gene database shows that ASD causative genes display vast diversity involving 
hundreds and possibly up to a thousand genes (Abrahams et al, 2013; Banerjee-
Basu and Packer, 2010). Additionally, a large number of rare genetic variants in 
protein-coding genes are causative for ASD, none of which individually account 
for more than 1% of the total number of ASD diagnoses. This complex landscape 
of autism genetics apparently underlies the great heterogeneity of 
endophenotypes, one of the major challenges in identifying and defining 
neuropathological abnormalities that are shared across the autism 
spectrum (Happe et al, 2006).  
As the understanding of genetic causes increases and data on the 
spatiotemporal expression and interaction of causative autism genes and the 
encoding proteins becomes available, the opportunity arises to classify autism 
cases and dissect the underlying pathology. For instance, several known autism 
genes, such as neurexin, neuroligin, and Shank have a defined role in synaptic 
adhesion and function (Toro et al, 2010). Co-expression network analyses of 
ASD-linked genes implicate early postnatal stages associated with neuronal 
differentiation and synaptic maturation as probable points of vulnerability in the 
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development of ASD (Parikshak et al, 2013). Additionally, developmental 
regulators found to be causative in autism, such as Chromodomain helicase 
DNA-binding protein 8 (CHD8), T-Box Brain Protein 1 (TBR1), and Fragile X 
Mental Retardation 1 (FMR1), are involved in prenatal co-expression networks of 
developing cortical projection neurons (Parikshak et al, 2013; Willsey et al, 
2013). These findings suggest that multiple processes during prenatal and early 
postnatal brain growth are linked to ASD, underscoring the vast heterogeneity of 
causative factors leading to ASD diagnoses. ASD-risk genes, their associated 
disorders and the neurodevelopmental processes they affect are shown in Table 
1.1. 
1.2 Alterations in neurogenesis in ASD 
1.2.1 Increased neuronal proliferation and macrocephaly in ASD 
A growing body of literature has provided strong evidence that subsets of 
individuals with ASD show aberrant brain growth patterns. In these cases, 
cerebral size is normal at birth but followed by a period of abnormal overgrowth 
and a subsequent period of regression compared to normal controls. Recent 
studies have shown an abnormal increase in the number of neurons in the 
prefrontal cortex, suggesting that an increase in cerebral size in autism may be 
driven by excess neuronal production (Courchesne et al, 2011). Additionally, 
children diagnosed with ASD sometimes show regions of abnormal laminar 
positioning of cortical projection neurons (Wegiel et al, 2010). Both the 
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development of proper lamination and the number of cortical neurons rely on 
temporally controlled proliferation of neural progenitors, therefore defects in 
neural progenitors may underlie ASD subtypes associated with overgrowth in the 
developing brain. 
Projection neurons comprise roughly 80% of neurons in the cortex and 
when taking into account their dendrites, axons, myelin and synapses, they 
indeed could contribute to an increase in gray and white matter volumes in 
children with ASD. Indeed, this theory has recently been supported with the 
comparison of neuron numbers in postmortem tissue from autistic and normal 
children, with a surprising 67% more neurons detected in the prefrontal cortex of 
autism patients (Courchesne et al, 2011). An aberrant increase in neuron 
numbers during prenatal neurodevelopment supports a role for the disruption of 
neurogenesis, which in humans occurs largely during the late embryonic and 
early fetal period, from gestational weeks 7 - 20. Because new cell generation is 
estimated to outnumber cell elimination by at least 100-fold in the developing 
brain, the role of cell death in macrocephaly seems to be negligible during this 
period (Rakic and Zecevic, 2000). 
Proper developmental neurogenesis depends upon the tightly regulated 
balance between symmetric divisions of radial glial cells, which produce more 
radial glial cells, and asymmetric divisions, which generate intermediate 
progenitors and post-mitotic neurons. Newly formed projection neurons, 
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principally generated via symmetric divisions of intermediate progenitors in the 
sub-ventricular zone (SVZ), migrate radially outward to establish the six-layered 
neocortex in an “inside-out” fashion. This mode of migration forms deeper layer 
neurons first, followed by later born neurons that migrate to form the outer 
cortical layers (Gupta et al, 2002; Kriegstein and Noctor, 2004; Nadarajah and 
Parnavelas, 2002). Thus, alterations in neurogenesis could lead to changes in 
the total number of neurons yielded from the progenitor populations, and/or in the 
overall laminar structure. For example, a study identified abnormalities in cortical 
lamination and excess neuronal numbers in seven out of eight ASD cases that 
they examined, via magnetic resonance imaging (MRI) and postmortem 
histology (Hutsler et al, 2007). Cerebral dysplasia in multiple regions has been 
reported in ASD cases, indicative of dysregulated neurogenesis, neuronal 
migration and/or maturation (Wegiel et al, 2010). Additionally, Stoner et al. 
identified regions of disorganized cortical lamination in ten out of the eleven ASD 
cases they examined (Stoner et al, 2014). These studies have provided strong 
support for the theory of altered neural progenitor proliferation as a key 
dysregulation in ASD associated with macrocephaly and cortical lamination 
defects. Although astrocytes are generated from the same progenitor pool as 
neurons, the underlying cause of macrocephaly may be largely due to increased 
numbers of cortical projection neurons, as an associated increase in glia cells is 
not observed (Courchesne et al, 2011; Morgan et al, 2014). Similarly, cerebral 
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white matter, largely composed of myelinated axons of cortical projection 
neurons and glia, has not been found to be significantly increased in ASD 
patients with macrocephaly (Friedman et al, 2006; Hazlett et al, 2005). These 
findings suggest a preferential up-regulation in neuronal differentiation and 
proliferation in ASD.  
The phosphatase and tensin homolog (PTEN) gene was the first gene to 
be clearly linked to macrocephaly in autism (Butler et al, 2005; Buxbaum et al, 
2007; Goffin et al, 2001; Varga et al, 2009). Pten was originally identified as a 
tumor suppressor and key negative regulator of phosphatidylinositol 3-kinase 
(PI3K) signaling, with Pten mutations found in a variety of cancers that affect 
cellular proliferation and cell cycle arrest (Zhao et al, 2004). In Pten-deficient 
mouse models, enhanced levels of phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3) lead to activation of protein kinase B (AKT) and downstream mammalian 
target of rapamycin (mTOR). The mTOR pathway is well known for its ability to 
regulate cell growth and proliferation and consistently Pten-deficient animals 
show neuronal over-growth, brain enlargement, seizures, and premature 
death (Garcia-Junco-Clemente and Golshani, 2014; Kwon et al, 2006; Ogawa et 
al, 2007). 
Chromodomain helicase DNA-binding protein 8 (CHD8) has emerged as a 
key ASD-linked gene. Strikingly, 80% of individuals carrying CHD8 alleles with 
mutations exhibit macrocephaly, a significantly higher percentage than total 
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macrocephaly cases in ASD patients without CHD8 mutations (Bernier et al, 
2014). Using a mouse model, Katayama et al. have shown increased brain 
weight, mirroring the macrocephaly observed in humans. Using transcriptome 
analysis of the entire brain, the authors concluded that major targets of Chd8 
were genes regulated by the RE-1 silencing transcription factor (REST), which is 
a transcriptional repressor of neuronal genes (Katayama et al, 2016). 
WD repeat and FYVE domain containing 3 (WDFY3) was identified 
through surveys of de novo variants linked to ASD (Iossifov et al, 2014; Iossifov 
et al, 2012), which is implicated in macrocephaly and altered neural progenitor 
proliferation. Wdfy3 is a scaffold protein, involved in macroautophagy of large 
aggregation-prone proteins (Filimonenko et al, 2010). Loss of Wdfy3 expression 
in mice has pronounced effects on neural progenitor proliferation and neuronal 
migration. Wdfy3 mutant mice also display macrocephaly resulting from a shift of 
radial glia divisions from asymmetric to symmetric (Orosco et al, 2014). This shift 
in the proliferative mode of radial glial divisions ultimately increases the neuronal 
progenitor population and therefore, the cerebral size. The mechanism by which 
Wdfy3 exerts control over cellular division remains uncertain, but expression 
analyses have shown that it is up-regulated in neural progenitors during 
mitosis (Orosco et al, 2014), possibly acting on the autophagic degradation of 
specific proteins required for cell cycle control, ultimately resulting in a shortened 
cell cycle in Wdfy3 mutant mice. Additionally, because progenitor expansion and 
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neurogenesis initiates anterolaterally and concludes posteromedially (Caviness 
et al, 2009), Wdfy3 mutant mice show a more pronounced affect in the 
anterolateral areas. This finding is in line with some MRI studies of brains of ASD 
children, in which temporal and frontal cortical areas showed the largest size 
increases (Carper et al, 2002; Hazlett et al, 2005; Schumann et al, 2010). 
Notably, these region-specific changes in cerebral overgrowth may be linked to 
the core behavioral symptoms observed in ASD. In humans, these areas contain 
the superior temporal sulcus, orbitofrontal and ventrolateral prefrontal cortex and 
the insula of the temporal cortex, which are key regions involved in sociability, 
reward, reinforcement and emotional processing that are largely affected in ASD 
patients (Gasquoine, 2014; Gotts et al, 2012; Pelphrey and Carter, 2008; 
Redcay, 2008). 
The association of macrocephaly with specific clinical phenotypes in ASD 
has been inconsistently reported in previous studies and some have described a 
higher level of functioning in children with macrocephaly and ASD in comparison 
to those with normal head circumference (Courchesne and Pierce, 2005; Sacco 
et al, 2007). Larger head circumferences have been found in ASD patients with 
special abilities, compared to those without special abilities (Ben-Itzchak et al, 
2013). However, other studies have found no correlation between head 
circumference and cognitive abilities (Ben-Itzchak and Zachor, 2007; Gillberg 
and de Souza, 2002). 
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1.2.2 Genes associated with mitotic dysregulation of neural progenitors 
and microcephaly in ASD 
Although macrocephaly has been widely studied, microcephaly has been 
investigated less in individuals with ASD. Previous studies have reported an 
increased prevalence of microcephaly in ASD, up to 20% of cases, in 
comparison to 3% reported in the general population. Additionally, microcephaly 
is more frequent in individuals with ID and higher ASD severity  (Ben-Itzchak et 
al, 2013; Cody et al, 2002; Fombonne et al, 1999; Miles et al, 2005). 
Autosomal recessive primary microcephaly (MCPH) is a disease 
characterized by an abnormally small head circumference that manifests during 
prenatal development (Tunca et al, 2006). The underlying microcephaly has a 
prominent effect on forebrain development and is accompanied by ID (Bond et al, 
2003; Roberts et al, 2002). Mutations in genes that localize to the centrosome 
are known to result in the development of MCPH (Kaindl et al, 2010), including 
Microcephalin 1 (MCPH1). MCPH1 is a gene expressed during fetal development 
and mutations in MCPH1 produce microcephaly (Jackson et al, 2002; Jackson et 
al, 1998). Studies have found rare variants in the MCPH1 gene that are 
associated with ASD (Neale et al, 2012; Ozgen et al, 2009), and play a role in 
chromosome condensation, DNA-damage repair and the transcriptional 
regulation of DNA-damage genes (Richards et al, 2010; Thornton and Woods, 
2009). Mechanistically, it has been shown that Mcph1 regulates neuroprogenitor 
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division by coupling centrosomal maturation and mitotic spindle orientation with 
mitotic entry (Gruber et al, 2011). 
 Abnormal Spindle Primary Microcephaly (ASPM, MCPH5) has been 
implicated in spindle organization, spindle orientation, mitotic progression, and 
cytokinesis (Fish et al, 2006; Higgins et al, 2010; Passemard et al, 2009; 
Passemard et al, 2016). Aspm mutant mice display mild microcephaly without 
increases in apoptosis, supporting that aberrations in embryonic neural 
progenitor proliferation underlie MCPH (Pulvers et al, 2010). Additionally, Aspm 
is a positive regulator of the Wnt signaling pathway (Major et al, 2008), and over-
expression of β-catenin, a positive transdcuer of the Wnt pathway, can rescue 
neurogenesis deficits in mice (Buchman et al, 2011). 
Mutations in WD Repeat Domain 62 (WDR62) are associated with 
microcephaly and other cortical abnormalities in humans (Bilguvar et al, 2010; Yu 
et al, 2010). Wdr62 deficient mice have reduced brain size due to decreased 
neural progenitor cell populations cells show mitotic spindle instability, mitotic 
arrest and cell death after loss of Wdr62 expression (Chen et al, 2014). 
Mutations or loss of Wdr62 expression therefore leads to mitotic delay and death 
of neural progenitor cells, thereby resulting in microcephaly. 
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1.3 Alterations in neuron migration in ASD 
1.3.1 Excitatory projection neuron migration 
The position of neurons within defined layers of the cerebral cortex is dependent 
upon their birth-date and their proper movement from their place of origin to their 
accurate laminar location. The six layers of the cerebral cortex are composed of 
neurons that are born in different areas but are subsequently organized 
according to their birth dates (Angevine and Sidman, 1961). Neurons born 
relatively late during neurogenesis reside in more superficial layers above earlier 
born neurons, due to an “inside-out” mode of neuronal migration. Early in 
development, multipolar neurons usually move using cellular locomotion. Later, 
neurons migrating along this route attach to radial glia, which provide a scaffold 
for directed migration (Ayala et al, 2007; Hatten, 1999; Kriegstein et al, 2004; 
Rakic, 1972). Neurons migrating along radial glia exhibit a bipolar structure and 
once these cells reach their correct laminar position, they detach from the radial 
glia and continue to move into their final location (Figure 1.1). Additionally, 
daughter neurons in different cortical layers that were generated from the same 
mother progenitor are radially aligned in minicolumnar structures, which 
ultimately become highly connected during later stages of development most 
likely constituting a functional unit in the brain (Gao et al, 2013). 
 Studies have shown that defects in neuronal migration are associated with 
changes in neuron density and soma size, irregular minicolumns, and 
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heterotopias (mis-localized neurons) (Chen et al, 2015; DiCicco-Bloom et al, 
2006; Reiner et al, 2016; Uppal et al, 2014). In humans for example, two 
separate studies have demonstrated evidence of aberrant cell patterning in the 
boundary of cortical gray–white matter, suggesting defects in neuronal 
migration (Avino and Hutsler, 2010; Hutsler et al, 2007). In another study, 
abnormal lamination and cortical disorganization of neurons, but not glia, were 
detected in prefrontal and temporal cortex in the majority of ASD children brain 
samples (Stoner et al, 2014). 
Reelin is one of the best known regulators involved in neuronal 
migration (Folsom and Fatemi, 2013; Sekine et al, 2014). Reelin is a glycoprotein 
secreted from Cajal–Retzius cells in the marginal zone and binds to the 
lipoprotein receptors Apoer2 and Vldlr on the cell membrane of target neurons, 
thereby inducing tyrosine phosphorylation of the adaptor protein Dab1, which 
subsequently initiates intracellular signaling cascades (Forster et al, 2006; Pardo 
and Eberhart, 2007). Reelin is involved in the termination of migration, proper 
neuronal layering, as well as the multi-polar to bipolar transition during the initial 
stages of neuron migration. Studies using postmortem human samples suggest 
aberrant Reelin signaling in ASD patients (Bonora et al, 2003; Fatemi et al, 2005; 
Persico et al, 2001). Reelin mutations in humans produce lissencephaly, 
cerebellar hypoplasia, abnormal cortical neuronal migration and abnormal axonal 
connectivity (Hong et al, 2000). In the well-studied Reelin knockout (KO) mice, 
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neuronal migration abnormalities result in an inversion of cortical 
layering (D'Arcangelo et al, 1995; Falconer, 1951; Hirotsune et al, 1995). 
Behavioral studies in these mice show abnormal gait, social aggression, impaired 
spatial memory, novel-object detection, fear conditioning, and sensorimotor 
reflex (Salinger et al, 2003). 
Reelin seems to also play an important role in dendritic arborization in 
hippocampal and cortical neurons  (Chameau et al, 2009; Hoe et al, 2009; Jossin 
and Goffinet, 2007; MacLaurin et al, 2007; Matsuki et al, 2010; Niu et al, 2004). 
Reelin, and its downstream signaling pathway through Vldrl/Apoer2-Dab1, serves 
to promote dendrite development. Reeler mice carry a mutation in the RELN 
gene and lack Reelin function, have reduced dendritic arborization in the 
hippocampus (Niu et al, 2004). Additionally, Reelin has been shown to affect 
dendritic growth in cortical neurons in vivo (Hoe et al, 2009) and Reelin injection 
into Reelin-deficient mouse brain explants can promote dendritic growth (Nichols 
and Olson, 2010). The role of alterations in neurite growth and branching and the 
associated ASD-linked genes, are described in detail later. 
T-Box Brain Protein 1 (TBR1) encodes a brain-specific T-box transcription 
factor, which plays an important role in brain development and neuronal 
migration and has been identified as a causative gene for ASD (De Rubeis et al, 
2014; Deriziotis et al, 2014; Neale et al, 2012). Highly expressed in deep layers 
of the cerebral cortex, Tbr1 is involved in the differentiation of intermediate 
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progenitors into early born, post-mitotic neurons (Dwyer and O'Leary, 2001; Han 
et al, 2011; Willsey et al, 2013). Tbr1 target genes include multiple autism risk 
factors (Chuang et al, 2015), including the activation of Autism Susceptibility 
Candidate 2 (AUTS2), which has been identified as an ASD and ID associated 
gene (Bedogni et al, 2010; Srinivasan et al, 2012). Interestingly, TBR1 KO mice 
do not express subplate, layer 6 or Cajal-Retzius cell markers and show a large 
reduction in Reelin expression, however later-born upper cortical layers are 
typically normal (Hevner et al, 2001).  
Multiple mutations within AUTS2 have been identified in patients, strongly 
linking it as a causative factor for ASD (Cheng et al, 2013; Huang et al, 2010; Liu 
et al, 2015; Pinto et al, 2010; Sultana et al, 2002; Talkowski et al, 2012). The 
Auts2 protein is predominantly nuclear localized and evidence suggests a role for 
Auts2 in regulating gene expression during brain development (Bedogni et al, 
2010; Gao et al, 2014; Srinivasan et al, 2012). Binding of Auts2 with polycomb 
repressive complex 1 (PRC1) inhibits PRC1 activity leading to activation of gene 
transcription (Gao et al, 2014). In addition to the nuclear component, there is also 
a cytoplasmic pool of the Auts2 protein, which is involved in the regulation of 
cortical neuronal migration and neurite growth during brain development (Hori et 
al, 2014).  
In a cohort of Amish children, mutations within contactin-associated 
protein-like 2 gene (CNTNAP2) were found to be implicated in ASD and 
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epilepsy (Strauss et al, 2006). CNTNAP2 is a transmembrane scaffolding protein 
and a member of the Neurexin family, whose members have previously been 
associated with multiple ASD-linked proteins (Comoletti et al, 2004; Jamain et al, 
2003). Ectopic neurons were identified in patients with CNTNAP2 mutations, 
suggesting its involvement in the regulation of neuronal migration (Strauss et al, 
2006). Additionally, CNTNAP2 mutations are linked to seizures, epilepsy and 
ADHD, pathologies that are also commonly found in ASD patients (Elia et al, 
2010; Jackman et al, 2009; Mefford et al, 2010). Additionally, CNTNAP2 has 
been associated with abnormal social interactions and impaired language 
processing (Condro and White, 2014; Toma et al, 2013; Whalley et al, 2011). 
CNTNAP2 KO mice show ectopic neurons in the corpus callosum and mis-
localization of the Cux1-positive upper layer neurons in the deep layers V–
VI (Penagarikano et al, 2011). CNTNAP2 is part of a neuron-glia adhesion 
complex with contactin 2, therefore it play may play a key role in radial glia-
guided neuronal migration  (Denaxa et al, 2001; Poliak et al, 1999). 
Astrotactin 1 (ASTN1) is a neuronal cell surface antigen that regulates 
neuron-glia interactions and has been show to play an important role in neuron 
migration (Edmondson et al, 1988; Zheng et al, 1996). Astn1 KO mice have 
slower cerebellar granule cell migration, decreased glia-neuron interactions, 
abnormal Purkinje cell morphology, and impaired balance and coordination 
compared to wild type mice (Adams et al, 2002). Astn1 interacts with and 
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regulates Astn2 expression on the neuronal membrane, thereby affecting 
neuronal adhesion to glia during migration (Wilson et al, 2010). Genome wide 
association studies identified ASTN2 as an ASD candidate gene (Lesch et al, 
2008). Patients with ASTN2 deletions are often classified with ASD or other co-
morbid diagnoses such as ADHD, obsessive compulsive disorder and delayed 
language development (Lionel et al, 2014).  
NudE nuclear distribution E homolog (NDE1) is a gene involved in brain 
disorders. The Nde1 protein is involved with regulation of neuron proliferation, 
migration, and intracellular transport as part of the Lis1/Nde/Ndel1/cytoplasmic 
dynein complex (Feng et al, 2000; Kitagawa et al, 2000; McKenney et al, 2010; 
Niethammer et al, 2000; Sasaki et al, 2000). LIS1 (Lissencephaly 1) was the first 
gene identified with an involvement in disrupted neuron migration (Reiner et al, 
1993) via its interactions with cytoplasmic dynein, Nde1, Ndel1, and cytoplasmic 
linker protein 170 (CLIP-170) (Coquelle et al, 2002; Reiner, 2000). Multiple 
studies have shown a major role for Lis1 in regulating neuronal 
migration (Cahana et al, 2001; Hippenmeyer et al, 2010; Tsai et al, 2007) and a 
cross between an Nde1 KO mouse with Lis1 heterozygous mouse produced a 
severe disruption of the morphology of the ventricular zone progenitors and radial 
glia, as well as a significant decrease in brain size (Pawlisz et al, 2008). This was 
shown to be regulated via stabilization of the dystrophin/dystroglycan 
glycoprotein complex (Pawlisz and Feng, 2011) and an alteration of the MAPK 
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scaffold protein Kinase Suppressor of Ras (KSR), subsequently producing 
hyperactivation of MAPK/ERK pathway (Lanctot et al, 2013). In support of these 
findings, additional studies have shown that dysregulation of the MAPK/ERK 
pathway affects social behavior in mice and produces ASD phenotypes, while 
multiple links between ASD and hyperactivation of the Ras signaling have been 
reported (Crepel et al, 2011; Faridar et al, 2014; Levitt and Campbell, 2009; 
Rauen et al, 2010). 
1.3.2 Inhibitory neuron migration 
Interneurons, which are primarily inhibitory, utilize a different mode of migration 
known as tangential migration, and migrate tangentially into the neocortex and 
across the plane of radial glia fibers (Ayala et al, 2007; Kriegstein et al, 2004; 
Lavdas et al, 1999; Marin et al, 2001; Nery et al, 2002). Once interneurons reach 
the cerebral cortex, they migrate along radial glia to their proper laminar 
position (de Carlos et al, 1996; Polleux et al, 2002; Poluch and Juliano, 2007; 
Wichterle et al, 2001). Therefore, when radial glia-mediated migration is 
disrupted, the position of inhibitory neurons in the cerebral cortex will also be 
affected.  
Distal-less homeobox (Dlx) genes belong to the family of homeodomain 
transcription factors closely related to the Drosophila distal-less (Dll) 
gene (Panganiban and Rubenstein, 2002). Dlx1/2 are largely expressed in the 
ganglionic eminences (GE) with strongest expression in the medial ganglionic 
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eminence (MGE) of the developing brain and play a crucial role in controlling the 
tangential migration of GABAergic neurons from the MGE to the cortex. Dlx1 KO 
mice exhibit a reduction in inhibitory neurons and develop late-onset epilepsy, a 
commonly observed pathology observed in ASD patients (Cobos et al, 2005). 
Dlx1/Dlx2 double KO mice show major aberrations in the migratory stream of 
GABAergic neurons and also an accumulation of neuronal precursors in the 
GE (Anderson et al, 1997; Ghanem et al, 2007). Arx, an X-linked homeobox 
gene and immediate downstream target of Dlx, may regulate Dlx’s role in 
tangential neuronal migration (Colasante et al, 2008). Patients identified with 
mutations in Arx display ID, autistic features and epilepsy (Stromme et al, 2002; 
Turner et al, 2002). 
1.4 Alterations in neurite growth and spine formation in ASD 
Neurons are highly specialized cells with distinct morphologies composed of 
three main compartments: the cell body (soma) containing the nucleus and the 
majority of the cellular organelles; a long axonal process to transmit information; 
and a complex dendritic arbor to receive information from neighboring neurons. 
Of the three compartments, dendrites are the most morphologically complex and 
occupy a large volume in neural tissues (Tahirovic and Bradke, 2009).  
 Dendrite morphogenesis can be viewed as discreet steps. After birth from 
neural progenitors, neurons start as a simple round soma and must first undergo 
cellular polarization. Neurons first adopt a multipolar morphology with the 
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extension of minor neurites. The movement of migrating neurons is achieved 
through the generation, maintenance, and constant remodeling of microtubules in 
response to extracellular cues and intracellular polarity signals. During migration, 
the cell first extends a leading process. Stabilization of a single neurite is 
required for newly generated neurons to exit the multipolar stage to enter the 
cortical plate. This stabilization ultimately results in formation of the leading 
process while the trailing process eventually develops into the future axon (Shim 
et al, 2008; Witte and Bradke, 2008). Next, in order to move forward, the nucleus 
undergoes a translocation into the stabilized leading neurite. During this process, 
termed nucleokinesis, the attachment of microtubules from the centrosome to the 
nuclear envelope exerts a traction force, pulling the nucleus into the leading 
neurite attached to a radial glia process (Bellion et al, 2005; Tahirovic et al, 
2009).  
 Once neurons reached their destined cortical layers, substantial dendritic 
outgrowth is undertaken to form dendritic arbors characteristic of a neuron 
subtype. At this stage, neurons are tasked with the processes of growing each 
branch to the correct size, initiating a new branch at the right site to complete a 
specific branching pattern, and directing each branch’s growth into an 
appropriate spatial location (Jan and Jan, 2010; Tahirovic et al, 2009). The early 
postnatal stages of neurite growth are depicted in Figure 1.2. 
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Dendrites are vastly different from axons in their ultimate morphology, 
function and developmental processes. In mammalian neurons, a notable 
distinction is the manner in which the microtubules are organized. Initially all 
neurites contain microtubules oriented with their plus-end localized distally from 
the soma. The neurite specified to become the axon will maintain this distal plus-
end orientation, while neurites that become dendrites will adopt a mixed 
orientation (Baas et al, 1989; Baas et al, 1988; Burton, 1988). Additionally, 
compared to axons, dendrites have an enrichment of cellular organelles that are 
transported with the aid of microtubule motors like dynein, such as Golgi outposts 
and mitochondria, which are utilized for membrane and protein supply necessary 
for their growth (Horton et al, 2005; Horton and Ehlers, 2004; Kapitein et al, 
2010).  
 The morphology of the dendritic arbor is largely established during early 
embryonic development; however, dendrites are dynamic and they maintain the 
overall morphology with various maintenance mechanisms throughout adult life. 
Disruptions in either the early developmental phase, or during the later 
maintenance phase can be deleterious, leading to aberrant neuronal network 
function. Abnormalities in neuronal connectivity between the higher-order 
association areas have been considered one of the major defects in 
ASD  (Geschwind and Levitt, 2007). MRI studies have shown both large-scale 
and small-scale changes in the neuronal connectivity; however, the 
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neurobiological basis for this disconnectivity remains to be fully 
elucidated (Casanova and Casanova, 2014; Maximo et al, 2014). A great deal of 
autism research has been on dendritic development, although mainly on the 
aspects concerning spine morphology and synapse function, which will be 
discussed in detail below (Bourgeron, 2009; Kelleher and Bear, 2008; Persico 
and Bourgeron, 2006). However, the current body of research suggests that this 
is not the only morphological defect, as children with autism are frequently 
identified to with large-scale anatomical abnormalities, suggesting dysregulation 
in dendritic growth and development. For example, both macrocephaly and 
microcephaly are present in autistic children, with 15% of autistic individuals 
presenting with macrocephaly, while 20% present with microcephaly (Cody et al, 
2002; Fombonne et al, 1999; Lainhart et al, 1997; Pardo et al, 2007).  
 One of the proposed causes leading to macrocephaly has been suggested 
to be a result of increased dendrite number and size, which may be a product of 
increased dendritic branching, and/or decreased dendritic pruning (Jan et al, 
2010). Although other factors can contribute to increased brain and head size, 
including the number and size of neurons and glia, the number of dendrites 
seems to be a more reasonable explanation, at least in some cases of 
macrocephaly. Brain volumes in newborns with autism are generally of normal 
size, but they display aberrant overgrowth during the postnatal period. This later 
timing of increased brain size cannot be fully explained by an increase in the 
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number of neurons resulting from dysregulated neurogenesis, as the largest 
areas of the brain have mostly completed this process prior to birth, except for 
regions such as the hippocampus where limited neurogenesis continues 
postnatally (Ming and Song, 2005; Zhao et al, 2008). This timing can be well 
explained by an increase in dendritic branching, a process which largely occurs 
after birth in most of the brain. In humans, neurons continue to grow and branch 
dendrites, axons and synapses until age 5, with experience-based remodeling of 
synapses until the age of 20 (Pescosolido et al, 2012; Stiles and Jernigan, 2010; 
Tau and Peterson, 2010). Dendrites continue to extensively grow after birth, in an 
activity-dependent manner. Therefore, a large portion of brain volume increase in 
the early postnatal period is likely due to increased dendritic growth (Redmond et 
al, 2002).  
Previous genetics studies have identified a large number of high-risk 
genes for autism that are involved in diverse functions, including synapse 
formation and function, membrane trafficking, as well as growth cone motility and 
neurite development (Bakos et al, 2015; de Anda et al, 2012; Miao et al, 2013; 
Volders et al, 2011). Recently, it has been estimated that 88% of genes 
considered to be high-risk for autism are involved in early neurodevelopmental 
processes such as neuronal induction and neuroblast differentiation. Importantly, 
~80% of these genes regulate later stages of neuronal development such as 
neurite growth and synapse formation (Casanova et al, 2014).  
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Dendrites on a single neuron can contain hundreds to thousands of spines 
and a typical mature spine has a single synapse located at its head. Spines and 
synapses are produced in excess numbers during development, but synaptic 
numbers are later fine-tuned through activity-dependent stabilization or 
elimination (Changeux and Danchin, 1976). Spines are highly dynamic and 
undergo constant turnover and morphological plasticity with a dependency on 
both developmental stage and activity.  
Based on their morphology, dendritic spines are typically classified as thin, 
stubby and mushroom, with the latter considered more mature. Mushrooms and 
stubby spines are stable, persist for long periods of time, and form strong 
excitatory synapses (Kasai et al, 2003; Trachtenberg et al, 2002), while thin 
spines are very motile, unstable, and often transient, representing weak or silent 
synapses (Rochefort and Konnerth, 2012). Actin and actin-binding proteins are 
enriched in dendritic spine heads and F-actin dynamics play a key role in spine 
formation and structural dynamics (Chazeau and Giannone, 2016). Previous 
studies have shown that dendritic spine morphogenesis is a major cellular 
process affected in autism (Bourgeron, 2009; Kelleher et al, 2008; Phillips and 
Pozzo-Miller, 2015). Using Golgi staining, postmortem analysis of cortical 
projection neurons from autistic patients shows a higher dendritic spine density 
compared to normal patients (Hutsler and Zhang, 2010). Some of the high-risk 
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autism genes implicated in dendritic growth and branching spine formation and 
synapse maturation are described below. 
Methyl CpG binding protein 2 (MECP2) is an X-linked gene coding for a 
protein that binds to methylated DNA, which has been reported to function both 
as transcriptional activator and repressor (Chahrour et al, 2008). Mutations in 
MeCP2 were initially identified as the genetic cause for Rett syndrome 
(RTT) (Amir et al, 1999), a neurodevelopmental condition characterized by 
speech and motor function impairments, cognition deficits, and autism. RTT is 
typically caused by loss-of-function mutations in MeCP2; however, there are rare 
cases that are also caused by MeCP2 duplications.  
Using Golgi staining in brain slices from MeCP2 KO mice, reductions in 
dendritic growth and branching have previously been reported in both apical and 
basal arbors of motor cortical neurons (Kishi and Macklis, 2004; Stuss et al, 
2012). Additionally, to investigate MeCP2 duplication, mice over-expressing the 
human MeCP2 gene have shown excessive dendritic branching, indicating that 
MeCP2 over-expression can induce dendritic overgrowth (Jiang et al, 2013). It is 
possible that in subtypes of neurons MeCP2 may act as activator during dendrite 
development, but as repressor in other neurons, or during different 
developmental stages. For example, it could act as activator in early dendrite 
morphogenesis and as a repressor later during dendrite maintenance. An 
important aspect to these findings is that MeCP2 overexpression affects only 
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dendrites, while leaving axon growth intact, suggesting a selective role of MeCP2 
in dendrite development. Recent work has provided evidence for the role MeCP2 
plays in dendritic development, showing that MeCP2 can regulate gene 
expression post-transcriptionally. According to this study, MeCP2 controls 
microRNA (miRNA) processing via a direct interaction with DiGeorge syndrome 
critical region 8 (DGCR8), which is involved in mediating the genesis of miRNAs 
thought to regulate dendrite morphogenesis (Cheng et al, 2014; Gregory et al, 
2004).  
RTT animal models have shown that loss of MeCP2 protein affects the 
number of excitatory hippocampal synapses and changes in synapse numbers. It 
has also been widely reported that loss of the X-linked RTT protein MeCP2 in 
mice, results in abnormal dendritic spine morphology as well as decreased spine 
density (Chapleau et al, 2012; Stuss et al, 2012; Zhou et al, 2006). Additionally, 
MeCP2 over-expression produces dendritic overgrowth in mice and these 
animals show a greater rate of spine gain and loss, with a bias toward spine 
elimination (Jiang et al, 2013; Jugloff et al, 2005). Taken together, MeCP2, the 
established factor underlying RTT with autism, has a clear role in dendritic 
morphogenesis and synapse formation, both of which should play a major role in 
the cognitive deficits observed in RTT patients. 
Fragile X mental retardation gene 1 (FMR1) is causative factor for the 
single-gene disorder Fragile X syndrome (FXS), which is characterized by mental 
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retardation with 15–30% of patients also displaying autism phenotypes (Kelleher 
et al, 2008; Krawczun et al, 1985; Persico et al, 2006; Santoro et al, 2012). FXS 
is typically results from an expansion of a CGG triplet in the 5’-UTR region of the 
FMR1 gene, but a small number of deletions and missense mutations have also 
been reported (Santoro et al, 2012). Fragile X mental retardation protein (FMRP), 
the FMR1 gene product, plays an key role in negatively regulating translation, 
especially local translation at the synapse (Santoro et al, 2012). In terms of 
FMRP’s role in dendritic development, studies in mice have produced somewhat 
contradictory data. In visual cortex pyramidal neurons of FMR1 KO mice, one 
study has shown defects in dendritic spines, with no observable changes in 
dendritic morphology (Irwin et al, 2002). Conversely, multiple other studies have 
shown that FMRP is critical for dendritic growth and branching. In FMR1 KO 
mice, visual cortex pyramidal neurons show reduced basal dendrite length and 
branching (Restivo et al, 2005). Using neural stem cells from brains of FMR1 KO 
mice, or from postmortem tissues of FXS human fetuses, differentiated neurons 
showed fewer and shorter neurites with smaller cell bodies (Castren et al, 2005). 
It is important to note that these studies involved loss-of-function or deletion of 
FMRP; however, FXS in humans is rarely caused by deletions or missense 
mutations in the FMR1 gene, but rather via an expansion of the CGG triplet 
repeat. This has been addressed in studies using transgenic mice with a FXS 
knock-in mutation consisting of 120-140 CGG repeats. Indeed, these animals 
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display significantly impaired dendritic morphogenesis in addition to alterations in 
dendritic spine density and morphology (Berman et al, 2012). Studies from 
Drosophila have elucidated the mechanistic function of FMRP in dendritic growth 
by showing that FMRP is involved in the transport of mRNA encoding the 
GTPase Rac1 inside ribonucleoprotein complexes. In agreement with this, Rac1 
was also found to interact with FMRP and play a role in dendritic branching, 
suggesting that FMRP’s role in dendrite morphogenesis may be in part through 
its interaction with Rac1 (Lee et al, 2003). These findings strongly support a role 
for FMRP in dendritic arbor morphogenesis. 
FMRP is localized within dendrites and in addition to abnormal dendritic 
growth and branching, brains from FXS patients display synaptic 
immaturity (Rudelli et al, 1985). Specifically, FXS patients have a higher density 
of dendritic spines on the distal segments of apical and basal dendrites in 
neocortex and more spines characterized by an immature morphology. 
Additionally, Golgi studies from human FXS patients reveal a significant increase 
in longer dendritic spines with fewer shorter dendritic spines than control subjects 
in multiple cortical areas (Hinton et al, 1991; Irwin et al, 2001). In FMR1 KO 
mouse models, spine phenotypes correlate with those observed in humans with 
FXS. For example, FXS mice have significantly longer dendritic spines and fewer 
short dendritic spines than control mice. Similarly, FXS mice have more dendritic 
spines with an immature morphology and fewer with a more mature 
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morphology (Irwin et al, 2002; Irwin et al, 2001; McKinney et al, 2005). In 
addition, changes in synaptic proteins such as postsynaptic density-95 kDa 
(PSD-95) have been observed in FXS (Ifrim et al, 2015).  
Although FMRP’s role in impaired spine formation and morphology in FXS 
is not yet fully elucidated, FMRP is known to interact with multiple proteins that 
are linked to dendritic and spine regulation. Cytoplasmic FMRP-interacting 
protein 1 (CYFIP1), a functional binding partner of FMRP, is a protein that has 
recently generated interest as its genetic locus is within a hot spot for ASD 
(chr15q11.2). When bound to FMRP, CYFIP1 represses neuronal protein 
synthesis and regulates actin-nucleating activity. This process can therefore 
regulate the formation and retraction, as well as the labiality and shape of 
dendritic spines (De Rubeis et al, 2013). A down-regulation of CYFIP1 mRNA 
has been detected in subgroups of FXS patients that show severe ASD and 
obsessive-compulsive behavior (Nowicki et al, 2007). Over-expression of 
CYFIP1 leads to increased dendritic complexity in vitro, while neurons that are 
haploinsufficient for CYFIP1 show decreased dendritic complexity and an 
increase in the ratio of immature to mature spines in hippocampal 
neurons (Pathania et al, 2014). 
Pten is a phosphatase that dephosphorylates PIP3, and inhibits the 
PI3K/AKT/mTOR pathway (Garcia-Junco-Clemente et al, 2014; Kwon et al, 
2006; Ogawa et al, 2007). Mice lacking Pten selectively in the central nervous 
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system display macrocephaly, neuronal hypertrophy, as well as hypertrophic and 
ectopic dendrites and axons. These phenotypes are accompanied by the 
activation in AKT/mTOR/S6K signaling pathway (Kwon et al, 2006). Pten knock-
out during early development, as well as in adult mice have shown impairments 
in neuronal morphology, suggesting that Pten is not only necessary for proper 
neuronal formation during early cortical development, but also plays an important 
role in dendritic growth and maintenance into adulthood (Chow et al, 2009; Kwon 
et al, 2006). Therefore, Pten, a protein with a clear link to autism, has a definitive 
role in dendrite morphogenesis. 
TSC1 and TSC2 are tumor-suppressing genes that have been linked to 
brain tumors in tuberous sclerosis complex (TSC) (Huang and Manning, 2008). 
However, their involvement in neurodevelopmental disorders including epilepsy, 
autism and ID has become increasingly studied (Kwiatkowski and Manning, 
2005; Persico et al, 2006). In pheochromocytoma 12 (PC12) cells, an inducible 
neuron-like cell line, transfection of TSC1 antisense oligonucleotides was shown 
to increase neurite outgrowth through RhoA activation, while knockdown of Tsc2 
decreased neurite growth (Floricel et al, 2007). In another study, overexpression 
of Tsc1/Tsc2 was found to impair axon formation. Knockdown of Tsc1/Tsc2 in 
vitro induced multiple axons, while genetic deletion in vivo in the mouse induced 
ectopic axons (Choi et al, 2008). There is strong evidence that TSC genes are 
suspected autism-related factors that are involved in neurite development, 
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therefore it will be important to further elucidate their mechanistic role in neuron 
morphogenesis and ASD in future research. 
Mammalian target of rapamycin (mTOR) is an evolutionarily conserved 
serine/threonine protein kinase that controls cell growth and is induced by growth 
factors and environmental cues (Laplante and Sabatini, 2012). mTOR has been 
shown to play a role in shaping the actin cytoskeleton with a particular role in 
dendritogenesis, and proteins that inhibit mTOR have been linked to ASD and 
play major roles in dendritic and spine development (Skalecka et al, 2016; 
Thomanetz et al, 2013), including Pten and Tsc 1/2  (Weston et al, 2014). Pten 
serves to inhibit the PI3K/AKT/mTOR signaling pathway, thereby affecting growth 
and protein translation, and Pten mutations have been discovered in multiple 
individuals diagnosed with ASD. Additionally, mice carrying mutations or genetic 
deletions of Pten show impaired social interactions and increased responses to 
sensory stimuli. Loss of Pten in neurons in the cerebral cortex and hippocampus 
of these mice results in hypertrophic and ectopic dendrites and axonal tracts with 
increased synapses (Kwon et al, 2006; Orloff et al, 2013). Conversely, 
knockdown of Pten in the basolateral amygdala produces a significant decrease 
in spine density, with an increase in mushroom spines and decrease in thin 
protrusions (Haws et al, 2014). Additionally, it has been previously shown that 
the TSC pathway regulates growth and synapse function in neurons, and loss of 
Tsc 2 expression produces an enlargement of neuronal somas and dendritic 
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spines in hippocampal pyramidal neurons of mice and rats (Tavazoie et al, 
2005). These findings provide strong evidence that mTOR, and its interacting 
proteins, are involved in regulating both dendritic and spine development in ASD. 
Neurofibromatosis is a condition in which tumors grow in the nervous 
system. Mutations in Neurofibromatosis-1 (NF1) produce neurofibromas and 
between 30% and 65% of children with NF1 mutations display learning 
disabilities and display significantly higher rates of autism, suggesting a causal 
relationship to autism  (Garg et al, 2013; Rosser and Packer, 2003). 
Neurofibromin, the protein product of the NF1 gene, is a GTPase activating 
protein that negatively regulates the Ras signaling pathway (Costa and Silva, 
2003). NF1 conditional KO mice display impaired dendritic morphogenesis and 
Golgi staining from NF1 KO mouse brains reveals shorter apical dendrites in 
pyramidal neurons. NF1’s function in dendrite morphogenesis has been shown to 
signal through the cAMP/PKA/Rho/ROCK pathway (Brown et al, 2012). The 
RhoA pathway is a major mediator of actin dynamics and neurite outgrowth and 
complexity. Extensively branched processes can be induced when RhoA 
inhibited, and when RhoA is activated, dendrite length and the dendritic field is 
decreased (Li et al, 2000; Nakayama et al, 2000; Wong et al, 2000).  
Ubiquitin protein ligase E3A (UBE3A) is the causative gene for Angelman 
syndrome, a developmental disorder characterized by language impairments, 
ataxia, ID, and hyperactivity (Williams et al, 2006). Individuals identified with 
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Angelman syndrome are often co-diagnosed with autism (Peters et al, 2004; 
Steffenburg et al, 1996). In addition, Ube3A over-expression leads to autism in 
humans and in animal models (Bucan et al, 2009; Noor et al, 2015; Smith et al, 
2011). UBE3A is an imprinted gene that encodes an E3 ubiquitin ligase, which is 
typically expressed from both parental alleles in most tissues, but is only 
expressed from the maternal allele in brain (Mabb et al, 2011). Ube3A has been 
shown to be required for dendrite morphogenesis in the mouse (Miao et al, 2013) 
and shRNA-mediated knockdown of Ube3A in vivo inhibits apical dendrite growth 
in mouse cortical pyramidal neurons (Miao et al, 2013). Additionally, studies in 
Drosophila strongly support a role for Ube3A in dendrite morphogenesis. Both 
loss-of-function and overexpression of the Ube3A Drosophila homologue have 
been shown to result in reduced dendritic branching in larval sensory 
neurons (Lu et al, 2009). These studies suggest that Ube3A plays a significant 
role in dendrite growth and support that dysregulated neuron morphogenesis 
may underlie developmental disorders like Angelman syndrome and ASD. 
Thousand-and-one amino acid kinase 2 (TAOK2) belongs to the family of 
MAP kinase kinase kinases (MAPKKK) and is located in chromosome 16 in a 
region thought to carry susceptibility to autism (Weiss et al, 2008) and 
schizophrenia (McCarthy et al, 2009). Taok1 and Taok2 activate the mitogen-
activated protein kinase (MAPK) pathways JNK and p38 which results in 
regulation of gene transcription  (Chen and Cobb, 2001; Chen et al, 2003). 
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Additionally, Taok2 mRNA is regulated by FMRP (Darnell et al, 2011), the 
causative factor for FXS, providing an additional link to its involvement in 
neurodevelopmental disorders. A recent study in vivo has shown that knockdown 
or overexpression of Taok2 showed opposing effects on basal dendrite 
development in the neocortex (de Anda et al, 2012). Specifically, the number of 
primary dendrites was decreased after Taok2 knockdown, while primary 
dendrites were increased with overexpression. Additionally, this effect was found 
to be selective on basal dendrites, as Taok2 knockdown did not affect apical 
dendrite branching on the same neurons. This function of Taok2 was dependent 
on interactions with Neuropilin 1, a receptor that binds the secreted guidance 
molecule Semaphorin 3A, which leads to downstream activation of JNK 
signaling (de Anda et al, 2012). Interestingly, this finding shows that Taok2 
expression selectively affects specific dendritic areas, i.e. the basal dendrites, 
providing evidence that specialized molecular pathways are used for the 
formation of different dendritic areas. Finally, as Taok2 signals through cascades 
such as JNK and p38, there could be multiple possibilities for the exact 
mechanisms in which Taok2 may affect dendrite development and which might 
be behind the phenotypes observed in autism and schizophrenia. 
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1.5 The synapse  
Synapses are highly specialized structures required for signal transduction and 
plasticity within neuronal networks, making up the functional contact sites 
between neurons. A synapse is composed of an axon terminal, the presynapse, 
the synaptic cleft containing extracellular matrix proteins and adhesion 
molecules, and the postsynaptic density with receptors on a target neuron’s 
dendrites. The presynapse contains mitochondria and is characterized by a pool 
of synaptic vesicles filled with neurotransmitters. Action potentials arriving at the 
axon terminal mediate calcium influx, which causes the vesicles to fuse with 
specialized regions of the plasma membrane called active zones to release their 
content into the synaptic cleft. A precise coupling between the electrical stimulus 
(action potential) and release of neurotransmitter is crucial for proper signal 
transmission to the postsynaptic neuron. The postsynapse is characterized by 
the presence of receptors that bind neurotransmitters released from the 
presynapse, which initiates signaling cascades that ultimately propagate the 
electrical signal in postsynaptic neuron. Receptors are clustered in a region 
called the postsynaptic density (PSD) in the excitatory synapse.  
 Synapses are classified as excitatory and inhibitory, depending on 
whether they use glutamate or γ-aminobutyric acid (GABA) as their main 
neurotransmitter, respectively. Additionally, the formation and structure of 
excitatory and inhibitory synapses is uniquely different. Whereas excitatory 
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synapses are found on dendritic spines, inhibitory synapses are formed directly 
on the dendritic shaft. Additionally, both excitatory and inhibitory synapses have 
distinct proteomic profiles to specialize each synapse with the appropriate 
receptors and signaling molecules. Synaptic dysfunctions, whether they arise 
from functional mutations in pre- or postsynaptic proteins, are a common 
underlying pathology in ASD and are discussed in detail below. 
1.5.1 Presynaptic proteins linked to ASD  
Neurexins (NRXN) are a family of synaptic adhesion proteins that are 
located on the presynaptic membrane and bind to their postsynaptic partners, 
neuroligins (NLGNs). The NRXN family consists of three genes (NRXN1, 
NRXN2, and NRXN3) and rare copy number variations and/or point mutations in 
NRXN genes have been repeatedly identified in ASD diagnoses (Autism 
Genome Project et al, 2007; Bremer et al, 2011; Feng et al, 2006; Yangngam et 
al, 2014). In addition to being associated with ASDs, NRXN1 deletions have 
been reported in other psychiatric conditions, such as schizophrenia, bipolar 
disorder, ADHD, and Tourette syndrome (Guilmatre et al, 2009; International 
Schizophrenia, 2008; Lionel et al, 2011; Sundaram et al, 2010; Zhang et al, 
2009). 
NRXN1α KO mice exhibit impaired excitatory synaptic strength, with a 
decrease in the input–output relationship of evoked postsynaptic potentials and 
miniature excitatory postsynaptic current (mEPSC) frequency (Etherton et al, 
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2009). In behavioral tests, NRXN1 KO mice display increased grooming behavior 
but no change in social behavior or spatial learning tasks (Etherton et al, 2009). 
Studies in α-NRXN triple KO mice, where all three α-NRXNs (Nrxn1α/2α/3α) 
were deleted, showed synapse formation was normal but α-Nrxns were required 
to couple Ca2+ channels to vesicle exocytosis (Missler et al, 2003).  
The synapsins (SYN) are a family of presynaptic proteins involved in 
vesicle-mediated neurotransmitter release and neurite outgrowth (Rosahl et al, 
1995). The synapsin family of proteins contains three members in mammals 
(synapsin 1, synapsin 2, and synapsin 3), which are located on chromosomes 
Xp11.23, 3p25.2, and 22q12.3, respectively. Cultured neurons from SYN1/2/3 
triple KO mice display severely altered synaptic vesicle localization and a 
significant decrease in synaptic vesicle number (Fornasiero et al, 2012). 
Mutations in SYN1 (A51G, A550T, Q555X and T567A) have been identified in a 
French-Canadian family with epilepsy and autistic phenotypes, suggesting its link 
as a causative factor for ASD  (Fassio et al, 2011). Additionally, the Q555X 
nonsense mutation can reduce CaMKII and MAPK/ERK activity, which regulates 
the trafficking of synaptic vesicles and neurite outgrowth, and the missense 
mutation of A550T and T567A has been shown to impair synapsin targeting to 
nerve terminals (Fassio et al, 2011).  
In synapsin KO mice, studies have shown behavioral deficits in social 
novelty and avoidance behavior in social approach as well as epileptic activity, all 
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of which are typical in ASD (Greco et al, 2013; Ketzef and Gitler, 2014). SYN1/3 
double KO mice show impaired social transmission of food preference, while 
SYN1/2 double KO mice display decreased environmental interest. Additionally, 
SYN2 KO mice have deficits in short-term social recognition and have increased 
self-grooming behavior (Greco et al, 2013). These results demonstrate an 
involvement of synapsins in the development of behavioral traits typical of ASDs 
and the underlying synaptopathy in developmental disorders. 
1.5.2 Postsynaptic proteins linked to ASD  
Neuroligins (NLGN) are postsynaptic cell adhesion proteins that bind to 
presynaptic NRXNs and play an important role in synapse formation and 
function. The human Nlgn family contains five NLGN genes (NLGN1/2/3/4/4Y). 
Nlgns contain a large extracellular domain that shows sequence homology with 
acetylcholinesterase and is necessary for binding to β-Nrxn during synapse 
formation (Dean and Dresbach, 2006). Nlgns-1, -3, and -4 are localized to 
glutamatergic synapses, while Nlgn2 localizes to GABAergic synapses (Missler 
et al, 2003) Previous studies have shown that overexpression of Nlgn1 can 
increase excitatory synaptic strength and the synaptic NMDAR/AMPAR ratio both 
in vitro and in vivo (Schnell et al, 2012). Conversely, Nlgn2 overexpression 
increases inhibitory synaptic strength. Additionally, Nlgn1 expression selectively 
increases the maturation but not initiation of synaptogenesis of excitatory 
synapses in adult-born neurons (Chubykin et al, 2007; Schnell et al, 2012). 
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Shank family proteins, also known as ProSAP, are synaptic scaffold 
proteins that bind Nlgn-Nrxn and NMDAR complexes at the PSD of excitatory 
glutamatergic synapses. Shank contains multiple protein-protein interaction 
domains, including ankyrin repeats that bind to α-fodrin to link the actin 
cytoskeleton and calpain/calmodulin-mediated Ca2+ signaling, an SH3 domain 
that binds to glutamate receptor-interacting protein (GRIP) to link AMPA 
receptors to the postsynaptic scaffold, a PDZ domain that binds multiple proteins 
within the postsynaptic density, a proline-rich region domain that contains sites 
for Homer and cortactin, and a sterile alpha motif domain which is involved in the 
polymerization of Shank proteins (Lim et al, 1999; Yoo et al, 2014).  
There are three genes that encode Shank proteins (SHANK1, SHANK2, 
and SHANK3). All Shank proteins are expressed in the brain but exhibit different 
patterns. Shank1 is expressed in most parts of the brain, except for the striatum, 
and it is highly expressed in the cortex and hippocampus. Shank2 and Shank3 
are also present in the cortex and hippocampus. Shank2 is mostly absent from 
the thalamus and striatum, whereas Shank3 appears to be predominantly 
expressed in those regions. In the cerebellum, Shank2 is restricted to Purkinje 
cells, whereas Shank3 is restricted to granule cells (Sheng and Kim, 2000). 
Shank directly or indirectly binds to Nlgns in the PSD. In vitro and in vivo studies 
highlight the important role of Shank3 for synaptic function. Shank3 functions as 
a scaffolding protein in spine morphogenesis and synaptic plasticity and 
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knockdown of Shank3 in cultured hippocampal neurons leads to a reduced 
number and increased length of dendritic spines. When overexpressed in 
cultured hippocampal neurons, Shank3 promotes the maturation and 
enlargement of dendritic spines (Betancur et al, 2009). 
SHANK3 was the first gene in the Shank family of synaptic scaffolding 
proteins reported to be associated with ASDs. The SHANK3 gene is located on 
chromosome 22q13.3, and ASD-linked region with deletions linked to Phelan-
McDermid syndrome (PMS, also known as 22q13.3 Deletion Syndrome). PMS is 
characterized by hypotonia, developmental delay, absent or severely impaired 
language, autistic behavior and ID (Phelan, 2008). Mouse models harboring 
different SHANK mutations or deletions have been used to study the role of 
Shank in synapse formation, function and its role in autism pathology. Transgenic 
mice with genetic KO of SHANK3 exons 4–9, resulting in loss of the two longest 
isoforms of Shank3, have been shown to mimic human SHANK3 mutations by 
several groups. Although social impairments in these models have not been not 
consistent, they have all shown increased repetitive grooming, a behavior typical 
in ASD mouse models (Bozdagi et al, 2010; Peca et al, 2011; Wang et al, 2011; 
Yang et al, 2012). 
Postsynaptic density protein 95 (PSD-95, DLG4), is a member of the 
membrane-associated guanylate kinase (MAGUK) family of synaptic proteins. 
PSD-95 contains three PDZ domains, a single central SH3 domain, and a C-
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terminal guanylate kinase domain. The cytoplasmic domains of all three Nlgns 
bind to the third PDZ domain of PSD-95, whereas NMDA receptors and 
potassium channels bind to the first and second PDZ domains. PSD-95 is 
localized to spine heads in excitatory synapses and has been shown to promote 
synapse stabilization. PSD-95 is ubiquitinated by the ubiquitin E3 ligase, murine 
double minute-2 (Mdm2) and subsequently binds to protocadherin-10 (Pcdh10), 
linking it to the proteasome for degradation. Pcdh10 is an ASD-linked 
gene (Morrow et al, 2008) and its expression is regulated via the interaction of 
myocyte enhancer factor-2 (MEF2) and FMRP (Tsai et al, 2012). Additionally, in 
FMRP KO neurons, dysregulated Mdm2 prevents MEF2-induced PSD-95 
ubiquitination and synapse elimination (Tsai et al, 2012), providing evidence for 
altered activity-dependent synapse elimination in an ASD model. PSD-95 KO 
mice (DLG4 KO) show multiple behavioral and molecular abnormalities that are 
linked to ASD pathology. DLG4 KO mice display impaired communication and 
social interactions, decreased motor coordination, as well as increased anxiety 
and repetitive behaviors. Additionally, DLG4 KO mice display defects in dendritic 
spine morphology in the amygdala and aberrant expression of various synaptic 
genes in the forebrain (Feyder et al, 2010).  
Gephyrin is a key postsynaptic scaffolding protein in inhibitory synapses. 
Gephyrin’s three major domains include a G-domain in the N-terminal, an E-
domain in the C-terminal and a large linker domain between the two. Gephyrin 
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can interact with glycine receptors with high affinity and the α and β subunits of 
the GABAA receptor. Nlgn2 binds to gephyrin through a conserved cytoplasmic 
motif and activates collybistin, and the Nlgn2/gephyrin/collybistin complex is 
necessary for clustering of inhibitory receptors (Poulopoulos et al, 2009). 
Gephyrin KO mice die early and show decreased GABAA and glycine receptor 
clustering, whereas glutamate receptor localization remains normal (Grosskreutz 
et al, 2003; Kneussel et al, 1999). 
Rare exonic deletions within the gephyrin (GPHN) gene have been 
reported in subsets of patients with neurodevelopmental disorders and 
ASD (Lionel et al, 2013). In one family with a de novo 273 kb deletion in GPHN 
displayed developmental delay, cyclical seizures, as well as increased anxiety, 
obsessive compulsive disorders, tics, and impulsive behaviors (Lionel et al, 
2013). 
1.5.3 Adhesion complexes involved in ASD 
CNTNAP2 is a member of the Nrxn superfamily and is involved in neuron–
glia interactions and clustering potassium channels in myelinated axons. 
CNTNAP2 was first linked to ASD when a homozygous mutation was identified in 
Amish children with developmental disorders, seizures, and impaired 
language (Strauss et al, 2006). After genetic deletion of CNTNAP2, mice show 
reduced spine density and levels of the GluA1 subunit of AMPARs in spines. 
Additionally, an aggregation of GluA1 was observed in the cytoplasm, suggesting 
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that synaptic deficits may be in part due to a trafficking problem (Varea et al, 
2015). CNTNAP2 KO mice show common ASD behavioral phenotypes, including 
stereotypic motor movements, communication and social deficits (Penagarikano 
et al, 2011).  
Cadherins (CDH) are a family of transmembrane proteins that mediate 
cell-cell adhesion and play roles in neuron migration, dendritic growth, spine 
morphology, synapse formation, and synaptic remodeling (Bian et al, 2015; 
Egusa et al, 2016; Gilbert and Man, 2016; Redies et al, 2012; Tan et al, 2010). In 
genome-wide association studies, common variants in CDH9 and CDH10 genes 
on chromosome 5p14.1 have been identified to be associated with autism (Wang 
et al, 2009). Additionally, deletions within 16q23 in CDH13 have also been 
identified in ASD patients (Sanders et al, 2011). N-cadherin (neural cadherin) is a 
calcium dependent cell-cell adhesion glycoprotein that plays important roles in 
neurodevelopment (Garcia-Castro et al, 2000). A major molecule that interacts 
with the cytoplasmic C-terminal of N-cadherin is δ-catenin.  δ-catenin, a member 
of the p120 catenin family, is neuron specific and binds to the juxtamembrane 
segment of N-cadherin (Lu et al, 1999). The δ-catenin gene, CTNND2, is a major 
candidate gene in autism and part of a protein network that is strongly involved in 
regulating dendritic and spine growth and dynamics  (Bian et al, 2015; Turner et 
al, 2015; Yuan et al, 2015). Overexpression of δ-catenin can induce dendritic and 
spine protrusions in hippocampal neurons (Arikkath et al, 2009; Martinez et al, 
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2003), while loss of δ-catenin reduces growth and branching  (Arikkath et al, 
2008; Elia et al, 2006). Figure 1.3 depicts key synaptic proteins and signaling 
pathways linked to ASD. 
1.6 Synaptic plasticity and neuronal activity in ASD 
1.6.1 Long-term synaptic plasticity 
Synaptic plasticity is the property of neurons to strengthen or weaken 
synaptic connections in response to changes in the strength and temporal 
dynamics of neuronal activity. The basis of learning and memory is thought to be 
based on long-lasting activity dependent changes in synaptic strength (Ganguly 
and Poo, 2013).  
Long-term potentiation (LTP) is a persistent strengthening of synapses 
following repetitive, high frequency stimulation (HFS) of excitatory synapses that 
can last for hours or even months (Abraham, 2003; Bliss and Gardner-Medwin, 
1973; Bliss and Lomo, 1973). Due to its highly organized structure and readily 
inducible LTP, CA1 in the hippocampus has become a standard site of LTP study 
in mammals, particularly NMDA receptor-dependent LTP (NMDAR-
LTP) (Malenka and Bear, 2004). For NMDAR-LTP induction, both pre- and 
postsynaptic neurons must be activated coincidentally. This serves to depolarize 
the postsynaptic neuron and relieve Mg2+ blockade of NMDARs when glutamate 
is released from the presynaptic neuron. As a consequence, a large calcium 
influx through NMDARs is achieved, which activates intracellular signaling 
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cascades that ultimately are responsible for increased synaptic strength. 
NMDAR-LTP is therefore an input-specific and associative (sufficient activation of 
both the pre- and postsynapse are required) form of plasticity as proposed by 
Donald Hebb more than 60 years ago (Hebb, 1949). Additionally, an NMDAR-
independent form of LTP requires the activation of group I metabotropic 
glutamate receptors (mGluRs) and requires protein synthesis mediated by FMRP 
and activity regulated cytoskeleton protein (Arc) signaling (Balschun et al, 1999; 
Wang et al, 2016).  
The fact that LTP can last for extended periods means it requires new 
protein synthesis, however the fast initial expression of LTP does not (Frey et al, 
1988). Therefore, LTP can be separated into at least two phases: early-LTP (E-
LTP) and late-LTP (LTP). E-LTP is the phase that occurs immediately after LTP 
induction, lasts a few hours, and is dependent mostly on transient kinase activity. 
L-LTP begins a few hours after induction and depends on the activation of gene 
transcription (Frey et al, 1993; Frey et al, 1988). Additionally, the requirements 
for induction of E- and L-LTP are different. Whereas, a single train of HFS 
induces E-LTP, stronger stimulation protocols, such as three or four trains of 
HFS, are needed to induce L-LTP (Huang, 1998). Taken together, the 
characteristics of E-LTP and L-LTP suggests they may be the physiological 
mechanisms for short-term and long-term memory, respectively. 
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Long-term depression (LTD) is an NMDAR-dependent long-lasting 
reduction in the strength of neuronal synapses following longer, lower frequency 
stimuli (Ito and Kano, 1982). The magnitude of the calcium signal in the 
postsynaptic cell largely determines whether LTD or LTP occurs. LTD occurs 
after small, slower rises in postsynaptic calcium levels, whereas LTP is brought 
about by higher increases in postsynaptic Ca2+. Additionally, LTP results from the 
activation of protein kinases which subsequently phosphorylate target proteins, 
whereas LTD arises from activation of calcium-dependent phosphatases that 
dephosphorylate target proteins (Bliss et al, 1973; Malenka, 1994).  
The induction of LTD can be achieved with low frequency stimulation 
(LFS) without postsynaptic activity. Due to incomplete block of NMDARs by Mg2+ 
at resting membrane potentials (Jahr and Stevens, 1993), Ca2+ enters the 
postsynaptic neuron in response to LFS (Bloodgood et al, 2009; Bloodgood and 
Sabatini, 2007). Therefore, the repeated incidence of this smaller NMDAR-
dependent Ca2+ influx triggers LTD induction. 
Another commonly used, but less well understood form of LTD, is 
metabotropic glutamate receptor (mGLuR)-LTD. mGluR-LTD was first 
characterized in the cerebellum in parallel fiber Purkinje cells (Ito et al, 1982) and 
is dependent on an increase in intracellular Ca2+ and activation of postsynaptic 
group I mGluRs (Linden et al, 1991; Shigemoto et al, 1994). mGluRs were first 
shown to mediate hippocampal LTD induction when depotentiation at CA1 
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synapses was blocked by the group I/II antagonist α-methyl-4-
carboxyphenylglycine (MCPG)  (Bashir et al, 1993). A key property of mGluR-
LTD in the hippocampus is that it is NMDAR-independent and LTD induction by 
either mGluR or NMDAR activation is not mutually exclusive, meaning the two 
forms of LTD use different mechanisms (Bashir, 2003; Huber et al, 2001; Oliet et 
al, 1997).  
1.6.2 Short-term synaptic plasticity 
Multiple forms of short-term synaptic plasticity, that last milliseconds to 
several minutes, have been identified in organisms ranging from simple 
invertebrates to mammals (Zucker and Regehr, 2002). Short-term plasticity is 
thought to play important roles in fast adaptations to sensory inputs and 
temporary forms of memory (Citri and Malenka, 2008). Most forms of short-term 
synaptic plasticity are triggered by short bursts of activity producing a temporary 
accumulation of calcium in presynaptic nerve terminal, which in turn causes 
changes in the probability of neurotransmitter release by affecting the 
mechanisms of synaptic vesicle exocytosis (Zucker et al, 2002). 
A commonly used paradigm to study pre-synaptic short-term plasticity is 
the paired-pulse ratio (PPR). Paired-pulse facilitation (PPF) and paired-pulse 
depression (PPD) occur when two stimuli are applied within a short interval (20-
500 ms for facilitation, less than 20 ms for depression), and the response to the 
second stimulus can either be enhanced or depressed relative to the first 
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stimulus, respectively (Katz and Miledi, 1968; Sivaramakrishnan et al, 1991; 
Zucker et al, 2002). PPF results from residual calcium left over from the invasion 
of the first stimulus, which subsequently contributes to additional vesicle release 
during the second stimulation. Conversely, PPD results from an inactivation of 
voltage-dependent sodium or calcium channels, or due to a depletion of the 
readily-releasable pool of vesicles docked at the presynaptic terminal (Zucker et 
al, 2002). Whether PPF or PPD occurs at a synapse can depend on the recent 
level of activation at that synapse. Short-term plasticity is largely influenced by 
the probability of neurotransmitter release (p); therefore, synapses that have a 
high p tend to depress their response to the second pulse due to depletion of the 
synaptic vesicle pool or channel inactivation (Dobrunz and Stevens, 1997). 
Conversely, synapses with a low p are more likely to have increased release in 
response to the second stimulus. Therefore changes at the presynapse that 
impair synaptic vesicle release and lower p, for example mutations or loss-of-
function of synaptic vesicle docking proteins, will exhibit PPF, while the reverse is 
true for PPD. 
1.6.3 ASD-linked genes that alter synaptic plasticity and neuronal activity 
Based on the different ASD-linked pathways discussed previously, it can be 
inferred that changes in synaptic plasticity via altered synaptic strength and/or 
number, may be an underlying pathology in ASD patients and mouse models. 
Interestingly, many ASD-linked mutations results in altered gene transcription 
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and protein synthesis of synaptic related transcripts, effects which can also be 
observed with changes in neuronal activity (Akins et al, 2009; Darnell et al, 2011; 
Gilbert and Man, 2014; Kelleher et al, 2008; Qiu et al, 2012). 
Initial findings from FMR1 mutant mice, the mouse model of FXS, did not 
show impairments in LTP using a standard HFS paradigm (Godfraind et al, 1996; 
Li et al, 2002). However, using a low threshold stimulation protocol, LTP 
induction was reduced in several brain regions including the hippocampus and 
somatosensory cortex (Larson et al, 2005; Lauterborn et al, 2007; Zhao et al, 
2005). Additionally, mGluR-LTP was impaired in the basolateral amygdala and 
visual cortex (Suvrathan et al, 2010; Wilson and Cox, 2007). These findings 
provide evidence that different brain regions or synapse-specific deficits occur in 
FMRP deficient mice. However, the most prominent change in synaptic plasticity 
has been observed with enhanced mGluR-LTD in CA1 hippocampus and 
cerebellum (Huber et al, 2002; Koekkoek et al, 2005). Enhanced LTD in the 
hippocampal CA1 region has led to the theory that loss of FMRP at the synapse 
leads to the up-regulation of mGluR-mediated signaling (Bear et al, 2004; Huber 
et al, 2002; Osterweil et al, 2010). Additionally, genetic reduction or 
pharmacological inhibition of mGluR5 can rescue the behavioral phenotypes in 
FMR1 mutant mice (Dolen et al, 2007; Michalon et al, 2012). These rescue 
experiments raise an interesting possibility for the potential reversal of 
neurological impairments in human FXS patients. The different synaptic defects 
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that are found in various brain regions in FMR1 mutant mice provide evidence of 
a correlation between defective synaptic plasticity and disrupted behavior in 
ASD. These studies also provide evidence that the FMR1 KO mouse may be a 
good model to explore the pathophysiology of ASD and investigate possible 
treatment strategies (Bhakar et al, 2012). 
Synaptic plasticity has been studied extensively in UBE3A maternally 
deficient mice, the Angelman syndrome mouse model. In the CA1, LTP is 
reduced in transgenic mice using an induction protocol of two trains of HFS and 
the reduction in CA1 LTP could be rescued with a stronger stimulation 
protocol (Weeber et al, 2003). These findings indicate that Ube3a’s role in 
synaptic plasticity may be as a modulator of LTP expression, not necessarily 
required for LTP induction. In the same study, reduced calmodulin-dependent 
protein kinase II (CaMKII) activity was observed in transgenic mice, and genetic 
reduction of CaMKII’s inhibitory autophosphorylation rescued deficits in LTP and 
learning and memory tasks in transgenic animals (van Woerden et al, 2007). 
These findings provide evidence that altered CaMKII activity mediates the 
impairment in synaptic plasticity in UBE3A deficient mice; however, it remains to 
be elucidated how loss of UBE3A alters the activity of CaMKII. 
Both homozygous TSC1 or TSC2 KO mice are embryonic lethal; however, 
heterozygotes with TSC1 or TSC2 mutations display synaptic dysfunction and 
cognitive impairments (Ehninger et al, 2008; Kobayashi et al, 2001; von der 
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Brelie et al, 2006). In TSC2 heterozygous rats, LFS-LTD was decreased and L-
LTP was enhanced in hippocampal CA1; however, E-LTP was 
unaffected (Ehninger et al, 2008; von der Brelie et al, 2006), suggesting changes 
in protein synthesis pathways necessary for L-LTP expression. Additionally, in 
TSC2 heterozygous mice, mGluR-LTD was decreased but LFS-LTD was 
intact (Auerbach et al, 2011). A reduction in mGluR-LTD in TSC2 heterozygous 
animals is opposite to what is observed in FMR1 KO mice; however, mGluR-LTD 
in both animals show insensitivity to protein synthesis inhibitors (Auerbach et al, 
2011). An additional study using mice with specific deletion of TSC1 in cerebellar 
Purkinje cells showed impaired social interactions, increased repetitive behaviors 
and abnormal ultrasonic vocalizations; however, synaptic plasticity was not 
investigated in the cerebellum (Tsai et al, 2012). These findings suggest that 
impaired synaptic plasticity is a major pathology in TSC mouse models of autism, 
underlying the observed deficits in social interaction in both in TSC1 and TSC2 
heterozygous animals. 
In MECP2 KO mice, reductions in LTP and LFS-LTD in CA1 hippocampus 
have been reported. It’s interesting to note that younger mice (~3-5 weeks of 
age) show no impairments in synaptic plasticity, indicating that impaired synaptic 
plasticity correlates with the delayed regression observed in human RTT 
patients (Asaka et al, 2006; Chen et al, 2001). In a mouse model with a 
truncation of MeCP2 (MeCP2308/Y), LTP and paired-pulse low frequency 
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stimulation, but not mGLuR-LTD, was reduced in hippocampal CA1 from male 
mice (Shahbazian et al, 2002; Weng et al, 2011). Interestingly, another study has 
shown that impaired LTP in CA1 hippocampus could be rescued by genetically 
reintroducing MeCP2 (Guy et al, 2007; Weng et al, 2011). 
Shank proteins regulate levels and modulate the signaling of both 
metabotropic and ionotropic glutamate receptors at excitatory synapses, and 
synaptic transmission and plasticity have been examined in multiple brain 
regions in Shank3 mutant mice (Tu et al, 1999; Uchino et al, 2006). Investigation 
of mEPSC frequencies and amplitudes, paired pulse ratio (PPF and PPD), 
input/output curves, and population spikes have indicated that synaptic 
transmission show different abnormalities in hippocampal CA1 synapses in of 
mice with various Shank3 truncations (Wang et al, 2011). Additionally, 
hippocampal LTP is reduced at CA1 synapses in subsets of mice with Shank3 
truncations, as well as LFS- LTD and mGLuR-LTD (Bangash et al, 2011; 
Bozdagi et al, 2010; Wang et al, 2011). 
It has been hypothesized that disruptions in neuronal circuits involved with 
language and social behavior in subtypes of autism may be caused by 
unbalanced high levels of excitation, or disproportionately weak inhibition (Gao 
and Penzes, 2015; Rubenstein and Merzenich, 2003). With a more excitable 
cortex, the brain would have broad abnormalities in perception, memory, 
cognition and motor control, and would be highly susceptible to 
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epilepsy (Rubenstein et al, 2003). In support of this theory, a decrease in 
glutamate decarboxylase 67 (GAD67) mRNA in autistic cerebellar Purkinje tissue 
has been identified in human autism samples (Yip et al, 2007). Additionally, 
another study has shown suppressed GABAergic inhibition as a common factor 
in autism patient samples (Hussman, 2001), indicating that decreased 
GABAergic inhibition may disrupt the excitation/inhibition balance within neuronal 
networks in autism. 
As a novel form of synaptic regulation opposing the Hebbian type 
plasticity, homeostatic synaptic plasticity (HSP) is a negative feedback response 
that serves to compensate for changes in network activity (Hou et al, 2011; Pozo 
and Goda, 2010; Turrigiano et al, 1998; Wang et al, 2012; Yu and Goda, 2009). 
In response to global decreases or increases in network activity from a 
homeostatic set-point, synaptic strengths are scaled up or down, 
respectively (Turrigiano et al, 1998). HSP may be important for maintaining 
network activity homeostasis and avoiding potential epileptogenic states and 
sleep may be necessary for synaptic homeostasis (Kuhn et al, 2016; Tononi and 
Cirelli, 2003). Studies in Drosophila for example, have shown that the size and 
number of synapses decreases after sleep and increases within a few hours of 
waking (Gilestro et al, 2009). Interestingly, Nlgns regulate levels of glutamatergic 
and GABAergic currents after sleep deprivation, indicating they play an important 
role in this sleep-dependent HSP (El Helou et al, 2013; Gilestro et al, 2009; 
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Huber et al, 2004) and Nlgn defects could lead to the abnormal sleep and 
circadian rhythms that are commonly found in ASD patients (Bourgeron, 2007). 
FMRP, the RNA-binding protein involved with regulating dendritic protein 
synthesis, has also been shown to be required for increases in synaptic strength 
after neuronal activity blockade or application of retinoic acid in the mouse 
hippocampus, indicating that some symptoms of FXS may be due to impaired 
HSP (Soden and Chen, 2010). Release of brain-derived neurotrophic factor 
(BDNF) from postsynaptic neurons has previously been shown to be required for 
a retrograde homeostatic up-regulation of presynaptic function. Increased BDNF 
levels in ASD patient blood samples has been observed as well as higher plasma 
levels of serotonin and N-acetylserotonin (NAS), a potent agonist of the BDNF 
receptor tyrosine receptor kinase B (TrkB) (Halepoto et al, 2014; Jang et al, 
2010; Kasarpalkar et al, 2014; Pagan et al, 2014). Excess levels of NAS could 
therefore increase TrkB-induced PI3K signaling, leading to increased protein 
synthesis, similar to the effect of mutations in components of the mTOR pathway. 
1.6 The novel gene KIAA2022/KIDLIA in intellectual disability and ASD 
The KIAA2022 gene was identified from an X chromosomal breakpoint after a 
pericentric inversion in two male members in a family who had ASD phenotypes 
and severe ID (Cantagrel et al, 2004). The KIAA2022 locus is at Xq13.2 
containing 4 exons spanning 192 kilo-base pairs (kb) of DNA. It has a reading 
frame of 4551 base pairs (bp) with a large 180 kb intron between exons 1 and 
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2 (Cantagrel et al, 2004) (Figure 1.4A). In situ hybridization studies in mouse 
have shown that the KIAA2022 mRNA transcript is highly expressed in the 
developing fetal brain as well as the adult cerebral cortex. Additionally, KIAA2022 
mRNA levels show an increase in expression from embryonic day 14.5 (E14.5) to 
postnatal day 3 (P3) and remains detectable in adult mouse cerebral cortex, 
hippocampus, cerebellum and olfactory bulb (Cantagrel et al, 2009). The 
spatiotemporal brain expression patterns of KIAA2022 is consistent with a role in 
neurodevelopment and an involvement in ASD and/or ID.  
  We have named the KIAA2022 gene product protein as KIDLIA 
(KIAA2022 gene that causes intellectual disability with language impairment and 
autistic behavior), also referred to as XPN (X-linked protein related to neurite 
extension) (Ishikawa et al, 2012; Magome et al, 2013). KIDLIA is a large 170 kDa 
protein in humans and has no known function or significant homology with other 
known proteins (Cantagrel et al, 2004). Primary sequence analysis of KIDLIA 
predicts two nuclear localization sequences (NLS) contained within the Domain 
of Unknown Function 4683 (DUF4683) (Figure 1.4B). Additionally, analysis with 
Support Vector Machine software (SVM-Prot) for functional classification of 
proteins, predicts KIDLIA to be a DNA binding (89.3% confidence) and zinc-
binding (97.5% confidence) protein (Cai et al, 2003).  
Clinical examinations of patients with KIDLIA mutations or a loss of 
expression, display enlarged ventricles, Virchow-Robin spaces, a thin corpus 
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callsoum and small cerebellar vermis. Additionally, strabismus has been 
observed in all patients, with some dysmorphic features including a round face in 
infancy, febrile seizures, severely impaired or no language, stereotypical hand 
movements and delayed acquisition of motor milestones (Cantagrel et al, 2009; 
Cantagrel et al, 2004). Interestingly, a patient with decreased KIDLIA expression 
had only mild ID with severe language delay and repetitive behaviors typical of 
ASD, indicating that the effects may be gene-dosage dependent (Van 
Maldergem et al, 2013). 
It has previously been shown that transient siRNA-mediated knockdown of 
KIDLIA in vitro was sufficient to decrease both axonal and dendritic 
outgrowth (Van Maldergem et al, 2013). Additionally, recent findings have shown 
that suppression of KIDLIA increases mRNA and protein levels of N-cadherin 
and β1-integrin in PC12 cells, two important cell adhesion molecules (CAMs) 
involved in cell-cell and cell-matrix adhesion, respectively (Magome et al, 2013). 
However, as a newly identified autism protein, the role of KIDLIA in brain 
development and function remains to be elucidated. 
1.8 Thesis rationale  
Given that KIDLIA is a novel ASD-linked protein with largely unknown functions, 
additional studies to elucidate the role of KIDLIA in multiple steps of neuronal 
development including neuron morphogenesis, synapse maturation, synaptic 
plasticity and behavior could provide important insight into neurodevelopmental 
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processes and brain function in ASD.  Additionally, in vivo characterization and 
behavioral analysis of a KIDLIA KO animal would be a great tool for ASD 
research, as human patients with loss of KIDLIA expression display major 
developmental abnormalities and cognitive impairments (Cantagrel et al, 2009; 
Cantagrel et al, 2004; Kuroda et al, 2015; Van Maldergem et al, 2013). Loss of 
function mutations in single genes that are causative for ASD has given 
researchers important windows into the mechanistic machinery involved in 
neurodevelopment. Therefore, the goal of my thesis is to understand how KIDLIA 
regulates neurodevelopment and brain function including the investigation of 
neuron migration, neurite growth, synapse formation and function in the brain, 
and how this relates to the behavioral and cognitive phenotypes observed in 
humans. 
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Table 1.1 Human ASD-risk genes 
Protein Gene Symbol SFARI Score 
Associated 
Disorders 
Affected 
Developmental 
Processes 
Astrotactin 2 ASTN2 3 
ASD, ADHD, DD, 
EP, ID, OCD, 
SCZ 
Neuron Migration, 
Cell-Cell Adhesion 
Autism 
susceptibility 
candidate 2 
AUTS2 S ASD, ADHD, DD, EP, ID, SCZ 
Neuron Migration, 
Neurite Growth 
Cadherin 10 CDH10 4 ASD Cell-Cell Adhesion 
Cadherin 13 CDH13 N/A ASD Cell-Cell Adhesion 
Cadherin 9 CDH9 4 ASD Cell-Cell Adhesion 
Chromodomain 
helicase DNA-
binding protein 8 
CHD8 1S ASD, DD, ID, SCZ Cell-Cell Adhesion 
Contactin-
associated 
protein-like 2 
CNTNAP2 2S 
ASD, ADHD, DD, 
EP, ID, OCD, 
SCZ, TS 
Neuron Migration, 
Synapse 
Formation, 
Synaptic Function 
Postsynaptc 
Density 95 KDa DLG4 N/A 
ASD, EP, ID, 
SCZ Synaptogenesis 
Distal-less 
homeobox 1/2 DLX1/2 5 ASD Neuron Migration 
Fragile X mental 
retardation gene 
1 
FMR1 S ASD, ADHD, DD, EP, ID 
Translation, 
Synapse 
Formation, 
Synaptic Plasticity 
Gephyrin GPHN 3 ASD, EP, ID, SCZ Synaptogenesis 
KIDLIA KIAA2022 3 ASD, ID Neurite Growth 
Lissencephaly 1 LIS1 N/A ASD, DD, ID, EP 
Neurogenesis, 
Neuron Migration, 
Intracellular 
Transport 
Methyl CpG 
binding protein 2 MECP2 S 
ASD, ADHD, DD, 
EP, ID, SCZ 
Transcription, 
Neurite Growth, 
Synaptogenesis, 
Synaptic Plasticity 
NudE nuclear 
distribution E 
homolog 1 
NDE1 N/A ASD, ADHD, DD, ID, EP, SCZ 
Neurogenesis, 
Neuron Migration, 
Intracellular 
Transport 
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Neurofibromatosis 
1 NF1 4S ASD Neurite Growth 
Neuroligin 
1/2/3/4/4Y NRLG1/2/3/4/4Y N/A  
Cell-Cell 
adhesion, 
Synaptogenesis 
Neurexin 1/2/3 NRXN1/2/3 2 
ASD, ADHD, 
BPD, DD, EP, ID, 
SCZ, TS 
Cell-Cell 
adhesion, 
Synaptogenesis 
phosphatase and 
tensin homolog PTEN 1S 
ASD, 
ADHD,DD,EP,ID 
Neurogenesis, 
Neurite Growth, 
Translation, 
Synaptogenesis 
Reelin RELN 2 ASD, DD, EP, ID Neuron Migration, Neurite Growth 
Shank1/2/3 SHANK1/2/3 1S ASD, BPD, DD, EP, ID, SCZ 
Synaptogensis, 
Synaptic Plasticity 
Synapsin 1/2/3 SYN1/2/3 4 ASD, EP, ID Synaptogenesis, Synaptic Function 
Thousand-and-
one amino acid 
kinase 2 
TAOK2 N/A ASD Neurite Growth 
T-Brain-1 TBR1 1 ASD, ADHD, DD, EP, ID Neuron Migration 
Tuberous 
Sclerosis 1 TSC1 S ASD, DD, ID 
Neurite Growth, 
Synaptogenesis, 
Synaptic Plasticity 
Tuberous 
Sclerosis 2 TSC2 S ASD, DD, ID, EP 
Neurite Growth, 
Synaptogenesis, 
Synaptic Plasticity 
Ubiquitin protein 
ligase E3A UBE3A 3S ASD, DD, EP, ID 
Neurite Growth, 
Synaptic Plasticity 
WD repeat and 
FYVE domain 
containing 3 
WDFY3 3 ASD Neurogenesis 
δ-catenin CTNND2 2 ASD Neurite Growth 
 
Table 1.1.  
Summary of the genes reviewed including their associated disorders and the 
developmental processes they affect. The SFARI score = 1, high confidence; 2, 
strong candidate; 3, suggestive evidence; 4, minimal evidence; 5, hypothesized 
but untested; S, mutations are associated with a high degree of increased risk 
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and are frequently associated with additional features not required for an ASD 
diagnosis. N/A, not applicable. ASD, Autism Spectrum Disorder; ADHD, Attention 
Deficit Hyperactivity Disorder; DD, Developmental Delay; ID, Intellectual 
Disability; EP, Epilepsy; OCD, Obsessive Compulsive Disorder; SCZ, 
Schizophrenia . TS, Tourette’s Syndrome. 
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Figure 1.1 
 
Figure 1.1. Radial-glia guided neuronal migration  
Radial glia cells (green), extend long basal process to the pial surface, with their 
somas located in the ventricular zone. Neurons (blue) are born in the ventricular 
zone and migrate along radial glia fibers. The cortical plate is established in an 
inside-out pattern such that later-born neurons destined for more superficial 
layers pass through earlier-born neurons in deeper layers (progressively darker 
blue shading). The marginal zone contains horizontally-oriented Cajal-Retzius  
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cells which release the extracellular signaling glycoprotein Reelin (red). Adapted 
from Bielas and Gleeson, 2004.  
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Figure 1.2 
 
Figure 1.2. Stages of neurite growth. 
Representative neocortical mouse pyramidal neuron morphologies at different 
early postnatal time points during development. P = postnatal. Adapted from 
Zhang, 2004. 
  
65 
 
 
Figure 1.3
 
 
Figure 1.3. Synaptic proteins and signaling pathways linked to ASD.  
ASD-linked synaptic proteins and signaling pathways that relate to 
synaptogeneis and synaptic function. Stars mark ASD-linked proteins discussed 
in Chapter 1. Abbreviations: AMPAR, AMPA receptor; NMDAR, NMDA receptor; 
mGluR, metabotropic glutamate receptor; PSD-95, postsynaptic scaffolding 
protein 95 kDa; CNTNAP2, contactin-associated protein-like 2 gene; PI3K, 
phosphoinositide-3 kinase; Ras, RhoGTPase; GTP, Guanosine-5'-triphosphate; 
MeCP2	
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NF1, Neurofibromatosis type 1; PTEN, phosphatase and tensin homolog; Akt, 
serine/threonine specific kinase; TSC, tuberous sclerosis complex; mTOR, 
mammalian target of rapamycin; Raf, Rapidly Accelerated Fibrosarcoma serine 
threnonine kinase, MEK, Mitogen-activated protein kinase kinase; ERK, 
extracellular signal–regulated kinase; 40S, ribosomal subunit; FMRP, fragile-X 
mental retardation protein; CREB, cAMP response element-binding protein, CBP, 
CREB binding protein; MeCP2, methyl CpG binding protein 2; KIDLIA, KIAA2022 
gene with intellectual disability and language impairment in autism; P, phosphate 
group. 
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Figure 1.4
 
 
Figure 1.4. Identification of KIAA2022 and KIDLIA protein structure. 
(A) The human KIAA2022 gene was identified after a pericentric inversion on the 
X chromosome producing a breakpoint in the intron between exon 1 and 2 at 
Xq13.2 (B) The KIDLIA protein is 1516 amino acids long containing a putative 
DUF4683 domain with two NLS sequences. 
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CHAPTER TWO: 
MATERIALS AND METHODS 
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2.1 Cloning and plasmids 
For lentiviral shRNA, two KIDLIA shRNA sequences and a scrambled shRNA 
sequence were designed using the siRNA Wizard v3.1 (Invivogen). The KIDLIA 
shRNA sequences were CAGGAGCTACTAAGAATCAC and 
CAGGTAGCTTTGAGGTGTCA which recognize mouse, rat and human KIDILIA 
transcripts. The control, scrambled shRNA sequence was 
CCGCAGGTATGCACGCGT. The shRNA sequences were cloned into the 
pLKO.1-TRC cloning vector (Addgene, Cat. #: 10878, RRID: SCR_005907), 
using the AgeI and EcoRI sites, for lentivirus production. For in utero 
electroporation, the same shRNA sequences were cloned into the pCGLH-GFP 
(generous gift from the Haydar lab) vector using the BglII and SalI sites. KIDLIA 
siRNA oligomers for transfection were purchased from Qiagen. Each shRNA was 
cloned into the pLKO.1  
A list of all plasmids and their corresponding information can be found in 
Table 2.1.  
2.2 Cell culture 
2.2.1 Primary cultures of rat hippocampal and cortical neurons 
Pooled cerebral hemispheres were collected in Hank's balanced salt solution 
(HBSS) from embryonic Wistar rats (embryonic day 18; Charles River). The 
meninges were removed from each hemisphere before the hippocampus and 
cortex were separated by micro-dissection, transferred to a digestion solution (14 
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ml HBSS, 0.15 ml 500 mM EDTA pH 8.0, 0.5 ml 4 mg/ml L-cysteine, 0.5 ml 15 
mg/ml papain) and incubated in a 37°C water bath for 20 min, inverting the tube 
every 5 min. Primary tissue was then transferred to a trituration solution [21 ml 
HBSS, 27 µl 1% DNase, 3 ml 10/10 solution (HBSS with 10 mg/ml BSA and 10 
mg/ml chicken egg white partially purified Ovomucoid)] and triturated using a 
pipet, until tissue was dissociated. Neurons were counted using a 
hemacytometer and plated onto glass coverslips (Carolina) coated with poly-L-
lysine at a density of 0.6 - 0.8 x 106 cells per dish (containing five coverslips). 
Alternatively, neurons were plated onto 60 mm dishes (Greiner Bio-One) coated 
with poly-L-lysine at a density of 3 x 106 cells for western blot analysis. 6 h after 
plating, the medium was changed to feeding medium (Neurobasal medium with 
2% B27supplement, 1% horse serum, 0.8 mM glutamine and 1% 
penicillin/streptomycin). 
2.2.2 Culture of human embryonic kidney cell line (HEK293T) 
To resuscitate frozen HEK293T cell lines (ATCC® CRL-3216™), an aliquot was 
transferred to a 37°C water bath for 1-2 min, or until fully thawed. The entire 
thawed aliquot was pipetted into a 10 cm cell culture dish (Greiner Bio-One) 
containing 10 ml of pre-warmed Dulbecco's modified eagle medium (DMEM) 
(Invitrogen; supplemented with 1% penicillin/streptomycin, 10% fetal bovine 
serum). The dish was incubated in a tissue culture incubator with 5% CO2 and 
the medium was replaced with new supplemented DMEM every 48 h. To split 
71 
 
 
confluent cells, the old media was removed, the cells were washed twice with 5 
ml of pre-warmed, sterile phosphate buffered saline (PBS). 1 ml of trypsin-EDTA 
(Invitrogen) was added to the cells and they were incubated at room temperature 
(RT) for 5 min to free adherent cells from the bottom of the culture dish. The 
trypsin reaction was neutralize with the addition of 10 ml supplemented DMEM. 
The suspended cells were then transferred to a 15 ml centrifuge tube and spun 
at 100 × g for 5 min to pellet cells. The supernatant was then removed and 3 ml 
of pre-warmed supplemented DMEM was added to re-suspend the pellet with 
trituration. The cells were then plated at the appropriate concentration into a new 
culture dish. The cell dish was placed at 37°C in a culture incubator To freeze 
cell aliquots for future use, confluent cell cultures were trypsinized and isolated 
as previously described and re-suspended in DMEM supplemented with 10% 
fetal bovine serum/10% DMSO at a concentration of 2-4 x 106 cells/ml. 1 ml of 
the cell suspension was pipetted into a cryovial (Nalgene). Each cryovial was 
then placed in a −20°C freezer overnight prior to transferring vials to a −80°C 
freezer for long-term storage. 
2.3 Immunofluorescent microscopy 
2.3.1 Cell culture immunocytochemistry  
Cells to be imaged were washed 3X with cold artificial cerebral spinal fluid 
(ACSF) containing (in mM) (124 NaCl, 2 KCl, 2 MgSO4, 1.25 NaH2PO4, 2.5 
CaCl2, 26 NaHCO3, 10 D-glucose, pH 7.4, 310 mOsm) on ice and fixed with 4% 
72 
 
 
Paraformaldehyde/4% sucrose dissolved in PBS solution for 10 min at room 
temperature. Cells were then permeabilized with 0.3% Triton X-100 in PBS for 10 
min. Non-specific antibody binding was inhibited by blocking with 10% normal 
goat serum dissolved in PBS for 45 min. Cells were labeled with monoclonal or 
polyclonal antibodies directed against target proteins and incubated for 2 h at RT. 
A list of all antibodies and their corresponding information can be found in Table 
2.1. After primary antibody incubation, cells were labeled with Alexa Fluor-
conjugated secondary antibodies (1:700; Invitrogen) for 1 h. Coverslips were 
then washed and mounted on pre-cleaned microscope slides (VWR) using 
Prolong Gold antifade reagent (Invitrogen). Slides were allowed to air dry for 30 
min in the dark and stored at 4°C until viewing. 
2.3.2 Brain slice immunohistochemistry 
Mice older than postnatal day 0 (P0) underwent transcardial perfusion with ice 
cold PBS prior to removing the brain from the skull. For embryonic day 17 (E17) 
and P0 animals, brains were left in the skull for fixation and slicing. 
Brains were fixed in 4% paraformaldehyde for 4-6 h and cryoprotected in 
30% sucrose/PBS. The tissue was then frozen in OCT (Tissue-Tek) compound 
and cut into 20 µm sections using a LEICA CM1850 cyrostat (LEICA 
Biosystems). Sections were mounted onto SuperFrost microscope slides (Fisher 
Scientific) and stored at −80°C for future use. Prior to immunostaining, sections 
were rinsed with PBS for a minimum of 2 h and antigen retrieval was performed 
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by microwaving brain sections in sodium citrate buffer (10 mM, pH 6) at 800 
watts for 1 min followed by 80 watts for 10 min. Sections were then blocked in 
5% goat serum, 0.3% Triton X-100/PBS for 1 hour followed by incubation with 
primary antibodies overnight at 4°C. The following day, sections were washed 
with PBS and incubated with the appropriate Alexa fluor conjugated secondary 
antibodies. Brain slices were then washed 3X with PBS, with the first wash 
containing Hoescht (1:3000,Thermo Fisher). Sections were then mounted with 
ProLong-Gold mounting medium (Invitrogen), allowed to dry at room temperature 
for overnight and stored at −20°C. 
2.3.3 Microscopy 
For in vitro analysis of cultured neurons, a Carl Zeiss inverted fluorescent 
microscope was used to collect images with AxioVision software (Release 4.5).  
Brain sections were imaged using a Zeiss LSM 700 laser scanning confocal 
microscope using the Zen software package.  
2.3.4 Sholl analysis  
MAP2-positive dendrites were traced from images of neurons stained with MAP2 
and tau1 using the NeuronJ plugin in ImageJ. The Snapshot tool in NeuronJ was 
used to save the tracings as an image file that was converted to 8-bit and these 
images were analyzed with the Sholl analysis plugin in ImageJ. The range of 
measurement was set using the straight line tool traced from the center of the 
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soma to the outermost neurite. Dendrite intersections were analyzed from a 
starting radius of 10 µm with 10 µm steps to the outer radius. The resulting 
number of intersections per cell were used to calculate the mean and the 
standard error mean for each radius interval. Treatments were applied to sister 
cultures that originated from the same neuron culture preparation. 
2.3.5 Synaptic puncta analysis 
For accurate quantification, all images were collected in 8-bit gray scale and 
saved for raw data analysis with Image J software. A multi-colored image (red 
and/or green from stained synaptic proteins and a DIC image for morphology) 
was separated into multiple channels with Image-J software, and the windows 
were synchronized. By tracing a neuron’s dendrites in the DIC channel, the 
corresponding synaptic puncta were able to be precisely located in the red or 
green channels. 
A glow scale look-up table was used to monitor the saturation level and 
set within the dynamic range of the signal. Once the parameters were set, they 
were fixed and used throughout the experiment. Three to five sections of 
proximal dendrites per cell were used for analysis. Synaptic puncta were 
individually inspected to avoid contamination with nonspecific signals. 
Synaptic puncta size was calculated as the product of size and 
fluorescence intensity of each puncta. The average was calculated per cell and 
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the cells were averaged. Greater than 100 hundred puncta were measured per 
cell. 
2.4 Golgi impregnation 
Golgi impregnation of whole brains from C57BL/6J wild-type and KIDLIA knock-
out mice was performed with the FD Rapid GolgiStainTM Kit (FD 
NeuroTechnologies, Inc), following the manufacturer’s protocol. Mice were 
sacrificed at the indicated time in a 4% CO2 chamber for 5 min and the brains 
were immediately removed and rinsed in MilliQ water. Brains were then 
immersed in a Golgi-Cox solution containing potassium dichromate, mercuric 
chloride, and potassium chromate. The mixture of solutions was replaced once 
after 16 hours of initial immersion, then stored at room temperature in the dark 
for 2 weeks. After the immersion period in the Golgi-Cox solution, the embedded 
brains were transferred to a cryoprotectant solution and stored at 4°C for at least 
1 week in the dark prior to cutting. The brain slices were sectioned in the coronal 
plane at 100-200 µm thickness on a microtome. Brain slices were transferred 
onto gelatin-coated slides and were air dried at room temperature in the dark 
overnight before further processing. After drying, sections were rinsed with 
distilled water and stained in a developing solution and subsequently dehydrated 
with 50%, 75%, 95%, and 100% ethanol. Finally, the sections were defatted in 
xylene substitute and mounted onto coverslips with Permount mounting liquid 
(Fisher Scientific). Images were acquired with a Carl Zeiss Axiovert 200M 
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microscope and AxioVision software (Release 4.5). Each neuron was scanned 
under high magnification (63X, oil immersion, numerical aperture (N.A.): 1.4) by 
varying the depth of the Z plane, to ensure that all parts of the cell (especially 
dendrites) were intact. The number and size of apical and basal spines, and the 
length of dendrites on hippocampal CA1 pyramidal neurons was measured blind 
to the genotype with Image J software.  
2.5 Immunoblotting 
2.5.1 Sample preparation of rat neuronal cultures 
Cortical neurons cultured in either 60 mm (3 × 106 cells / dish) or 6-well plates 
(106 cells / well) were collected and lysed in 2X Laemmli sample buffer (4% 
sodium dodecyl sulfate (SDS), 10% 2-mercaptoethanol, 20% glycerol, 0.004% 
bromophenol blue, 0.125 M Tris HCl) and boiled for 10 min at 95°C to prepare for 
SDS-PAGE. 
2.5.2 Sample preparation of mouse brain samples 
Brains were dissected on ice immediately after sacrificing animals at the 
appropriate time points. For a ~5 mg piece of tissue, ~300 µL of ice cold lysis 
buffer (50 mM Tris-Cl, 150 mM NaCl, 1% NP40, 1% sodium deoxycholate 
(SDOC), 1% SDS) supplemented with a protease inhibitor cocktail (Complete 
tablets, Roche) was added an samples were homogeneneized mechanically with 
a pestle, followed by sonication (10X for 10 s each). Samples were then head-to-
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toe rotated for 2 h at 4°C. gels. Brain lysates were then centrifuged for 20 min at 
13,000 rpm at 4°C in a microcentrifuge. The tubes were placed on ice and the 
supernatant was carefully aspirated and placed into a fresh tube kept on ice. 
Samples were subjected to a BCA assay according to the manufacturer’s 
protocol (Pierce) to determine protein concentrations. Protein levels were 
normalized with RIPA lysis buffer cells, an equal volume of 2X Laemmli sample 
buffer and the lysates were boiled for 10 min at 95°C to prepare for SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). 
2.5.3 Western blot 
SDS-PAGE was performed to separate proteins of interest using standard 
procedures. Proteins were transferred to PVDF membranes and blocked for one 
hour in 5% milk prepared in PBS. Following block, membranes were probed with 
the appropriate primary antibody overnight at 4°C in Tris buffered saline 
supplemented with 0.05% Tween (TBST). Membranes were washed 3X in TBST 
and then incubated with the appropriate secondary antibody for 1 h. Following 
secondary incubation, membranes were washed 3X with TBST, followed by 1X 
with PBS to remove excess Tween. Blots visualized using a chemiluminescence 
detection system (GE Healthcare) and exposed to Fuji medical X-ray films 
(Fisher Scientific), scanned and analyzed using ImageJ.  
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2.5.4 Immunoprecipitation  
Brain tissues or cultured neurons were lysed in 1X radio-immunoprecipitation 
assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl, 1% NP-40, 1% 
SDOC, 0.1-1% SDS) supplemented with protease inhibitor cocktail tablets 
(Roche) to minimize protein degradation. Stringent RIPA buffer (1% SDS) was 
used in immunoprecipitation IP experiments to ensure clean protein 
immunoprecipitation while mild RIPA buffer (0.1% SDS) was used in co-
immunoprecipitation (Co-IP) experiments for protein-protein interaction assays. 
Cell lysates were then incubated with specific antibodies for 1 hour then another 
4 hours with protein A-agarose beads (Santa Cruz Biotechnology). Agarose 
beads were then washed 3X with NP-40 buffer (25 mM Tris-HCl, pH 7.4; 150 mM 
NaCl, 1 mM EDTA, 1% NP-40). The agarose beads were then boiled with 
Laemmli 2X sample buffer for 10 min at 95°C prior to western blot analysis. 
2.5.5 Surface biotinylation 
Live cultured neurons were incubated with EZ Link-Sulfo-NHS-LC-Biotin (Thermo 
Scientific) dissolved in ACSF (1 mg/ml) for 10 min at room temperature and 
another 20 min at 4°C. Excess biotin reagent was quenched with two washes of 
ACSF with 20 mM glycine followed by another two washes with ACSF. Neurons 
were then lysed in lysis buffer 1 (1X PBS with 0.5% SDS, 0.5% SDOC, 1% 
Triton-X-100) with the addition of a protease inhibitor cocktail (Roche), sonicated, 
then head-to-toe rotated at 4°C for 30 min to achieve thorough cell lysis. After 
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spinning down at 13,000 rpm for 15 min, 1/10 of the supernatant volume was 
mixed with an equal volume of Laemmli 2X sample buffer, boiled 10 min at 95°C 
and saved as a total lysate control. The rest of the supernatant was removed to a 
new Eppendorf 1.5 ml tube containing 40 µl pre-equilibrated NeutrAvidin beads 
(Thermo Fisher), while the pellet was discarded. NeutrAvidin beads, along with 
the supernatant, were head-to-toe rotated at 4°C for at least 2 h. The beads were 
rinsed 3X in PBS (with 0.5% Triton-X-100), before being mixed with an equal 
volume of Laemmli 2X sample buffer and boiled 10 min at 95°C in preparation for 
western blot analysis. 
2.6 Cell death assay  
Live neuron cultures were treated with propidium iodide (PI, 1 µg/ml, Sigma-
Aldrich) to label the nuclei of dying cells and Hoescht (1 µg/ml, Cell Signaling) to 
label all nuclei. Both PI and Hoescht were added at the same time, directly to the 
culture media, and allowed to incubate for 20 min at 37°C. As a positive control, 
one set of neurons was treated with glutamate (30 µM) for 30 min, washed with 
ACSF and the media replaced and returned to the incubator for 3 h prior to PI 
and Hoescht labeling. Cells were then washed with ACSF and fixed with 4% 
paraformaldehyde/ 4% sucrose for 10 min. Following a wash with PBS, neuronal 
coverslips were mounted onto slides with Prolong Gold Anti-fade Reagent for 
microscopy. The ratio of PI-positive nuclei to total nuclei (Hoescht) was 
calculated to determine the percentage of dying cells. 
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2.7 RhoA activation assay 
RhoA activity was assessed using a RhoA Activation Assay Kit (Cytoskeleton 
Inc.). GTP-RhoA was immunoprecipitated from whole cell lysates prepared in 
RIPA lysis buffer (0.1% SDS) with glutathione S-transferase-tagged Rhotekin 
bound to glutathione-agarose beads. The beads were washed and the 
immunoprecipitates were analyzed by western blot using a RhoA-specific 
monoclonal antibody. The lysate was also probed for total RhoA and the GTP-
RhoA was normalized to total RhoA levels. 
2.8 Transfection of neurons and HEK293T cells 
Hippocampal neurons were transfected at the time indicated, or HEK 293T cells 
(ATCC® CRL-3216™) that were split and cultured overnight, were transfected 
with Lipofectamine 2000 (Life Technologies). Plasmid DNA or siRNAs were 
added to an Eppendorf tube containing 1X Dulbecco's Modified Eagle's Medium 
(DMEM, Corning) and Lipofectamine 2000 was added to another tube (1 µl 
Lipofectamine 2000: 1µg DNA) containing DMEM, and allowed to incubate for 5 
min at room temperature. The tube containing plasmid DNA and Lipofectamine 
2000 were then combined and allowed to incubate for 20 min at RT to form the 
transfection complex. The transfection complex was incubated with the neurons, 
or HEK 293T cells, in culture medium for 4 h at 37°C in the cell culture incubator. 
The medium, along with the transfection complex, was then removed and 
replaced with fresh culture medium. For neurons, half of the fresh feeding 
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medium was supplemented with conditioned feeding medium to minimize cell 
death. HEK 293T cells were cultured in the following medium: 1X DMEM with 
10% fetal bovine serum, 1% penicillin/streptomycin and 1% L-Glutamine.  
2.9 Production of lentivirus and adenovirus 
Recombinant lentiviruses were produced by transfecting HEK 293T cells with the 
appropriate over-expression or shRNA plasmids together with viral packaging 
and envelope proteins (pRSV/REV, pMDLg/RRE, and pVSVG) using 
Lipofectamine 2000. Conditioned medium containing lentivirus was harvested 
after 48 h, centrifuged at 1000 × g for 10 min, filtered through a 0.45 µm filter and 
incubated with a 1:5 v/v ratio of polyethylene glycol (PEG-IT, SBI) at 4°C 
overnight. The next day, the mixture was centrifuged at 1500 × g for 15 min, the 
supernatant was aspirated and discarded, and the viral pellet was re-suspended 
in 1/100th the initial volume of cell culture media with sterile PBS. Aliquots were 
made in cryovials and stored at −80°C. Neurons were infected with lentivirus on 
the day of plating and media was changed 1 d later to feeding medium.  
Recombinant adenoviruses were produced by transfecting HEK 293T cells 
with the appropriate over-expression plasmids, together with viral packaging and 
envelope proteins (pXX680 and pCAP), using Lipofectamine 2000. Conditioned 
medium was collected and filtered through a 0.45 µm filter and stored on ice. 
HEK293T cells were washed 1X with 2 ml of 10mM Tris-HCl, pH 7.8. HEK cells 
were then collected into a 15 ml tube with a sterile cell scraper and the cells were 
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re-suspended with 2 ml of 10 mM Tris-HCl, pH 7.8. Cells were freeze/thawed 3X 
by rotating through a dry ice/methanol bath and 37°C water bath (7min/round), 
respectively. The crude lysate was then sonicated at 4°C, 5X for 20 s, with 20 s 
rest in between sonications. The cell lysate was then centrifuged at 3000 × g for 
30 min at 4°C and the supernatant was collected and filtered with a 0.45 µm filter 
and combined with the previously filtered culture media. PEG-IT was added to 
the lysate/media at a ratio of 1:5 v/v and placed at 4°C overnight. The next day, 
the mixture was centrifuged at 1500 × g for 15 min, the supernatant was 
aspirated and discarded, and the viral pellet was re-suspended in 1/100th the 
initial volume of cell culture media with sterile PBS. Aliquots were made in 
cryovials and stored at −80°C. 
2.10 Fluorescence recovery after photo-bleaching 
Fluorescence after photo-bleaching (FRAP) experiments were performed using a 
Zeiss LSM 700 laser scanning confocal microscope. The microscope was 
equipped with an incubation system featuring temperature and CO2 control. All 
experiments were performed at 37°C and 5% CO2. Live images were acquired 
using a 63X oil immersion objective lens (N.A. 1.4).  
FRAP experiments were conducted with the following protocol: 3 single 
pre-bleach scans were acquired at 3 s intervals, followed by up to 5 bleach scans 
at full laser power until the fluorescence reached 25% of the original pre-bleach 
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levels, over a circular area of 4 µm in diameter. During the post-bleach period, 
scans were acquired at 3 s intervals. 
Fluorescence was quantified using the FRAP plugin in ImageJ. 
Background fluorescence was measured in a random field outside of the region 
of interest and subtracted from all the measurements. Growth cone fluorescence 
was determined for each image and normalized to the initial pre-bleach 
fluorescence to determine the rate of fluorescence recovery. 
The net fluorescence recovery (mobile fraction, Mf) measured in the region 
of interest was determined as Mf = (Fpre – Fpost) - (Fpre – Fend) and the immobile 
fraction (IMf) was calculated as IMf = (Fpre – Fpost) - (Fend – Fpost), where Fend is the 
region of interest (ROI) mean intensity at the steady-state, Fpost represents ROI 
intensity after photo-bleaching, and Fpre is the mean ROI intensity pre-bleach. 
2.11 In utero electroporation 
In utero electroporation (IUE) was performed on timed pregnant CD-1 dams 
(Charles River Laboratoies) at embryonic day 14.5 (E14.5). Dams were 
anesthetized via intraperitoneal (IP) injection of a ketamine/xylazine mixture and 
the uterine horns were exposed via midline laparotomy. One to two microliters of 
plasmid DNA mixed with 0.1% fast green dye (Sigma-Aldrich) was injected 
intercerebrally through the uterine wall and amniotic sac using a pulled glass 
micropipette. The plasmid vectors were used at a final concentration of between 
2 and 3 µg/µl. The anode of a tweezertrode (Harvard Apparatus) was placed 
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over the dorsal telencephalon above the uterine muscle and four 35 V pulses (50 
ms duration separated by a 950 ms interval) were applied with a BTX ECM830 
pulse generator (Harvard Apparatus). Following electroporation, the uterine 
horns were returned to the abdomen and the cavity was filled with a warm saline 
solution and the incisions were closed with silk sutures. The dams were then 
placed in a clean cage and monitored closely during recovery. The pups were 
allowed to mature with the mother until the times indicated. To collect the 
electroporated brains, animals were anesthetized with an IP injection of 
ketamine/xylazine and transcardially perfused with ice-cold PBS. The brains 
were removed and placed into a 4% paraformaldehyde in PBS solution at 4°C for 
6 h, followed by overnight incubation in a 30% sucrose PBS solution at 4°C. The 
brains were placed in trays and submerged in OCT embedding medium (Tissue-
Tek) and flash frozen by placing the trays in a bath of methanol mixed with dry 
ice. Frozen brains were cut in 35 µm sections on a Leica CM 1850 cryostat 
(Leica Biosystems) at −20°C. All procedures were reviewed and approved by the 
Boston University Institutional Animal Care and Use Committee. 
2.12 Electrophysiology 
For in vitro mEPSC recordings, 14-15 days in vitro (DIV) cultured hippocampal 
neurons were treated with TTX (1 µM) for 24 h to induce homeostatic synaptic 
plasticity (HSP). The coverslip was then transferred to a recording chamber with 
an extracellular solution containing (in mM): 140 NaCl, 3 KCl, 1.5 MgCl2, 2.5 
85 
 
 
CaCl2, 11 glucose, and 10 HEPES (305 mOsm, pH 7.4,), which was 
supplemented with TTX (1 µM) to block action potentials, APV (50 µM) to block 
NMDARs and bicuculline (20 µM) to block GABAA receptor-mediated currents. 
To block CP-AMPARs, recordings were made in the presence of Philanthotoxin 
(PhTx, 2 µM) in the extracellular solution. Whole cell voltage-clamp recordings 
were made with patch pipettes filled with intracellular solution containing (in mM): 
110 Cs-methanesulfonate, 10 CsCl, 10 HEPES, 0.2 EGTA, 4 Mg-ATP, 0.3 Na2-
GTP, and 10 sodium phosphocreatine (295 mOsm, pH 7.4), with the membrane 
potential clamped at −70 mV. Recordings started 5 minutes after establishing 
whole-cell configuration to ensure equilibration between the pipette solution and 
the cytosol. mEPSCs were recorded with an Axopatch 200B amplifier and 
displayed and recorded digitally on a computer for subsequent off-line analysis 
with Clampfit (Molecular Devices).  
 Templates for a typical mEPSC were created using Clampfit software that 
averaged 25 manually selected typical events. The templates were used to scan 
the traces for events with highly similar kinetics and a moving baseline was 
created from each event to calculate amplitude. Data was then manually 
inspected for selection of typical mEPSC events. All data were presented as 
normalized mean ± SEM. For cumulative probabilities, the relationship between 
control and experimental amplitude and frequency distributions was determined 
by ranking an equal number of randomly selected values from all cells recorded 
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from each condition in ascending order. These amplitude distributions were 
linearly interpolated to plot each condition.  
To calculate the ratio of CP-AMPAR current to total AMPAR current, the 
amplitude of neurons recorded without philanthotoxin (PhTx) was subtracted 
from the amplitude of recordings in the presence of PhTx and divided by the 
amplitude of recordings performed without PhTx. To calculate N-AMPAR current, 
the amplitudes of recordings in the presence of PhTX was used.  
 For in vivo recordings, brain slice sections (300 µm) of the visual cortex 
(V1 area) were prepared using a vibratory microtome. Slices were allowed to 
recover at 32°C for 30 min then at RT for at least 1 h. The composition of ACSF 
(in mM) was 124 NaCl, 3 KCl, 1.25 NaH2PO4, 1.2 MgCl2, 2 CaCl2, 26 NaHCO3, 
and 10 dextrose (305 mOsm, pH 7.4). Brain slices were transferred to a 
recording chamber and continuously superfused with oxygenated ACSF (2 
ml/min) supplemented with TTX (1 µM), APV (50 µM) and bicuculline (20 µM) 
and maintained at room temperature. To block calcium-permeable AMPARs, 
philanthotoxin (5 µM) was added into the extracellular solution. 
Brain slices were visualized with IR-DIC using an Axioscope 2FS 
equipped with Hamamatsu C2400-07E optics. Recording electrodes were filled 
with an internal solution containing (in mM): 140 K-gluconate, 10 HEPES, 0.2 
EGTA, 2 NaCl, 2 MgATP, 0.3 NaGTP. Miniature events from each trace (>300 
consecutive events) were identified using template matching in Clampfit software 
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(Molecular Devices) with a threshold of 5 pA, 20%–80% rise time of less than 1 
ms and manually confirmed for analysis. All data were acquired at 10 kHz and 
filtered with a lowpass filter at 2 kHz. 
2.13 Visual deprivation 
Mice at 30±5 days old were anesthetized with 6% chloral hydrate (6 ml/kg; 
intraperitoneal injection) and the eyelids were covered with a black pellicle of 
appropriate size. Black ink powder is mixed with an epoxy adhesive (AB gel) to 
bond the black pellicle to the closed eyelids. The adhesive was applied across 
the neck, avoiding the leg, to stabilize the pellicle. After waking up, a powerful 
light was used to make sure that the visual deprivation procedure was 
successful. All mice were held for 24 h in a darkroom prior to electrophysiological 
recordings. Control animals were raised with a normal light cycle (12 h 
light/dark). Mice were injected with β-amyloid (Aβ) oligomers (10 µg) in the V1 
region (ML ±2.3 mm, AP 3.16 mm, DV 0.9 mm) followed by binocular visual 
deprivation.  
2.14 Quantitative real-time polymerase chain reaction 
Total RNA from rat cortical cultures was purified using TRIzol (Thermo Fisher) 
and reverse transcribed using the SuperScript III Reverse Transcription System 
(Thermo Fisher). The optical density A260/A280 ratio was confirmed to be >1.9 
for each sample.  For N-cadherin, we used the oligonucleotides: 
5′−ATCATTCGCCAAGAGGAAGG−3′ and 5′−GGCTGAAAATAGACCCTGTGA−3′ 
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and for Nrgn, we used the oligonucleotides: 5’−AGCATCGTACAAACCCACC−3’ 
and 5’−AGCGGGATGTCAAGAATATCG−3’ Quantitative real-time PCR was 
performed with a 7300 real-time PCR system (Applied Biosystems) using Power 
SYBYR Green Master Mix (Applied Biosystems) with the following PCR 
conditions: initial hold at 95°C for 10 min, followed by 40 cycles of a 15 s 
denaturing step at 95°C and a 60 s annealing and extension step at 60°C. 
Transcript levels were normalized to the housekeeping gene GAPDH using the 
oligonucleotides: 5′-CCATCAACGACCCCTTCATT-3′ and 5′-
CTGAGAATGGGAAGCTGGTC−3′. 
2.15 RNA sequencing 
Ingenuity Pathway Analysis® (Ingenuity Systems) was used to assess 
downstream effects that would most likely be associated with loss of KIDLIA 
expression. Core analyses were run with a cut-off of p<0.05 compared to 
controls. Signaling pathway analysis was run between scrambled shRNA and 
KIDLAI shRNA samples to identify top dysregulated pathways and were pulled 
out out based on the number of genes affected and p-value rank. 
 
2.16 Animal studies and characterization of the KIDLIA knockout mouse 
2.16.1 Generation of KIDLIA knockout mouse 
C77370tm1(KOMP)Wtsi (KIAA2022) KO mice were created by blastocyst 
injection of targeted embryonic stem (ES) cell clone EPD0411_7_H02 from the 
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NIH-funded Knockout Mouse Project (KOMP) (International Mouse Knockout et 
al, 2007; Pettitt et al, 2009). The ES cell clone was the result of deletion of exon 
4 of the KIAA2022 gene. A chimeric animal was generated through the Boston 
University Transgenic Core and mouse colonies were maintained in a C57BL/6J 
genetic background. Female mice heterozygous for KIAA2022 were crossed with 
wild-type male mice and knockout male mice were used in experiments. 
2.16.2 Animal care and use 
All the procedures involving animal use were in compliance with the policies of 
the Institutional Animal Care and Use Committee (IACUC) at Boston University. 
Mouse colonies were maintained in the Laboratory Animal Care Facility (LACF) 
at Boston University, Charles River Campus. Male mice, aged 8-12 weeks were 
used in behavioral studies. Only mice with normal body size and no observable 
disabilities were used for the experiments. This visual deprivation studies were 
approved by the Animal Care and Use Committee of Tongji Medical College. 
2.16.3 Genotyping 
A single tail snip was collected from mice at the time of weaning (postnatal day 
21) and placed into an Eppendorf tube. 75 µl of a base solution (25 mM NaOH, 
0.2 M EDTA) was added to each sample and the tubes were incubate at 95°C for 
30 min to extract genomic DNA. The tubes were allowed to cool to room 
temperature and 75 µl of a neutralization solution (40 mM Tris-HCl, pH 5) was 
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added and the mixture was vortexed. Touchdown PCR was performed using 2 µl 
of the DNA extract with a 2720 Thermo Cycler (Applied Biosystems) with the 
following conditions: initial hold at 94°C for 5 min, followed by 40 extensions 
cycles of a 15 s denaturing step at 94°C, with 10 cycles with an annealing step 
for 60 s annealing from 65-55°C (1°C stepdown/ cycle) followed by 30 cycles with 
a 60 s annealing step at 55°C, and an extension step of 40 s at 72°C, followed by 
a final extension step at 72°C for 5 min. PCR fragments were run on a 1% 
agarose gel with ethidium bromide to label DNA and visualized under ultraviolet 
light. 
Two sets of primers were used to genotype KIDLIA KO animals. One set 
was target against the deleted exon 4 region using the primers: 
5’−AGGACTTGCTTAGGTTGCTTCATGGAA−3’ and 
5’−CTTAAATTGCTCTACCTCAAGACCACCA−3’ with an expected PCR 
fragment of 949 bp. The other set was targeted against the KO cassette using 
the primers: 5’−ACACCTCCCCCTGAACCTGAAA−3’ and 
5’−TGGGCAAACAGTGCATAAACTACTCG−3’ with an expected PCR fragment 
of 1154 bp. 
2.16.4 Three chamber social test 
A three-chambered box was constructed from 0.75 in thick white plastic board 
measuring 65 × 28 × 28 cm. The walls to the center chamber had 4 × 4 in cut-out 
doors allowing movement between chambers. The two side chambers contained 
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small wire cages to later house social mice. Before the test, mice were 
habituated to the apparatus with empty cages in both side chambers, over a 3 d 
period for 5 m each session, and allowed to move freely between all three 
chambers. On the testing day, mice were singly placed into the center chamber, 
with the doors blocked with white plastic boards and a social mouse (Mouse 1) 
was placed into either of the side chamber under the wire cage. The doors were 
unblocked and the mouse was allowed to move freely within the apparatus for 5 
min. The test mouse was then gently nudged into the center chamber, the doors 
were blocked again and a second mouse (Novel Mouse) was placed into the 
other side chamber. The center doors were unblocked and the test mouse was 
allowed to move freely within the apparatus for another 5 min. The entire 
apparatus was wiped with 70% ethanol between mice to eliminate odor cuess 
between animals. Video recordings were captured with a Logitech c920 webcam 
during the test and the time spent interacting with each mouse or empty cage 
(nose ≤ 2 cm), time spent in each chamber, and locomotion tracks were scored 
using the MTrack plugin in ImageJ, blind to the genotype. 
2.16.5 Marble burying 
Marble burying was conducted in the animals home cage with fresh pine chip 
bedding added up to 3 in thickness. Sixteen shiny glass marbles (0.25 inch 
diameter) were arranged in a 4 × 4 grid on top of the bedding. Mice were singly 
placed back into the cage and allowed to move freely and bury marbles. Video 
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recordings were captured with a Logitech c920 webcam during the test and the 
number of marbles buried after 5, 10, 15 and 25 min was quantified. 
2.16.6 Open field test 
The open field test was conducted in a chamber constructed from 0.75 in thick 
white plastic board measuring 28 × 28 × 28 cm. The box was placed a on large 
white plastic board with a 9 × 9 grid drawn on the floor for later analysis. Lights in 
the testing room were off except for a small desk lamp in the corner allowing the 
experimenter to see. Mice were habituated to the testing room over three days 
and handled for 5 min each session. On the test day, each mouse was singly 
placed into the center of the box and allowed to freely explore the chamber. 
Video recordings were captured with a Logitech c920 webcam during the test 
and the time spent in the cent er square of the grid, within 3 cm of the walls of the 
chamber, track lengths and grooming nehaior were quantifed blind to the 
genotype of the animals. 
2.16.7 Barnes maze spatial memory test 
The Barnes maze was constructed made from a circular, 0.75 in thick, white 
plastic board with a 48 in diameter. Twenty-one holes with a diameter of 2 in 
were evenly spaced around the perimeter of the maze with a distance of 1 in to 
the edge. The maze was mounted on a pedestal that was 30 in above the ground 
and could rotate at its center. The escape cage was made from a black plastic 
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box with a ramp connected beneath the escape hole for easy access. Four bright 
ceiling lamps and a alarm were used as aversive stimuli during the test. The 
maze and escape cage were thoroughly cleaned with 70% ethanol between 
testing sessions to avoid any olfactory cues and the maze was rotated randomly 
after every mouse to avoid intra-maze odor or visual cues.  
 During the test, the mice were habituated to the maze on day 1. Each 
time, one mouse was placed in the center of the maze, covered with an opaque 
cardboard chamber for 15 seconds then slowly guided to the escape hole with a 
3 L glass beaker. Each mouse was given 3 min to enter the escape hole on its 
own, if not, the mouse was nudged gently into the hole or placed directly into the 
hole. Afterward, the mouse was allowed to stay in the escape hole for 2 min. The 
ceiling lights and white noise remained on while the mouse was exploring the 
maze and turned off immediately after they entered the escape hole. This 
procedure was repeated for all mice. On days 2-5, the mice were trained 
extensively to ensure a strong memory for the escape location (4 
times/mouse/day, 16 times in total) to learn to enter the escape hole by 
themselves. During these trials, the mice were allowed to stay in the escape 
cage for 1 min during each training trial. Memory of the escape hole location was 
probed 1 d and 5 d later. During the probe sessions, the escape hole was 
covered and spatial memory in the subject mice was tested. Video recordings 
were captured with a Logitech c920 webcam. The primary latency, total latency, 
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correct/error nose pokes, and traces of locomotion were scored in Image J using 
the plugin MTrack blind to the animal’s identity. 
2.16.8 Fear conditioning test 
The fear conditioning tests consisted of two parts: contextual- and cue-
dependent fear memory. Before the test, mice were habituated in a separate 
cage with a similar context as the testing cage (bars on the floor, white and 
smooth walls, pine wood bedding with an 8% acetic acid odor) for three 
continuous days (5 min/day). On experimental day 1, for each trial, one mouse 
was placed into the testing cage and allowed to explore the cage freely for 3 min, 
followed by a 30 s tone (80 db) and an electrical foot shock (2 s, 0.6 mV) at the 
end of the tone. The tone and foot shock were repeated three times in each trial 
with three 1 min intervals. The procedure was repeated for every mouse in the 
experiment. The whole cage was thoroughly cleaned with 70% ethanol and 8% 
acetic acid after every mouse to avoid potential olfactory cues from other mice. 
On experimental day 2, the mice were placed back into the same cage with 
exactly the same environment and acetic acid odor to test their contextual fear 
memory without any foot shock. The mice were allowed to explore the cage for 5 
min. On experimental day 3, the context of the cage was completely changed 
(smooth white floor, back wall decorated with dots, corn bedding with 20% vanilla 
odor) and the mice were allowed to explore the cage freely for 3 min followed by 
another 2 min with the same tone from day 1 played. The motion index and 
95 
 
 
freezing percentages of the mice were recorded and analyzed by Video Freeze® 
software (Med Associates Inc.). 
2.17 Statistical analysis 
Data from multiple trials were averaged to obtain the mean for each experiment. 
Multiple means of the same conditions were averaged to obtain the standard 
error of the mean, as indicated by the error bars in histograms. Statistical 
analysis for parametric data was performed using the two-population student's t 
test and analysis of variance (ANOVA) with Tukey post-test. For non-parametric 
data, a Kruskal-Wallis test was used to check for significance followed by the 
Mann-Whitney U to test between group comparisons, with a Bonferoni correction 
for multiple comparisons where appropriate. All statistical analyses were 
performed using Graphpad Prims 6 software. 
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Table 2.1 Plasmids 
Plasmid Name Vector Backbone 
Size 
(bp) 
Bacterial 
Resistance Source 
pcDNA3.1+ pcDNA3.1+ 3100 Ampicillin Addgene 
EGFP-N1 pEGFP-N1 4700 Kanamycin Addgene 
mcherry-N mCherry-C1 4750 Kanamycin Cloned In House 
mcherry-actin mCherry-C1 6600 Kanamycin Addgene 
mir124 
overexpression pEM 208 4200 Ampicillin 
Cloned In 
House 
GFP-delta-catenin pEGFP-N1 8400 Kanamycin Shernaz Bamji, UBC 
pLKO scrambled 
shRNA pLKO.1 TRC 7100 Ampicillin Addgene 
pLKO KIDLIA 
shRNA 365 pLKO.1 TRC 7100 Ampicillin 
Cloned In 
House 
pLKO KIDLIA 
shRNA 368 pLKO.1 TRC 7100 Ampicillin 
Cloned In 
House 
Nrgn-GFP lentivirus pLVX 8200 Ampicillin Weifeng Xu, MIT 
GFP Lentivirus pLVX 8000 Ampicillin Weifeng Xub, MIT 
pCGLH scrambled 
shRNA pCGLH 5700 Ampicillin Addgene 
pCGLH KIDLIA 
shRNA 365 pCGLH 5700 Ampicillin 
Cloned In 
House 
pCGLH KIDLIA 
shRNA 368 pCGLH 5700 Ampicillin 
Cloned In 
House 
miR124 siRNA pcDNA3.1+ 3200 Ampicillin Santa Cruz 
pBS_miR124 BS pcDNA3.1+ 3200 Ampicillin Cloned In House 
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Table 2.2 Antibodies 
Primary   
Antibodies         
Name Catalog Number Dilution Host Source 
Bassoon ab82958 1:250 (slice IHC) rabbit Abcam 
EVI-1 ab28457 1:1000 (WB) rabbit Abcam 
GABAα1 Ab33299 1:250 (slice IHC) 1:1000 (WB) Rabbit Abcam 
GAPDH ab8245 1:3000 (WB) mouse Abcam 
Gephyrin ab3220066 1:25 (slice IHC) 1:1000 (WB) rabbit Abcam 
GFAP MAB5804 1:100 (slice IHC) rabbit Millipore 
GluA1-C homemade 
1:200 (slice IHC) 
1:600 (ICC)  
1:1000 (WB) 
rabbit In House 
GluA1-N MAB2263 1:500 (ICC) mouse Millipore 
GluA2-N AB10529 1:500 (ICC) mouse Millipore 
HDAC1 5356P 1:1000 (WB) mouse Cell Signaling 
KIDLIA HPA000404 
1:100 (slice IHC) 
1:500 (ICC)  
1:500 (WB) 
Rabbit Sigma-Aldrich 
MAP2 ab70218 1:1000 (WB) mouse Abcam 
N-cadherin 610920 1:1000 (WB) mouse BD Transduction Labs 
NeuN MAB377 1:250 (slice IHC) mouse Millipore 
Neurogranin ab23570 1:250 (slice IHC) 1:1000 (WB) rabbit Abcam 
PSD-95 73-348 
1:100 (slice IHC) 
1:600 (ICC)  
1:1000 (WB) 
mouse Neuromab 
RhoA ARH03-A 1:500 (WB) mouse Cytoskeleton, Inc. 
Synapsin E018 
1:250 (slice IHC) 
1:500 (ICC)  
1:1000 (WB) 
rabbit Thomas Sudhof Lab 
Tau-1 MAB3420 1:1000 (ICC) mouse Millipore 
α-tubulin 20911 1:5000 (WB) rabbit Sigma-Aldrich 
δ-catenin 611536 1:1000 (WB)  mouse BD Transduction Labs  
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Secondary 
Antibodies       
Rb IgG-HRP 170-6515 1:5000 (WB) rabbit BioRad 
Ms IgG-HRP 170-6516 1:5000 (WB) mouse BioRad 
Rb Alexa Fluor 488 A11094 1:700 (ICC) rabbit Molecular Probes 
Rb Alexa Fluor 555 A21428 1:700 (ICC) rabbit Molecular Probes 
Ms Alexa Fluor 488 A21121 1:700 (ICC) mouse Molecular Probes 
Ms Alexa Fluor 555 A21127 1:700 (ICC) mouse Molecular Probes 
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CHAPTER THREE: 
 THE X-LINKED AUTISM PROTEIN KIAA2022/KIDLIA 
REGULATES NEURITE OUTGROWTH VIA N-CADHERIN AND 
δ-CATENIN SIGNALING 
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3.1 Abstract 
Our previous work showed that loss of the KIAA2022 gene protein results in 
intellectual disability with language impairment and autistic behavior (KIDLIA, 
also referred to as XPN). However, the cellular and molecular alterations 
resulting from a loss-of-function of KIDLIA and its role in autism with severe 
intellectual disability remain unknown. Here we show that KIDLIA plays a key role 
in neuron migration and morphogenesis. We find that KIDLIA is distributed 
exclusively in the nucleus. In the developing rat brain, it is expressed only in the 
cortical plate and subplate region but not in the intermediate or ventricular zone. 
Using in utero electroporation, we find that shRNA-mediated knockdown of 
KIDLIA leads to altered neuron migration and a reduction in dendritic growth and 
disorganized apical dendrite projections in layer II/III mouse cortical neurons. 
Consistent with this, in cultured rat neurons, a loss of KIDLIA expression also 
leads to a suppression in dendritic growth and branching. At the molecular level, 
we find that KIDLIA suppression leads to an increase in cell-surface N-cadherin 
and an elevated association of N-cadherin with δ-catenin, resulting in a depletion 
of free δ-catenin in the cytosolic compartment. The reduced availability of 
cytosolic δ-catenin leads to elevated RhoA activity and reduced actin dynamics 
at the dendritic growth cone. Furthermore, in neurons with KIDLIA knockdown, 
over-expression of δ-catenin or inhibition of RhoA rescues actin dynamics, 
dendritic growth and branching. These findings provide the first evidence on the 
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role of the novel protein KIDLIA in neurodevelopment and autism with severe 
intellectual disability. 
 
3.2 Introduction 
Autism spectrum disorder (ASD) is described on the basis of its three core 
symptoms of diminished language and communication, impaired social 
interactions and the tendency for repetitive behaviors (Lord et al, 1989). ASD is 
becoming increasingly devastating due to its high prevalence, impact on families 
and cost to society. Approximately 1 in 68 individuals in the United States have 
ASD and roughly 30% of those with ASD have intellectual disability (ID) (Baio, 
2014).  
The mammalian X chromosome is enriched with genes expressed in the 
brain, as demonstrated by the high incidence of X-linked ID (Nguyen and 
Disteche, 2006; Skuse, 2005). Previous work from our group and others 
identified loss of function of KIDLIA (also referred to as KIAA2022 or Xpn) at 
chromosome Xq13.2 as the gene responsible for severe ID and autistic behavior 
in several families (Cantagrel et al, 2009; Cantagrel et al, 2004; Charzewska et 
al, 2015; Ishikawa et al, 2012; Kuroda et al, 2015; Van Maldergem et al, 2013). 
We have previously shown that knockdown of KIDLIA in rat hippocampal 
neurons led to impaired neurite outgrowth (Van Maldergem et al, 2013). Patients 
with a loss of KIDLIA show symptoms typical of ASD including febrile seizures, 
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repetitive behaviors, impaired language, microcephaly and strabismus (Cantagrel 
et al, 2009; Cantagrel et al, 2004; Van Maldergem et al, 2013), establishing the 
gene as a causal factor for ASD with ID.  
Accumulating evidence has shown that alterations in neurite outgrowth 
and branching are a common phenotype in neurodevelopmental disorders 
including ID and ASD (DiCicco-Bloom et al, 2006; Zikopoulos and Barbas, 2010). 
Many autism-related mutations, such as those in phosphatase and tensin 
homolog on chromosome ten (PTEN), tuberous sclerosis complex 1 (TSC1), or 
SHANK3, result in an excess of branching (Kwon et al, 2006; Peça et al, 2011; 
Weston et al, 2014). While others, such as mutations in methyl CpG binding 
protein 2 (MECP2), thousand and one kinase 2 (TAOK2) and endosomal Na+/H+ 
exchanger 6 (NHE6) lead to diminished branching (Belichenko et al, 2009; de 
Anda et al, 2012; Ouyang et al, 2013). As a novel gene product involved in 
autism with severe intellectual disability, the role for KIDLIA in brain development 
including neurogenesis, neuron migration and neuron morphogenesis has not 
been investigated. Our previous work has suggested an involvement of KIDLIA in 
neurite outgrowth (Van Maldergem et al, 2013), but the molecular mechanisms 
remain unknown.  
N-cadherin-mediated extracellular interactions have been shown to be 
required for dendrite growth (Tan et al, 2010). A major molecule that interacts 
with the cytoplasmic C-terminal of N-cadherin is δ-catenin.  δ-catenin, a member 
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of the p120 catenin family, is neuron specific and binds to the juxtamembrane 
segment of N-cadherin (Lu et al, 1999). δ-catenin is a major candidate gene in 
autism and part of a protein network that is strongly involved regulating dendrite 
growth (Turner et al, 2015). Overexpression of δ-catenin can induce dendritic 
protrusions in hippocampal neurons (Martinez et al, 2003), while loss of δ-catenin 
reduces dendritic growth and branching (Arikkath et al, 2008; Elia et al, 2006).  
For the first time we report a role for KIDLIA in neuron migration and 
dendrite morphological development. We show that KIDLIA is expressed 
exclusively in the nucleus and is neuron specific. We find that loss of KIDLIA 
produces aberrant neuronal migration with major defects in apical dendrite 
growth and orientation in vivo. Knockdown of KIDLIA in vitro results in a 
decrease in dendritic growth and actin dynamics. A loss of KIDLIA also leads to 
increased N-cadherin at the plasma membrane and an elevated interaction 
between N-cadherin and δ-catenin. This increased association depletes the 
cytoplasmic pool of δ-catenin causing activation of RhoA-GTP. Consistent with 
this, we find that after KIDLIA knockdown in neurons, overexpressing δ-catenin 
or inhibiting RhoA activity rescues the defects in dendritic growth and actin 
dynamics. These findings strongly support a role for the N-cadherin-δ-catenin-
RhoA signaling system in the KIDLIA-dependent dysregulation of dendritic 
morphogenesis, providing novel insights into the mechanism of KIDLIA-
dependent autism and ID.  
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3.3 Results 
3.3.1 KIDLIA shows nuclear localization and neuron-specific expression in 
vivo 
In situ hybridization studies have shown a lack of KIDLIA mRNA in proliferating, 
BrdU positive cells, indicating that it may only be expressed in post-mitotic 
neurons (Cantagrel et al, 2009); however, KIDLIA protein expression has not 
been examined in neurons. By immunostaining KIDLIA in brain slices from 
postnatal day 0 (P0, day of birth) mouse cortex, we observed an exclusive 
nuclear localization of KIDLIA that co-localized with the nuclear marker Hoescht 
(Figure 3.1A). To further investigate the KDILIA expression pattern in cortical 
layers in vivo, we compared the KIDLIA distribution in embryonic day 17 (E17) 
and P0 mouse brains. In E17 brain slices, KIDLIA was not expressed in the 
ventricular zone (VZ) and intermediate zone (IZ). Up from the VZ, only minimal 
background staining of KIDLIA protein was detected until the subplate (SP) 
region where KIDLIA expression levels were sharply increased and maintained 
throughout the entire CP (Figure 3.1B). Similarly, immunostaining of P0 brains 
showed that strong KIDLIA expression was restricted to the CP in contrast to the 
VZ/IZ area (Figure 3.1C). To determine whether KIDLIA was preferentially 
expressed between neurons and glia, we co-immunostained KIDLIA with the 
neuron-specific marker NeuN, or the glial marker GFAP. We found that 
immunofluorescent signals of KIDLIA completely co-localized with NeuN positive 
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neurons at P0 and P14 (Figure 3.1D, 3.1E), but not with GFAP-positive glia (P14) 
(Figure 3.1F), indicating that KIDLIA expression was neuron specific. 
3.3.2 In utero electroporation of KIDLIA shRNAs disrupts neuronal 
migration but does not affect the multipolar to bipolar transition 
To investigate KIDLIA’s role in neuronal migration, we utilized in utero 
electroporation (IUE) to knockdown KIDLIA expression during early development. 
Two specific KIDLIA shRNAs with GFP, or a scrambled control, were 
electroporated into mouse embryonic brains at E15 and returned to the pregnant 
dam to develop (Figure 3.2A). Brains were first collected at E17 and 
immunostained for KIDLIA. Indeed, in GFP-positive shRNA electroporated 
neurons, KIDLIA expression was significantly reduced compared to scrambled 
controls and nearby non-electroporated neurons (Figure 3.2B). 
Callosally projecting pyramidal neurons are born around E15 in the VZ 
and migrate to their final location in layers II/III in the CP. At E17, 60% of the 
neurons electroporated with scrambled shRNA were found in the IZ and only 
13% had entered the CP. Strikingly, after electroporation of KIDLIA shRNAs, 
44% of the neurons were found in the IZ and 28% of the neurons had already 
migrated into the CP (Figure 3.2C, 3.2D). These results strongly indicate that 
loss of KIDLIA expression altered the migration process in the developing brain.  
To investigate the effect of KIDLIA on neuron migration at a later stage, 
we next collected brains at P0 after IUE at E15. In agreement with our findings at 
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E17, we found that 79% of KIDLIA-shRNA neurons had already reached the 
upper CP at P0, compared to only 64% in scrambled controls. Additionally, in 
shRNA electroporated brains, only 5% of neurons were found in the IZ compared 
to 15% in scrambled control brains (Figure 3.2E and 3.2F). Interestingly, 
although KIDLIA knockdown resulted in changes in the relative layer distribution 
of the migrating neurons, it did not affect their final laminar destination, with the 
majority of the electroporated neurons residing in layer II/III (Figure 3.2E).  
After birth in the VZ, multipolar pyramidal neurons move within the IZ/SP 
where they must adopt a bipolar morphology to enter the CP. This multipolar to 
bipolar transition (MBT) is key to proper migration and integration of neurons into 
the cortical plate. KIDLIA protein begins to be expressed in the SP region below 
the cortical plate at E17 and may be involved in neuronal migration, we therefore 
wanted to know whether loss of KIDLIA expression resulted in neurons 
bypassing the multipolar stage allowing them to move into the CP directly. In 
mice electroporated with KIDLIA shRNAs at E15, we found that in E17 brains 
both KIDLIA shRNA and scrambled control neurons showed a typical multipolar 
morphology in the IZ/SP region. Similar to controls, KIDLIA knockdown neurons 
showed a normal bipolar morphology after entering the CP (Figure 3.2G and 
3.2H). These findings suggest that KIDLIA doesn’t affect the MBT during 
neuronal migration. 
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3.3.3 Knockdown of KIDLIA affects apical dendrite growth and orientation 
in vivo 
To examine the role of KIDLIA in neuronal development, we analyzed dendritic 
growth and soma location of neurons following IUE of KIDLIA shRNAs at E15. At 
P4, neurons have reached their proper laminar location at layer II/III but the 
somas of neurons electroporated with KIDLIA-shRNAs were located closer to the 
pial surface (Figure 3.3A and 3.3C), possibly arising from a facilitated migration 
rate and/or a disruption in the termination of migration. Similar to scrambled 
controls, neurons with KIDLIA shRNAs showed a clear apical dendrite growing 
as single straight process directed orthogonally to the pial surface (Figure 3.3A 
and 3.3B). However, neurons expressing KIDLIA shRNAs had a longer apical 
neurite (Figure 3.3A, 3.3D). The percentage of cells whose apical neurites 
reached the pia was not significantly different from the control at P4 (Figure 
3.3E). 
Strikingly, brains analyzed at P14 showed that electroporation of KIDLIA 
shRNAs significantly disrupted the orientation of the apical dendrite. The apical 
dendrites of neurons after KIDLIA knockdown were largely disorganized and not 
directed toward the pia, compared to age-matched controls (Figure 3.3F and 
3.3G). A significant increase and variation in the angle of the apical dendrite to 
the pia was observed in KIDLIA shRNA electroporated brains compared to 
scrambled controls (Figure 3.3H). KIDLIA knockdown also produced a 35% 
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decrease in the length of the major apical dendrite and a significant decrease in 
the distance of their somas to the pia (Figure 3.3I and 3.3J). Additionally, after 
KIDLIA knockdown, the number of dendrite tips that reached the pia was 
significantly decreased compared to controls (Figure 3.3K), presumably due to a 
disorganization of the apical dendrite orientation and decreased dendritic growth. 
These in vivo results showed that after knockdown of KIDLIA, neuronal somas 
were positioned at sites closer to the pial surface at both P4 and P14. A loss of 
KIDLIA caused aberrant dendrite orientation and decreased apical dendrite 
growth, indicating that the directed outgrowth and branching of the dendritic tree 
was significantly impaired, possibly as a consequence of the neurons’ early 
arrival into the CP or a subtle shift in laminar localization.  
3.3.4 Knockdown of KIDLIA decreases dendritic growth and branching in 
vitro 
To further investigate the molecular mechanisms underlying the effect of KIDLIA 
on dendritic growth and arborization, we suppressed KIDLIA expression in 
primary cultured neurons. We infected cortical neurons at the time of plating (DIV 
0) with lentiviral shRNAs containing the same targeting sequences as those used 
for IUE in vivo, and found a ~60% reduction in KIDLIA protein expression 6 days 
after infection (Figure 3.4A and 3.4B).  Consistent with the in vivo observations, 
we confirmed a similar nuclear localization of KIDLIA in cultured neurons (Figure 
3.4A, 3.4C). 
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To investigate the effect of KIDLIA knockdown on dendritic outgrowth, we 
infected neurons with KIDLIA shRNA virus at DIV0 and immunostained for MAP2 
and tau1 at DIV12 to label the dendrite and axon, respectively (Figure 3.4D). 
Strikingly, Sholl analysis revealed a large decrease in dendritic branching after 
KIDLIA knockdown (Figure 3.4E). Compared to scrambled controls, we observed 
an ~25% reduction in the length of the longest dendrite, a nearly 50% reduction 
in the number of dendritic branches, and a 55% reduction in total dendritic length 
(Figure 3.4F-H). These results show that loss of KIDLIA expression severely 
stunted neuronal development in vitro.  
3.3.5 Knockdown of KIDLIA leads to an increase in surface N-cadherin and 
association of N-cadherin/δ-catenin 
N-cadherin, the neural member of the cadherin superfamily, has been shown to 
be involved in neurite outgrowth (Bard et al, 2008). N-cadherin is structurally 
composed of five extracellular cadherin domains, a single-pass transmembrane 
domain, and an intracellular domain that interacts with catenins which regulate 
downstream signaling cascades including the Rho GTPases.  
A previous study has indicated that in PC12 cells, knockdown of KIDLIA 
up-regulates the expression of N-cadherin (Magome et al, 2013). We therefore 
sought to investigate whether knockdown of KIDLIA affected N-cadherin 
expression and localization in neurons. In DIV6 neurons which were infected with 
KIDLIA shRNAs at DIV0, we found that KIDLIA knockdown led to a ~25% 
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increase in N-cadherin protein levels compared to scrambled controls (Figure 
3.5A and 3.5B). Because KIDLIA is localized in the nucleus, we next examined 
whether KIDLIA regulates N-cadherin gene transcription. We infected DIV0 
cultured cortical neurons with KIDLIA shRNAs for 7 days, and measured N-
cadherin mRNA by RT-PCR using the cell lysates. Indeed, after knockdown of 
KIDLIA we found a 35% increase in N-cadherin mRNA compared to scrambled 
shRNA and untreated controls (Figure 3.5C). This data suggests that the KIDLIA-
induced increase in N-cadherin protein amount may result from an up-regulation 
in its gene transcription and translation.  
To assess the membrane localization of N-cadherin after KIDLIA 
knockdown, we isolated cell-surface proteins through biotinylation and 
immunoprecipitation with Sulfo-NHS-LC-Biotin. Surprisingly, we found a greater 
than 2-fold increase in surface N-cadherin levels after shRNA-mediated 
knockdown of KIDLIA compared to scrambled controls (Figure 3.5D and 3.5E), 
indicating that KIDLIA knockdown not only increased overall N-cadherin 
expression, but also caused a translocation from the cytosolic compartment to 
the cell surface. 
δ-catenin is a critical functional mediator for N-cadherin via a direct protein 
association. δ-catenin expression can induce a dendritic-like morphology in 
fibroblasts (Yu and Malenka, 2003) and stimulates neurite outgrowth in 
hippocampal neurons (Martinez et al, 2003). Importantly, an increase in 
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membrane-localized N-cadherin suppresses the growth-promoting effects of δ-
catenin, suggesting that surface N-cadherin acts as a buffer regulating cytosolic 
δ-catenin availability (Kim et al, 2008). Given that δ-catenin is brain specific (Abu-
Elneel et al, 2008), and that its localization and ability to induce neurite outgrowth 
is tightly linked with N-cadherin, we hypothesized that the increased membrane 
expression of N-cadherin sequesters δ-catenin at the surface and thus depletes 
its cytosolic pool. 
To investigate this hypothesis, we performed co-immunoprecipitation 
studies using lysates of DIV6 cultured cortical neurons infected with viral KIDLIA 
shRNAs. We found that knockdown of KIDLIA significantly enhanced the 
association of N-cadherin with δ-catenin. Meanwhile, we observed a major 
reduction in the amount of free unbound δ-catenin in the supernatant following 
immunoprecipitation (Figure 3.5F). These results indicate that loss of KIDLIA 
results in an increase in the association of N-cadherin with δ-catenin at the 
plasma membrane, resulting in a reduction in free cytosolic δ-catenin.  
3.3.6 Loss of KIDLIA disrupts actin dynamics at the neurite growth cone via 
δ-catenin 
Because free cytosolic δ-catenin is required for its downstream signaling, we 
next examined whether over-expression of δ-catenin after loss of KIDLIA could 
rescue the deficits in neurite outgrowth and branching. Neurons were treated with 
scrambled, or KIDLIA lentiviral shRNA, at DIV0 and transfected with δ-catenin-
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GFP, or GFP control, one day later (Figure 3.5G). At DIV6, Sholl analysis 
revealed a large decrease in dendritic branching in shRNA + GFP cells 
compared to scrambled + GFP. However, in neurons over-expressing δ-catenin-
GFP + shRNA, neurite branching was restored to levels similar to scrambled 
controls (Figure 3.5H). These results strongly indicate that the decrease in 
neurite outgrowth and branching after knockdown of KIDLIA was caused by a 
reduction in free δ-catenin availability.  
Actin is dynamically regulated at the neurite tips, which plays a crucial role 
in neurite growth (Meberg and Bamburg, 2000; Nicholson-Dykstra et al, 2005). 
To examine whether KIDLIA is implicated in cytoskeletal dynamics, we 
performed fluorescence after photobleaching (FRAP) experiments with 
fluorescently labeled actin after knockdown of KIDLIA with siRNAs. To test the 
efficacy of the KIDLIA knockdown, scrambled or KIDLIA siRNAs were co-
transfected with GFP at DIV0, and immunostainings of KIDLIA at DIV4 showed a 
~60% reduction in protein expression (Figure 3.6A and 3.6B). Next, GFP-actin 
was transfected at DIV0 into hippocampal neurons with scrambled, or KIDLIA 
siRNAs, and FRAP was performed on the growth cones at DIV4 (Figure 3.6C). In 
neurites from KIDLIA siRNA transfected neurons, the recovery rate of the actin 
signal was drastically reduced (Figure 3.6D). Compared to scrambled siRNA 
controls, KIDLIA knockdown showed a 70% decrease in the mobile fraction (Mf) 
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of actin (Figure 3.6G) and a subsequent increase in the immobile fraction (IMf) of 
actin (Figure 3.6H).  
Due to the large reduction of free δ-catenin in the cytosol after KIDLIA 
knockdown, which is known to be involved in actin regulation, we next sought to 
examine whether over-expression of δ-catenin could rescue actin dynamics with 
the transfection of δ-catenin-GFP after siRNA-mediated knockdown of KIDLIA 
(Figure 3.6E). Indeed, FRAP revealed that in δ-catenin transfected neurons, actin 
dynamics were restored (Figure 3.6F) and the mobile and immobile fractions of 
actin returned to levels similar to controls (Figure 3.6G and 3.6H), indicating that 
the impaired actin dynamics likely resulted from a reduction of free cytoplasmic 
delta-catenin. 
3.3.7 Increased RhoA activation leads to impaired actin dynamics 
A major downstream effector of δ-catenin is the Rho-GTPase pathway, which 
links the cadherin/catenin complex to actin dynamics. RhoA GTPase activation 
leads to an inhibition in neurite growth (Kozma et al, 1997; Leeuwen et al, 1997). 
Studies have shown that free cytosolic δ-catenin, but not the membrane 
associated fractions, inhibit RhoA activity (Kim et al, 2008). Because KIDLIA 
regulates the association of δ-catenin to surface N-cadherin, and thus reduces 
the availability of cytosolic δ-catenin, we wanted to know whether KIDLIA 
knockdown affected RhoA activity. The Rho activity status alternates between an 
active, GTP-bound state and an inactive, GDP-bound state. To perform RhoA 
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activity assays, we infected neurons with lentivirus containing scrambled or 
KIDLIA shRNAs. Neuron lysates were incubated with a GST fusion protein 
containing the binding domain of the Rho effector protein rhotekin, so that the 
active form of RhoA was isolated by immunoprecipitation. We then probed for 
total RhoA in lysates and the immunoprecipitated active RhoA via western blot 
(Figure 3.7A). Interestingly, we found that KIDLIA knockdown led to a 60% 
increase in the amount of active RhoA compared to scrambled controls (Figure 
3.7B). Since RhoA activation prevents neurite initiation and induces neurite 
retraction, our findings suggest that the inhibitory effect of KIDLIA knockdown on 
dendrite growth may be mediated by RhoA.  
To further determine the role of RhoA activity in the KIDLIA-dependent 
effects on neuron development, we first performed FRAP experiments to 
examine the actin dynamics with the application of CN06, which directly inhibits 
the primary RhoA effector ROCK (Ishizaki et al, 2000). In KIDLIA knockdown 
neurons, application of CN06 1 h prior to FRAP was sufficient to rescue the actin 
dynamics to levels similar to scrambled controls (Figure 3.7C and 3.7D). 
Furthermore, we wanted to determine whether the RhoA signaling pathway was 
responsible for the KIDLIA-dependent impairment in dendritic arborization. We 
therefore infected neurons with KIDLIA shRNA virus at DIV0 followed by CN06 
treatment from DIV4-DIV7. Dendritic structure indicated by MAP2 staining was 
examined via Sholl analysis. Indeed, after KIDLIA knockdown in neurons, we 
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found that CN06 incubation rescued the defects in dendritic growth and 
branching (Figure 3.7E and 3.7F). These findings establish a molecular process 
in which KIDLIA knockdown induces an increase in membrane-bound N-cadherin 
and sequestration of cytosolic δ-catenin, leading to activation of the RhoA 
pathway and a subsequent alteration in actin dynamics, eventually causing 
suppression in neurite growth and branching (Figure 3.7G). 
 
3.4 Discussion 
Our study provides the first evidence showing that KIDLIA, the protein product of 
the recently identified XLID gene KIAA2022, plays an important role in neuron 
migration and morphogenesis. In mouse brain, knockdown of KIDLIA results in a 
redistribution of more neurons in the cortical plate at earlier time points and a 
subtle, but potentially consequential mis-localization of neurons within their 
destined cortical layers. In addition, we find that early growth of the leading apical 
neurite is positively regulated in KIDLIA knockdown neurons; however, at a later 
time point at P14, loss of KIDLIA causes an inhibition in apical dendrite growth 
and a disruption of dendritic orientation. Given that IUE only transfects a small 
portion of neurons derived at a specific time, the majority of the neighboring 
neurons remain unaffected, the effects of KIDLIA are likely neuron autonomous, 
rather than being caused by external environmental factors.  
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How neuron migration is regulated by KIDLIA remains to be investigated. 
KIDLIA protein expression was mostly restricted to the CP with a distinct band of 
expression turning on in the subplate region just prior to the CP at E17 in mouse 
brain. IUE of KIDLIA shRNA led to more neurons migrating to upper cortical 
layers with a closer positioning of the soma to the pia. After migration, neurons 
reached their proper laminar layers; however, the aberrant positioning of the 
soma relative to the pia may indicate a disruption in the termination of the 
migration process, and/or the final somal translocation after migration to layer 
II/III. However, we observed no change in the multipolar transition phase prior to 
entry into the CP. Future studies using in utero electroporation of KIDLIA shRNA 
at E12.5 to label layer V/VI neurons would be useful to investigate whether loss 
of KIDLIA could mis-localize deeper layer neurons to upper cortical layers. 
Additionally, aberrant soma positioning could be due to premature cell cycle exit 
during proliferation resulting in an earlier arrival of neurons to their destined 
cortical layers. The distinct expression pattern of KIDLIA within and just below 
the CP in embryonic brains suggests that KIDLIA may act as a checkpoint factor 
for CP entry; a loss of KIDLIA would therefore offer neurons free access to pass 
the IZ-CP border and enter into the CP.  
 We have observed similar changes in neurite growth in cultured neurons. 
KIDLIA knockdown led to a significant reduction in dendrite length and 
complexity. Using this in vitro system, we investigated the cellular mechanisms 
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responsible for the disrupted dendritic development. We found that loss of 
KIDLIA induced an increase in total N-cadherin levels with a substantial increase 
in the surfaced-localized fraction, which was accompanied with an elevated 
association of surface N-cadherin with δ-catenin. The increased δ-catenin/N-
cadherin association led to a depletion of the free cytosolic pool of δ-catenin 
thereby increasing the activation of the downstream RhoA pathway. The RhoA 
pathway is a major mediator of actin dynamics and neurite outgrowth and 
complexity. Extensively branched processes can be induced when RhoA is 
inhibited via δ-catenin. Conversely, when RhoA is activated, dendrite length and 
the dendritic field is decreased (Li et al, 2000; Nakayama et al, 2000; Wong et al, 
2000). The reduction in δ-catenin availability is responsible for the KIDLIA-
dependent effect on dendrite morphogenesis because overexpression of δ-
catenin rescued neurite growth and dendritic branching as well as actin dynamics 
in neurons after KIDLIA knockdown. In line with our findings that δ-catenin is a 
key mediator for the neuronal effects of KIDLIA, δ-catenin was identified as a 
major genetic target in autism population  (Turner et al, 2015). Interestingly, of 
the autism genes positively correlated with δ-catenin, there is a significant 
enrichment in genes involved in dendrite morphogenesis including PDLIM5, 
SHANK1, CDKL5, DLG4  (Turner et al, 2015). In addition, loss of δ-catenin is 
implicated in impaired cognitive function and intellectual disabilities  (Belcaro et 
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al, 2015; Hofmeister et al, 2015; Medina et al, 2000), indicating a crucial role for 
δ-catenin in brain development and function.  
 Under the condition of KIDLIA knockdown, we find an increase in N-
cadherin protein levels and an elevated association between N-cadherin and δ-
catenin, but the underlying mechanism remains unclear. It is possible that a lack 
of KIDLIA expression in the nucleus leads to an up-regulation in N-cadherin gene 
transcription and subsequent protein translation. Regarding KIDLIA-induced 
changes in protein interaction, it has been shown that δ-catenin is subject to 
protein palmitoylation  (Kang et al, 2008), a modification that causes enhanced 
association of δ-catenin with N-cadherin  (Brigidi et al, 2014). Also, by binding to 
the juxtamembrane domain of cadherin, δ-catenin is known to stabilize and 
increase the amount of N-cadherin at the surface  (Reynolds and Carnahan, 
2004). It is thus conceivable that a loss of KIDLIA may cause δ-catenin 
palmitoylation, possibly via enhancing the expression of the palmitoyl-acyl 
transferase DHHC5  (Brigidi et al, 2014), leading to higher levels of association 
between δ-catenin and N-cadherin.  
We found that the N-cadherin/δ-catenin effect is mediated by RhoA. The 
Rho GTPases regulate dendrite growth and branching via modulation of 
cytoskeleton components (Newey et al, 2005). The role for RhoA in dendritic 
branching has recently been established as RhoA activation leads to a reduction 
in dendritic branching (Nakayama et al, 2000), while RhoA inhibition enhances 
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branching (Neumann and Schweigreiter, 2002). Cytoplasmic δ-catenin has 
previously been shown to inhibit RhoA by keeping it in the inactive RhoA-GDP 
state, resulting in an increase in dendritic branching (Martinez et al, 2003). 
Constitutively active RhoA expression has been shown to reduce dendrite length 
and the volume of the dendritic field (Nakayama et al, 2000; Wong et al, 2000), 
while RhoA loss-of-function mutations has also been shown to cause abnormal 
dendritic arborization (Lee et al, 2000). 
RT-PCR of mRNA prepared from prenatal and postnatal mouse brain 
shows a sevenfold increase in KIDLIA expression between embryonic day 10.5 
(E10.5) and E18.5, indicating a role for KIDLIA in neural development. KIDLIA 
mRNA expression reaches a maximum at postnatal day 3 (P3) and is maintained 
at a low level into adulthood (Cantagrel et al, 2004; Ishikawa et al, 2012). Thus, 
KIDLIA expression peaks during key developmental time periods for neuronal 
growth and maturation. Both in vivo in mouse brain and in cultured neurons, 
immunostainings reveal a co-localization of KIDLIA with the nuclear marker 
Hoescht. KIDLIA is a large 170 kDa protein with monopartite and bipartite 
nuclear localization sequences. Given the specific nuclear localization, we 
suspect a major role for KIDLIA in gene regulation. It is possible that KIDLIA 
knockdown causes an up-regulation in N-cadherin gene transcription and thus an 
elevated amount of N-cadherin. 
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Attenuated growth and structural abnormalities in developing neurons lead 
to deficiencies in neuronal wiring and synapse formation during brain maturation. 
Aberrant neuron morphogenesis and synaptogenesis are associated with a 
number of brain disorders, including Fragile-X mental retardation, Rett syndrome, 
Down syndrome and CDKL5-related encephalopathy (Belmonte and Allen, 2004; 
Garner and Wetmore, 2012; Ricciardi et al, 2012; Shepherd and Katz, 2011). 
Given that KIDLIA is a novel gene with largely unknown functions, more studies 
are needed to elucidate the role of KIDLIA in multiple steps of neuron 
development including neurogenesis, morphogenesis, synapse maturation, 
synaptic plasticity and behavior. 
  
  
121 
 
 
Figure 3.1 
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Figure 3.1 KIDLIA is expressed in neurons and is localized in the nucleus 
(A) Immunohistochemistry in brain slices of P0 mouse cortex.  KIDLIA was co-
localized with the nuclear marker Hoescht. Scale bar = 10 µm. (B,C) 
Immunohistochemistry of KIDLIA at E17. KIDLIA expression began in the SP 
region of the upper IZ and throughout the cortical plate and was restricted to the 
cortical plate at P0. Scale bars = 20 µm.  (D, E) KIDLIA was expressed only in 
cells positive for the neuronal marker NeuN at P0 (left and P14 (right). (F) KIDLIA 
expression was not observed in cells expressing the glia marker GFAP at P14. 
Scale bars = 20 µm (full picture); 10 µm (enlarged area). UpCP = upper cortical 
plate; LoCP = lower cortical plate; SP = subplate; IZ = intermediate zone; VZ = 
ventricular zone. 
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Figure 3.2 
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Figure 3.2. In utero electroporation of KIDLIA shRNA disrupts neuronal 
migration but does not affect the multipolar to bipolar transition 
(A) Schematic of the in utero electroporation (IUE) procedure. Pups were 
injected with shRNA-GFP DNA into the lateral ventricle (LV) at E15 and the 
anode of the tweezertrode was placed above the dorsal telencephalon. Pups 
were the returned to the mother to mature until the times indicated. (B) 
Representative images of scrambled and KIDLIA shRNA electroporated neurons 
at E17. Immunostaining of KIDLIA shows a clear reduction of KIDLIA expression 
compared to scrambled controls and nearby non-electroporated neurons. Scale 
bare = 10 µm. (C) Brain slices taken at E17 after IUE of KIDLIA shRNA-GFP, or 
scrambled shRNA-GFP, at E15. Scale bare = 50 µm. (D) KIDLIA knockdown 
caused a greater percentage of neurons in the upCP and a smaller fraction in the 
IZ. More than 1,500 GFP+ neurons from five brains were analyzed in each group. 
(E) Brain slices taken at P0 after IUE of KIDLIA shRNA-GFP, or scrambled 
shRNA-GFP, at E15. Scale bare = 50 µm. (F) Analysis of neuronal migration at 
P0 showed that more neurons were in the upCP and less in the IZ compared to 
scrambled controls. More than 1,200 GFP+ neurons from four brains were 
analyzed in each group. (G and H) Analysis of the multipolar to bipolar transition. 
In E17 brain, multipolar neurons were observed in the upper IZ (magnified lower 
right) prior to CP entry and neurons showed a normal transition back to a bipolar 
morphology after CP entry (magnified upper right) in both KIDLIA and scrambled 
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shRNA electroporated neurons. Scale bars = 10 µm. Statistics: ** p<0.01, *** 
p<0.001. Error bars, SEM. Yellow dashed line indicates the pia. UpCP = upper 
cortical plate; LoCP = lower cortical plate; IZ = intermediate zone; VZ = 
ventricular zone. 
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Figure 3.3 
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Figure 3.3. Knockdown of KIDLIA affects apical dendrite growth and 
orientation in vivo 
(A) Images (left) and tracings (right) of P4 layer II/III cortical neurons after 
electroporation of GFP labeled shRNA constructs at E15. Yellow dashed lines 
indicate the pia; scale bar = 10 µm. (B) No significant change was observed in 
the apical dendrite angle to the pia after knockdown of KIDLIA. (C) An increase 
was observed in the length of the major apical dendrite (n = 6) and (D) a 
decrease in the distance of the soma to the pia (n = 6). (E) No significant 
difference was observed in the number of dendrite tips reaching the pia. (F) 
Images (left) and tracings (right) of P14 layer II/III cortical neurons after 
electroporation of GFP labeled shRNA constructs at E15.5. Dashed lines indicate 
the pia; scale bar = 10 µm. (G) Merged tracings of the major apical dendrites of 
P14 neurons after in utero electroporation of scrambled and KIDLIA shRNA 
showed that knockdown of KIDLIA disrupted the orientation of the apical 
dendrites toward the pia. Red bars show the average angle of the dendrites in 
relation to the pial surface (dashed line). (H) Quantification of the angle of the 
major apical dendrite toward the pia showed a significant increase after loss of 
KIDLIA expression (n = 5). An angle of 0° indicates a dendrite is growing directly 
toward the pia. (I) A significant decrease in the length of the major apical 
dendrite, (J) a decrease in the distance of the soma to pia and (K) a significant 
decrease in the percentage of dendrite tips that reached the pia were observed 
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after knockdown of KIDLIA in vivo. Statistics: * p<0.05, ** p<0.01, *** p<0.001. 
Error bars, SEM. 
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Figure 3.4 
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Figure 3.4. Knockdown of KIDLIA decreases dendritic growth and 
branching in vitro 
(A) Western blot after nuclear/cytoplasmic fractionation of primary rat 
hippocampal neurons shows clear nuclear expression of KIDLIA with no 
expression in cytoplasm. Neurons were treated with lentiviral KIDLIA shRNA, or 
scrambled shRNA, at DIV0 and collected at DIV6. (B) Analysis of the western 
blot data showed that the shRNA significantly reduced KIDLIA expression (n=5); 
Nuclear loading control: HDAC1; cytoplasmic loading control = GAPDH. (C) 
Immunostaining of KIDLIA in primary rat hippocampal neurons shows co-
localization with the nuclear marker Hoescht. (D) Immunostaining of dendrites 
(MAP2) and axons (tau1) at DIV12; scale bar = 10 µm. (E) Sholl analysis of 
dendrite growth at DIV12 showed a significant change in branching (n=14). (F) 
Analysis of MAP2-positive dendrites showed a decrease in the longest dendrite 
segment (n = 14), (G) a decrease in the number of dendrite branches (n= 14) 
and (H) a significant decrease in the sum dendritic length (n=14). Statistics: * 
p<0.05, ** p<0.01, *** p<0.001. Error bars, SEM. 
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Figure 3.5 
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Figure 3.5. Knockdown of KIDLIA leads to an increase in surface N-
cadherin and the N-cadherin/δ-catenin association 
(A) Western blot from DIV6 neuronal lysates after treatment with KIDLIA shRNA 
virus (DIV0) showing an increase in total N-cadherin levels. Loading control = 
GAPDH (B) Quantification of the western blot data represented in panel A (n = 3, 
each sample performed in duplicate and averaged). (C) Knockdown of KIDLIA 
expression by shRNA lentivirus caused an increase in N-Cadherin mRNA 
expression. Gene expression was normalized to the housekeeping gene, 
GAPDH (n=3, each sample performed in triplicate and averaged). (D) Surface 
biotinlyation of neuronal lysates after treatment with scrambled or KIDLIA shRNA 
virus showed an increase in surface N-cadherin levels. (E) Quantification of the 
western blot data shown in panel C (n = 4). (F) N-cadherin was co-
immunoprecipitated with a dramatically larger fraction of δ-catenin after lentiviral 
shRNA knockdown of KIDLIA in neuronal lysates. The increased binding of δ-
catenin to N-cadherin subsequently depleted the unbound, cytosolic fraction of δ-
catenin. (G) Images of neurons transfected with scrambled or KIDLIA shRNA 
either with GFP or δ-catenin-GFP; scale bar = 10 µm. (H) Sholl analysis of the 
transfected neurons from panel E showed that δ-catenin overexpression could 
rescue the decreased dendrite growth and branching observed after knockdown 
of KIDLIA (n = 10). * p<0.05, ** p<0.01, *** p<0.001 Error bars, SEM. 
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Figure 3.6 
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Figure 3.6. Loss of KIDLIA disrupts actin dynamics at the neurite growth 
cone via δ-catenin 
(A) Immunocytochemistry of primary rat hippocampal neurons after transfection 
of scrambled, or KIDLIA siRNA, with GFP. Neurons were transfected at DIV0 and 
immunostained for KIDLIA (red) at DIV4. (B) Analysis of the 
immunocytochemistry images showed that the siRNA significantly reduced 
KIDLIA expression (n=10 for both groups). (C) FRAP experiments after co-
transfection of KIDLIA siRNA, or scrambled siRNA, with actin-GFP. Regions at 
the growing neurite tip were selected for photobleaching at 488 nm and imaged 
every 3 seconds. (D) Analysis of the FRAP data showed that knockdown of 
KIDLIA produced a dramatic decrease in actin dynamics after photobleaching n = 
9). (E) Neurons were co-transfected with KIDLIA siRNA, or scrambled siRNA, 
with actin-mCherry and δ-catenin-GFP, or GFP alone, and were photobleached 
at 555 nm and imaged every 3 seconds. (F) Analysis of the FRAP data. 
Overexpression of δ-catenin rescued the actin dynamics after knockdown of 
KIDLIA (n = 7). (G) The mobile fraction, calculated as the difference between the 
average level of bleaching to the level of recovery, was significantly decreased 
after knockdown of KIDLIA (n = 7). (H) The immobile fraction of actin, calculated 
as the difference between the initial fluorescence and the level of recovery was 
significantly decreased (n = 7). Statistics: ** p<0.01, **** p<0.0001. Error bars, 
SEM.   
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Figure 3.7 
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Figure 3.7. Increased RhoA activation leads to impaired actin dynamics  
(A) Western blot at DIV6 after treatment with KIDLIA shRNA, or scrambled 
shRNA virus, at DIV0. RhoA stimulation was performed with treatment of 
nocodazole (10 µM) for 30 min prior to collection of neuronal lysates. Activated 
RhoA-GTP was selectively immunoprecipated using beads conjugated to the 
Rho binding domain of the Rho effector protein, rhotekin, and whole cell lysates 
were probed for total RhoA levels. Loading control = GAPDH. (B) Quantification 
of the RhoA assay showed a significant increase in the levels of activated RhoA-
GTP after KIDLIA knockdown (n = 4). (C) Images of neurons transfected with 
KIDLIA siRNA, or scrambled siRNA, with actin-mCherry and treated with CN06, 
or vehicle control, 1 h prior to FRAP experiments. (D) Analysis of the FRAP data 
showed that inhibition of the RhoA pathway could rescue the actin dynamics after 
knockdown of KIDLIA (n = 6). (E) Images of neurons treated from DIV4-7 with 
CN06, or vehicle control, after treatment with KIDLIA shRNA or scrambled 
control virus at DIV0; scale bar = 10 µm. (F) Sholl analysis of the images in panel 
C showed that chronic inhibition of the RhoA pathway was sufficient to rescue 
dendrite outgrowth and branching (n = 11). (G) Diagram depicting changes in the 
N-cadherin-δ-catenin signaling cascade after loss of KIDLIA expression. 
Increased surface N-cadherin sequesters δ-catenin after KIDLIA knockdown 
thereby depleting the cytosolic free fraction of δ-catenin. Less inhibition on RhoA 
increases its activation and subsequent inhibition on neurite outgrowth via 
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changes in actin dynamics.  Statistics: * p<0.05, ** p<0.01, *** p<0.001. Error 
bars, SEM. 
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CHAPTER FOUR: 
LOSS OF KIAA2022/KIDLIA PRODUCES DEFICITS IN 
SYNAPTIC FUNCTION, GENE TRANSCRIPTION AND 
BEHAVIOR IN A NOVEL AUTISM MOUSE MODEL  
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4.1 Abstract 
Loss of function or mutations in single X-linked genes are a common cause of 
autism spectrum disorder (ASD) and intellectual disability (ID) in males. Our 
previous work has shown that loss of the X-linked protein KIDLIA was the 
causative factor for ASD with ID and impaired neurite outgrowth. KIDLIA is highly 
expressed in the developing brain; however, little is known about its function in 
synaptogenesis and synaptic plasticity. Therefore, we generated KIDLIA 
knockout (KO) mice which showed typical symptoms of ASD and ID including 
impaired social interactions, increased repetitive behavior, as well as impaired 
learning and memory. Using RNA sequencing, we show that KIDLIA regulates 
multiple synaptic-related genes, especially the plasticity-related gene, 
neurogranin. Loss of KIDLIA expression results in a significant impairments in 
synaptogenesis, gene dysregulation and decreased miniature excitatory post-
synaptic currents (mEPSCs). Additionally, we show that overexpression of 
neurogranin after shRNA-mediated knockdown of KIDLIA expression was 
sufficient to rescue synaptic AMPA receptor content and mEPSC amplitude and 
frequency. These findings demonstrate a role for KIDLIA in synapse 
development and function and confirm the KIDLIA KO mouse as a new ASD 
model that will be valuable for ASD neurodevelopmental research. 
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4.2 Introduction 
Autism spectrum disorder (ASD) is described on the basis of its three core 
symptoms of reduced social interactions, impaired language and communication 
and the tendency for repetitive behaviors (Lord et al, 1989). Recent reports have 
identified that ASD prevalence can occur in 1 in 68 individuals in the United 
States with up to 50% of those with ASD being diagnosed with intellectual 
disability (ID, IQ <70) (Baio, 2014). Additional comorbidities such as attention 
deficit hyperactivity disorder (ADHD), anxiety, bipolar disorder and epilepsy are 
common in ASD patients and suggest major abnormalities in brain function and 
neuronal network activity (Reiersen and Todd, 2008; Storch et al, 2012; Towbin 
et al, 2005; Zafeiriou et al, 2007). 
The causative factors leading to a diagnosis of ASD are highly 
heterogeneous, nevertheless, synaptic dysregulation and imbalances in neuronal 
activity and/or function have emerged as a common underlying pathology in 
ASD (Berkel et al, 2010; Pfeiffer et al, 2010; Tabuchi et al, 2007). Synaptic 
development in the mammalian cerebral cortex is a complex process that 
involves coordination of spine growth, recruitment of cell adhesion and synaptic 
scaffolding proteins and ultimately the insertion of functional receptors at the 
membrane surface (Colon-Ramos, 2009; Craig and Kang, 2007; Greer and 
Greenberg, 2008; Greer et al, 2010; Missler et al, 2012; Waites et al, 2005). 
Additionally, the number and strength of synapses must be appropriately 
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maintained to allow for proper neuronal network function. Many genes associated 
with ASD play important roles in the development and function of synapses, such 
as neuroligin 3 (NLGN3), neuroligin 4X (NLGN4X), neurexin 1 (NRXN1), and 
SH3, and multiple ankyrin repeat domains 3 (SHANK3), and recent genetic 
studies have identified a large number of ASD candidate genes that implicate 
synaptic dysregulation (Bourgeron, 2009; Pinto et al, 2010; Zoghbi, 2003). 
The mammalian X chromosome is enriched with genes expressed in the 
brain, as demonstrated by the high incidence of X-linked ID (Nguyen et al, 2006; 
Skuse, 2005). Loss of function of KIDLIA (KIAA2022 gene with intellectual 
disability and language impairment in autism; also referred to as Xpn) at 
chromosome Xq13.2 is the causative factor for autistic features and ID in several 
families (Cantagrel et al, 2009; Cantagrel et al, 2004; Charzewska et al, 2015; 
Ishikawa et al, 2012; Kuroda et al, 2015; Van Maldergem et al, 2013). 
dynamics (Gilbert et al, 2016; Van Maldergem et al, 2013). Patients with 
mutations or loss of KIDLIA expression display symptoms typical of ASD 
including febrile seizures, repetitive behaviors, impaired language, microcephaly 
and strabismus (Cantagrel et al, 2009; Cantagrel et al, 2004; Van Maldergem et 
al, 2013). We have recently shown that KIDLIA knockdown in rat hippocampal 
neurons impairs neurite outgrowth via a disruption of N-cadherin/δ-catenin 
signaling and actin However, the role that KIDLIA plays in synaptogenesis, 
synaptic function and cognitive function however remains to be elucidated. 
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Here we confirm a KIDLIA knockout (KO) mouse as a novel ASD model 
and investigate the mechanisms underlying the ASD phenotypes with ID after 
loss of KIDLIA expression. We find that KIDLIA KO mice showed severe deficits 
in social behavior, increased repetitive self-grooming and deficits in learning and 
memory, consistent with findings reported in human patients with loss of KIDLIA 
function. Golgi staining from KIDLIA KO brains showed alterations in spine 
morphology and density, suggesting a major synaptopathy underlying the 
behavioral deficits observed in the animal model. Indeed, knockdown of KIDLIA 
resulted in a significant decrease in AMPAR synaptic puncta density and 
subsequent decrease in miniature excitatory post-synaptic currents (mEPSCs.)  
To identify candidate synaptic-related genes, we performed RNA 
sequencing (RNAseq) after knockdown of KIDLIA in mouse neuronal cultures. 
Indeed, gene ontology analyses identified an enrichment of synaptic related 
genes and glutamate receptor signaling pathways that were dysregulated after 
knockdown of KIDLIA, including the most down-regulated gene, neurogranin 
(Nrgn). A calmodulin-binding protein, Nrgn is expressed exclusively in the brain, 
is enriched in dendritic spines and has been show to play roles in synaptic 
plasticity and synaptogenesis (Gerendasy et al, 1994; Petersen and Gerges, 
2015; Ryoo et al, 2015; Zhong and Gerges, 2010). Strikingly, lentiviral-mediated 
over-expression of Nrgn-GFP was sufficient to rescue AMPAR-mediated deficits 
after loss of KIDLIA expression in vitro, suggesting that impairments in 
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synaptogenesis and synaptic function could be occluded with restoration of Nrgn 
signaling at the synapse. 
 These findings establish the KIDLIA KO mouse as a new ASD model with 
severe social deficits, increased anxiety and hyperactivity as well as major 
impairments in learning and memory. We hypothesize that the neurobiological 
alterations following loss of KIDLIA expression in patients and the animal model 
may result from disruptions in gene regulation and transcription, as indicated by a 
large number of up- and down-regulated mRNA transcripts. Additionally, we find 
that loss of KIDLIA significantly decreased dendritic spine number and excitatory 
synaptic strength, as well as Nrgn expression, an important synaptic signaling 
molecule. This study provides the first evidence that the human ASD protein 
KIDLIA is involved in synaptogenesis, synaptic function and gene regulation. 
Thus, the KIDLIA KO mouse faithfully displays the characteristics observed in 
human patients with loss of KIDLIA and can be used as an animal model for 
human ASD with ID. Additionally, with the re-expression of Nrgn, synaptic deficits 
could be alleviated, indicating that synaptic functional aberrations after loss of 
KIDLIA could be reversed with the restoration of key dysregulated genes like 
Nrgn. The KIDLIA KO mouse will be of great value to the ASD community given 
the clean genetic background (single gene deletion), strong autistic behavioral 
phenotype and potential to restore impairments in synapse regulation. 
 
144 
 
 
4.3 Results 
4.3.1 Generation of a KIDLIA knockout mouse  
Recently, we have shown impaired dendritic outgrowth and actin dynamics after 
shRNA-mediated knockdown of KIDLIA in rat neuronal cultures (Gilbert et al, 
2016). To extend our analyses on the function of KIDLIA in neurodevelopment 
and brain function, we generated a KIDLIA knockout mouse (KIDLIA KO, Figure 
4.1A). Mice were generated with blastocyst injection of KIAA2022 KO embryonic 
stem (ES) cells purchased from the knockout mouse project (KOMP, clone 
EPD0411_7_H02) and maintained in a C57BL6/J genetic background. Complete 
knockout of the KIAA2022 gene was not embryonically lethal. Because the 
KIAA2022 gene is on the X-chromosome, heterozygous female breeders (X-X+) 
were mated to wild type (WT) males (X+Y) and knockout male mice (X-Y) were 
used for all experimentation. Loss of the KIDLIA protein product was confirmed in 
western blot analyses with expression only detected in the nuclear fraction of WT 
mouse cortical lysates but not in cytoplasmic or KO animal lysates (Figure 4.1B) 
and in immunohistochemistry (IHC) (Figure 4.1C), with no detectable KIDLIA 
staining observed in brain slices from KO animals.  
KIDLIA KO animals displayed general good health and normal food 
consumption; however, animals began to exhibit seizures around 10-12 weeks of 
age. There was no difference in total body weight between WT and KIDLIA KO 
animals at P0 (Figure 4.1D). Additionally, analysis of overall brain structure didn’t 
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reveal any major structural abnormalities and no change in cell density was 
observed in neocortex (Figure 4.1E-F) or hippocampus (Figure 4.1G-H) at P30.  
4.3.2 The KIDLIA knockout mouse shows typical autistic features in social 
behavior 
Loss of KIDLIA expression in humans produces behavioral deficits typical of 
ASD, including repetitive behavior, decreased social behavior and intellectual 
disability (ID) (Cantagrel et al, 2009; Cantagrel et al, 2004; de Lange et al, 2016; 
Farach and Northrup, 2016; Kuroda et al, 2015; Van Maldergem et al, 2013; 
Webster et al, 2016). We first sought to characterize the social behavior of the 
KIDLIA KO mouse in the three chamber social task, a test broadly used for 
assessing mouse sociability and interest in social novelty (Crawley, 2007; Moy et 
al, 2009). Animals were habituated to the apparatus by allowing the mice to 
explore all three chambers, including the empty cages, prior to testing (Figure 
4.2A). To examine sociability, a first stranger mouse (Mouse 1) was placed into 
one of the chambers and the test mouse was allowed to freely navigate within 
the three chamber apparatus (Figure 4.2B). Representative track lengths during 
the test show that KIDLIA KO mice spent significantly less time interacting with 
Mouse 1 compared to the empty cage (Figure 4.2C). A significant decrease in 
the preference index for Mouse 1 was observed, indicating an impairment in 
sociability (Figure 4.2D, n = 9 for both groups, p < 0.05). To examine the KIDLIA 
KO animal’s interest in social novelty, a second mouse (Novel Mouse) was 
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placed into the empty cage after the test mouse had been allowed to interact with 
Mouse 1 (Figure 4.2E). Strikingly, KIDLIA KO animals showed no preference for 
the Novel Mouse as shown in the representative track lengths (Figure 4.2F) with 
a decrease in the preference index compared to WT animals, indicating a lack of 
interest in social novelty (Figure 4.2G, n = 9 for both groups, p < 0.001). 
4.3.3 KIDLIA knockout animals show increased repetitive behavior and 
anxiety 
To further examine behavioral phenotypes in the KIDLIA KO animals, we 
employed the marble burying task. WT mice placed in a cage with fresh bedding 
and marbles will spontaneously bury the marbles and perform digging behaviors. 
We hypothesized that KIDLIA KO mice would show increased marble burying, 
indicative of an increase in repetitive behaviors. Surprisingly, we found that 
KIDLIA KO mice buried significantly fewer marbles than WT mice across all time 
points during a 25 min observation period (Figure 4.3A and 4.3B). Several 
studies have previously indicated that marble burying depends on interest in the 
external environment and burying behavior does not change with increased 
experience with marbles or habituation to the marble-burying test (Greco et al, 
2013; Thomas et al, 2009). These findings therefore suggest that loss of KIDLIA 
expression dramatically decreases the animal’s interest in the external 
environment, a phenotype consistent with ASD.   
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To assess grooming behavior, mice were observed in their home cages 
and the amount of time and number of grooming episodes were quantified. In 
contrast to a decrease in marble-burying behavior, KIDLIA KO animals showed 
~3X increase in the time spent self-grooming (Figure 4.3C, n = 9 for both groups, 
p< 0.01) and the number of grooming episodes (Figure 4.3D, n = 9 for both 
groups, p < 0.01). Indeed, consistent with over self-grooming, we observed that 
KIDLIA KO animals developed patches of fur loss due to excessive repetitive 
grooming behaviors in the same body areas (Figure 4.3E). 
 We next assessed WT and KIDLIA KO animals in the open field test. The 
KO animals showed no signs of defects locomotion, but had a significant 
increase in their amount of movement during the test as shown in the 
representative tracks (Figure 4.3F). Quantification of the total track length 
showed that KIDLIA KO animals traveled a larger distance during the test (Figure 
4.3G, WT = 5.2 ± 0.97, n = 9; KO = 14.6 ± 2.62, n = 9; p < 0.001) and KO 
animals showed a significant increase in average velocity (Figure 4.3H, WT = 
5.82 ± 0.33, n = 9; KO = 15.23 ± 1.44, n = 9; p < 0.0001). Furthermore, 
quantification of the time spent in the center of the open field normalized to the 
total distance traveled showed that KIDLIA KO animals spent less time in the 
center (Figure 4.3I, WT = 1.00 ± 0.15, n = 9; KO = 0.35 ± 0.06, n = 9; p < 0.001). 
Taken together, these results indicate that KIDLIA KO animals were much more 
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mobile with tendencies of center avoidance in the open field, indicative of a 
phenotype of increased anxiety and/or hyperactivity. 
4.3.4 Impaired spatial memory in KIDLIA knockout animals 
Humans with loss of function mutations or genetic deletions of KIDLIA show 
autistic phenotypes accompanied with severe ID. We therefore sought to 
investigate whether our KIDLIA KO mouse showed learning and memory deficits 
to recapitulate the human condition. The first test we employed was the Barnes 
maze for spatial memory. In this task, mice were trained over a period of 4 days 
to learn the location of a target escape hole, using spatial cues placed within the 
testing room, on a board containing 21 holes around its circumference. KIDLIA 
KO animals showed the ability to learn the target escape hole location during 
acquisition training periods (Figure 4.4A). Additionally, we quantified the search 
strategy animals employed to find the target hole. A “direct” search was counted 
if the initial search was pointed toward the target hole or either hole directly 
adjacent to the target. A “mixed” search was classified as an unordered or 
random search of the maze and a “serial” search strategy was classified as 
finding the target hole after visiting at least two adjacent holes in a serial manner. 
Analysis of search strategies employed by the mice showed that KO animals 
were slower to use direct searches compared to WT animals, but did make 
progress in making more direct searches over the training sessions (Figure 
4.4B). It is interesting to note that although KIDLIA KO animals relied on direct 
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searches increasingly during training, they still used the serial strategy 
significantly more than the WT animals, perhaps due to hyperactivity, more 
anxiety and/or deficits in learning and memory.  
 After spatial acquisition training, the target hole was covered and the 
number of nose pokes made at each hole location was quantified 24 h and 5 d 
later. In the 24 h probe for spatial memory, KIDLIA KO animals did not show 
difference in the number of nose pokes made at the target hole; however, KIDLIA 
KO mice did have an increase in the time (primary latency) and track length to 
find the target hole, compared to WT animals  (Figure 4.4C-E).  
Probing spatial memory 5 d after training showed that KIDLIA KO animals 
had impairments in memory of the target hole location, with less nose pokes at 
the target and adjacent holes and a broader search of the board (Figure 4.5A 
and 4.5B). Quantification of the primary latency to find the target hole showed 
that KIDLIA KO animals took much longer to find the target hole (Figure 4.5C, n = 
9 for both groups, p < 0.05) and traveled much longer prior to making an initial 
nose poke at the target hole (Figure 4.5D, n = 9 for both groups, p < 0.01). These 
findings suggest that loss of KIDLIA impairs spatial memory which may be a 
contributing factor to the ID observed in humans with loss of KIDLIA and ASD 
with ID. 
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4.3.5 Loss of KIDLIA affects hippocampal and amygdala-dependent 
memory in fear conditioning tests 
We next performed a fear conditioning test to probe learning and memory 
behavior in KIDLIA KO animals. On day 1, mice were placed into the fear 
conditioning chamber and subjected to a stimulation protocol with a 2 s foot 
shock followed by a 30 s tone, repeated three times (Figure 4.6A1-A2). 1 d later 
the animals were placed back into the same box under the same conditions, and 
the contextual memory was assessed by quantifying the amount of time spent 
with no motion (freezing). The following day, the entire environment of the box 
was changed including lights, odorants, wall, floor and ceiling materials/design. 
The cued memory was then measured by quantifying the amount of freezing time 
after the conditioned tone was played. The fear conditioning paradigm used in 
our study is shown in Figure 4.6A-C. 
 Prior to fear conditioning, both WT and KO mice did not show significant 
freezing behavior when placed in the test chamber. Additionally, both mice 
learned to associate the tone with the foot shock during the conditioning 
paradigm, indicated with an increase in freezing time with each subsequent tone 
played during the conditioning paradigm (Figure 4.6D and 4.6E).  
On day 2, KIDLIA KO mice showed a significant impairment in 
hippocampal-based, contextual fear memory compared to WT animals, with an 
increase in the motion index and decrease in freezing time across trial blocks 
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(Figure 4.6F and 4.6G). The most striking difference was the large decrease in 
amygdala-dependent, cued fear memory in KIDLIA KO animals. Both WT and 
KO animals showed minimal freezing behavior when placed into the chamber 
with a completely new setup, indicating they did not have a fear association in 
the new environment. However, when the tone was played, WT animals showed 
a robust increase in freezing behavior, while KO animals showed no change in 
movement compared to their pre-tone activity (Figure 4.6H and 4.6I). These 
results indicate that both contextual and cued fear memory was impaired in the 
absence of KIDLIA expression, suggesting major deficits in learning and 
memory. 
4.3.6 KIDLIA KO mice have abnormalities in dendritic spine formation and 
synaptic function 
We hypothesized that the autistic phenotypes and severe impairment in learning 
and memory in KIDLIA KO mice may result from aberrations in dendritic spine 
growth and synaptogenesis. To investigate this, we first performed Golgi staining 
on postnatal day 90 (P90) animals and quantified spine density and morphology 
in the hippocampus (Figure 4.7A). The morphology of dendritic spines can be 
classified from “thin” (and long) to “stubby” and “mushroom” types, with the more 
latter representing mature and more stable spines. The more elongated filopodia 
(>3 µm in length), are immature dendritic protrusions that are highly motile and 
not considered to be functional spines (Figure 4.7B). Quantification of the Golgi 
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stainings showed a significant increase in filpodia and thin protrusions, with less 
stubby spines in the KIDLIA KO compared to age-matched WT mice (Figure 
4.7C). Additionally, a 35% reduction in the density of dendritic protrusions (Figure 
4.7D) and a 33% increase in the average length of protrusions (Figure 4.7E) was 
observed in the KO animals. Thus, loss of KIDLIA expression resulted in a 
reduction in mature spines, suggesting that aberrant spine formation may 
underlie some of the behavioral abnormalities observed. 
 To investigate changes in synaptic protein expression, we next performed 
immunohistochemistry (IHC) analyses of P0 hippocampal brain slices. We first 
examined the glutamatergic system which is crucial for synaptic plasticity, 
neuronal network function and higher cognitive abilities. Immunostainings 
revealed obvious decreases in the excitatory synaptic scaffolding protein PSD-95 
and the AMPAR subunit GluA1 (Figure 4.7F).  
To examine synaptic changes in more detail we used an in vitro model 
with lentiviral-mediated shRNA knockdown of KIDLIA to avoid compensatory 
mechanisms that may arise in the KO mouse. Neuronal cultures were treated 
with lentiviral shRNAs at DIV0 and analysis of GluA1 and PSD-95 synaptic 
puncta was performed at DIV14 (Figure 4.7G). Strikingly, a 45% reduction in 
GluA1 puncta density and 20% reduction in GluA1 puncta intensity was observed 
after shRNA-mediated knockdown of KIDLIA compared to scrambled shRNA 
controls (Figure 4.7H and 4.7I). Additionally, analyses of immunostained PSD-95 
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showed a 60% reduction in puncta density with no change in synaptic intensity 
(Figure 4.7J and 4.7K). These findings indicate that loss of KIDLIA expression 
has a profound effect on glutamatergic synapse formation, with a large decrease 
in spine and synapse number, as well as a significant decrease in the amount of 
GluA1 accumulation at the synapse. 
4.3.7 RNAseq identifies dysregulated synaptic genes after loss of KIDLIA 
expression 
The KIDLIA protein is nuclear localized and predicted to be DNA binding 
(89.3% confidence) and zinc-binding (97.5% confidence) in analysis with SVM-
Prot software for protein functional classification (Cai et al, 2003). We therefore 
hypothesized that it may be involved in the regulation of synaptic gene 
expression to drive the morphological changes observed at the synapse. To 
identify candidates involved in synaptic dysregulation after loss of KIDLIA 
expression, we utilized an RNAseq approach. To avoid compensatory 
mechanisms that may result after germline KO of KIDLIA in vivo, we used mouse 
neuronal cultures and infected with lentiviral KIDLIA shRNA at DIV0 (day of 
plating), and collected total RNA at DIV14. 
 RNAseq data were analyzed to determine changes in the expression of 
synaptic transcripts and important developmentally regulated signaling cascades 
between KIDLIA and scrambled shRNA treated neuronal cultures. We identified 
a total of 1,097 significantly up-regulated and 961 down-regulated genes and 
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characterized synaptic related genes of interest according to their membrane, 
cytoplasm, nucleus or extracellular localization (Table 4.1).  
 Gene ontology (GO) enrichment analyses of the RNAseq dataset 
identified several key neuronal components and developmental processes that 
were dysregulated, including a major enrichment of synapse related genes 
(Figure 4.8A). Indeed, pathway analysis of the top dysregulated signaling 
pathways using Ingenuity Pathway Analysis (IPA, QIAGEN, 
www.qiagen.com/ingenuity), revealed glutamatergic signaling as one of the top 
the dysregulated pathways, with 12% of the pathway genes showing a significant 
down-regulation. Additionally, key synaptic plasticity processes such as LTP and 
LTD, which underlie learning and memory and cognitive function, were 
significantly enriched within the dataset (Figure 4.8B).  
 The top down-regulated gene identified in RNAseq was neurogranin 
(Nrgn), with an 85% decrease in mRNA transcripts (Table 4.1). To confirm this 
hit, we performed qPCR on neuronal lysates after treatment with lentiviral KIDLIA 
shRNA and saw a 72% reduction in mRNA transcript levels, confirming our 
findings from RNAseq (Figure 4.8C). Nrgn is a calcium-sensitive protein that is 
neuron specific and enriched in dendritic spines. Additionally, Nrgn has 
previously been shown to play key roles in synaptic plasticity and may play a role 
in activity-dependent synaptogenesis via interactions with calmodulin and the 
protein kinase C signaling pathway (Saneyoshi et al, 2008; Zhong et al, 2009). 
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Therefore, a decrease in Nrgn expression after knockdown of KIDLIA may 
underlie some of the synaptic deficits observed. To examine changes in Nrgn 
protein expression levels, brain slices from WT and KIDLIA KO animals were 
immunostained at P0. Indeed, we saw a large reduction in Nrgn immunostaining 
in both cortical (Figure 4.8D) and hippocampal (Figure 4.8E) brain slices after 
loss of KIDLIA expression.  
4.3.8 KIDLIA knockout shows significant alterations in the expression of 
synaptic proteins 
To further investigate changes in synaptic proteins after loss of KIDLIA 
expression, western blot analyses were performed on hippocampal brain lysates 
from P30 WT and KIDLIA KO animals (Figure 4.9A). We found a 60% reduction 
in total Nrgn protein levels in KIDLIA KO hippocampus compared to WT controls, 
confirming our previous findings in qPCR and IHC (Figure 4.9B). Additionally, we 
observed a 32% reduction in GluA1 (Figure 4.9C); however, no change in total 
PSD-95 protein levels was observed (Figure 4.9D). In immunostaining synaptic 
PSD-95 density was decreased; however, synaptic intensity was not, indicating 
that protein distribution and not levels of PSD-95 may change after loss of 
KIDLIA expression. Furthermore, we observed a 25% decrease in the inhibitory 
synaptic scaffolding protein, gephyrin (Figure 4.9E), and no change in total levels 
of the presynaptic protein synapsin (Figure 4.9F). These results suggest that 
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changes in glutamatergic synapse composition may be a major component 
affecting synaptic function and behavior in the KIDLIA KO mouse. 
4.3.9 Expression of neurogranin rescues KIDLIA knockdown-mediated 
synaptic deficits 
We have observed major synaptic deficits in the KIDLIA KO mice in vivo and in 
shRNA-mediated KIDLIA knockdown in cultured neurons in vitro. We next 
wanted to examine whether re-expressing Nrgn, the primary down-regulated 
target identified in RNAseq, could rescue synaptic deficits. To perform these 
experiments, we treated rat hippocampal neuron cultures with lentiviral KIDLIA 
shRNA at DIV0, together with lentiviral GFP or Nrgn-GFP. Neurons were fixed 
and immunostained for GluA1 at DIV14 (Figure 4.9G). Analyses of GluA1 puncta 
intensity showed that loss of KIDLIA reduced synaptic GluA1 content. However, 
strikingly, over-expression of Nrgn-GFP rescued synaptic GluA1 intensity and 
puncta density to levels similar to the control neurons transfected with scrambled 
shRNA (Figure 4.9H and 4.9I). 
 To investigate the functional consequence of KIDLIA knockdown, 
mEPSCs were recorded from  DIV14-16 hippocampal neurons after application 
of lentiviral KIDLIA shRNA at DIV0 (Figure 4.9J). In line with the decreased in 
GluA1 expression observed in IHC experiments, KIDLIA knockdown produced a 
significant reduction in mEPSC amplitude (Figure 4.9K, n = 10-11 cells/group, p 
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< 0.05), accompanied with a marked decrease in mEPSC frequency (Figure 
4.9L, n = 10-11 cells/group, p < 0.001). 
4.4 Discussion 
In this study, we established a KO mouse model for ASD and ID. We provide the 
first investigation on the role of the human ASD protein KIDLIA, in behavior and 
synapse development, both in vivo in the KO animal and in vitro in neuronal 
cultures. This mouse line should be useful for future ASD studies as it displays 
multiple cognitive, morphological and functional deficits, and reflects a condition 
in human patients with ASD and ID. 
Here we report that KIDLIA KO mice display impairments in the three 
chamber social task, with decreased sociability and decreased interest in social 
novelty. KO mice spent less time interacting with a novel mouse, suggesting that 
they either could not discern it was novel or had no interest in its novelty. We 
also found significant impairments in the marble-burying test, with KIDLIA KO 
animals burying less marbles during the task, a phenotype that suggests a 
decreased interest in their surrounding environment. Taken together, these two 
findings suggest that a loss of interest in external stimuli may be a major 
phenotype in this mouse line and could underlie some of the social deficits 
observed in the three chamber test. KIDLIA KO mice also displayed increased 
repetitive grooming and anxiety-like behaviors, common phenotypes observed in 
ASD mouse models (Kalueff et al, 2016; Silverman et al, 2010).  
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KIDLIA KO mice displayed major deficits in both spatial and fear memory, 
in line with findings of moderate-to-severe ID in human patients with KIDLIA 
mutations (Cantagrel et al, 2009; Cantagrel et al, 2004; Kuroda et al, 2015; Van 
Maldergem et al, 2013). KIDLIA KO mice were able to acquire the target hole 
location over the course of the Barnes maze training, suggesting no major 
impairments in visual system function, and only showed impairments when 
probing their memory 5 d later. Additionally, KIDLIA KO mice were able to 
associate a tone with the foot shock during the first day of the fear conditioning 
paradigm, indicating their auditory system was functional. Therefore, the deficits 
observed in the learning and memory tasks should not be a result of impaired 
sensory input, but rather impairments in higher level processing. Golgi analysis 
from KIDLIA KO mouse brain revealed significantly decreased spine densities 
with an increase in immature spine morphologies. Additionally, we observed a 
major dysregulation in synaptic protein expression. These findings provide strong 
evidence that the KIDLIA KO mouse recapitulates the autistic and ID phenotypes 
observed in human patients and that major abnormalities in synapse formation 
and function may underlie behavioral deficits. 
Abnormalities in synaptogenesis and synaptic function are key underlying 
factors that lead to social and cognitive deficits during brain development (Zoghbi 
and Bear, 2012). Dysfunction in neural network function, or synaptopathies, are 
associated with a number of brain disorders, including Rett Syndrome, Fragile-X 
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mental retardation, Angleman Syndrome and Phelan-McDermid 
Syndrome (Belmonte and Allen, 2004; Garner and Wetmore, 2012; Ricciardi et 
al, 2012; Shepherd and Katz, 2011). Given that we’ve previously shown loss of 
KIDLIA impairs neurite outgrowth and actin dynamics, future studies with 
knockdown of KIDLIA after neurite growth and synaptogenesis could clarify 
whether synaptic and spine deficits result from aberrant structural growth and if 
KIDLIA plays a role in synapse maintenance and function after synaptogenesis. 
Additionally, re-expression of KIDLIA in the KO mouse, or after shRNA-mediated 
knockdown, at different time points during development would be useful to 
determine if morphological, functional and/or behavioral deficits could be 
rescued. 
Because KIDLIA is expressed in the nucleus and we observed 
significant changes in synaptic mRNA transcripts and genes related to 
neurodevelopment, it is possible that KIDLIA plays a role in gene transcription. 
Most synaptic-related transcripts were down-regulated after KIDLIA knockdown, 
including Nrgn, the primary down-regulated gene. These findings suggest that 
KIDLIA may normally enhance synaptic gene expression during development, 
therefore loss of KIDLIA resulted in decreases in the expression of synapse-
related genes. Strikingly, we found that over-expression of Nrgn could rescue 
both the number and strength of excitatory synapses after loss of KIDLIA 
expression, suggesting that some of the synaptic deficits were reversible and 
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mediated through decreased Nrgn expression. Future studies to investigate 
KIDLIA’s role in the nucleus, whether it functions as a transcription factor or part 
of another regulatory complex, and key binding partners, would be interesting to 
provide more insight into KIDLIA’s molecular function during development.  
Nrgn has previously been shown to play an important role in mediating 
excitatory synapse formation and function (Gerendasy et al, 1994; Petersen et al, 
2015; Ryoo et al, 2015; Zhong et al, 2010), therefore we chose to investigate its 
role in synapse development and function after loss of KIDLIA in this study. 
However, additional synaptic and developmentally related genes were identified 
in RNAseq, such as subsets of potassium channels that may regulate neuronal 
excitability and contribute to the seizures observed in older KIDLIA KO animals. 
Additionally, further investigation of changes in GABAergic synapses and 
alterations in the presynaptic compartment should be useful in better 
understanding the functional consequences of loss of KIDLIA expression. A 
common underlying pathology in ASD is an imbalance in the excitation-to-
inhibition ratio, a condition in which excitatory and inhibitory synapses are 
disproportionately affected, therefore characterization of the signaling cascades 
involved in the development and function of inhibitory synapses should provide 
valuable information for this mouse model.  
Given that KIDLIA is a novel ASD protein with largely unknown functions, 
more studies are needed to elucidate the role of KIDLIA in multiple steps of 
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neuron development including neurogenesis, morphogenesis, synapse 
maturation and synaptic plasticity. With this mouse model, future work should 
provide valuable insight into the molecular underpinnings involved in proper 
neurodevelopment and brain function, and key processes that are disrupted in 
ASD and ID. 
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Figure 4.1. KIDLIA knockout mice have similar body weight and cell density 
compared to WT animals  
(A) Image of a 3-month old male KIDLIA KO mouse. (B) KIDLIA expression was 
observed only in the nuclear fraction of wild type (WT) mouse cortical lysates but 
not in cytoplasmic or knockout (KO) animal lysates (C) Immunohistochemistry in 
P0 mouse cortical brain slices shows KIDLIA signal in the cortical plate from WT 
animals, with only background signal in brain slices from KO animals. (D) No 
change was observed in body weight at P0 between WT and KO animals. . (E-H) 
Cell density in cortex (E and F) or in hippocampus (G and H) was similar in KO 
and WT animals at P0. UpCP = upper cortical plate, LoCp = lower cortical plate, 
IZ = intermediate zone, VZ = ventricular zone, CA1 = cornu ammonis area 1, 
CA3 = cornu ammonis area 3, DG = dentate gyrus; yellow dashed line = pia. ns = 
not significant.  
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Figure 4.2 
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Figure 4.2 KIDLIA knockout mice show impaired social behavior in the 
three chamber social test 
(A) Habituation paradigm for the three chamber social test. Mice were released 
from the center chamber, with empty cages in the adjacent chambers, and 
allowed to move freely within the apparatus. (B) Paradigm for the sociability test. 
An unfamiliar mouse (Mouse 1) was place into either of the side chambers and 
the test mouse was allowed to move freely within the apparatus. (C) Traces of 
animal track paths in the sociability test for WT and KO mice. (D) Quantification 
of the preference index showed a decrease in preference for Mouse 1 in KIDLIA 
KO animals compared to WT controls (WT = 52.70 ± 7.10, n= 9; KO = 33.65 ± 
7.75, n = 9; p < 0.05). (E) Paradigm for the social novelty test. A second mouse 
(Novel Mouse) was placed into the remaining empty chamber opposite to Mouse 
1, and the test mouse was allowed to interact with both mice. (F) Traces of 
animal track paths in the social novelty test for WT and KO mice. (G) In the social 
novelty test, KO animals showed no preference for the novel animal (WT = 42.30 
± 8.00, n= 9; KO = -7.93 ± 7.81, n = 9; p < 0.001). .*p<0.05 , ***p<0.001. 
 
 
166 
 
 
Figure 4.3 
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Figure 4.3. KIDLIA knockout mice show decreased interest in the external 
environment and increased anxiety and repetitive grooming behavior 
(A,B) In the marble burying test, KO animals buried significantly less marbles 
indicating a decreased interest in the environment (5 min: WT = 1.33 ± 0.33, KO 
= 0.38 ± 0.18, p < 0.05; 10 min: WT = 3.56 ± 0.69, KO = 0.75 ± 0.31, p < 0.01; 15 
min: WT = 5.33 ± 0.99, KO = 2.38 ± 0.73, p < 0.05; 20 min: WT = 8.56 ± 1.11, KO 
= 3.88 ± 0.95, p < 0.01; 25 min: WT = 10.33 ± 0.83, KO = 5.25 ± 0.94, p < 0.01; n 
= 9 for both groups). (C) Increased grooming behavior was observed in KIDLIA 
KO animals resulting in fur loss. (D,E) KIDLIA KO mice showed increased time 
spent grooming (D; WT = 14.2 ± 0.83 s, n = 9; KO = 48.0 ± 8.24 s, n = 9; p < 
0.01) and an increase in grooming episodes (E; WT = 1.95 ± 0.32 m, n = 9; KO = 
4.93 ± 0.48 m, n = 9; p < 0.01). (F) Track paths of WT and KO animals in the 
open field test. (G-I) KO animals showed increased track lengths (G, WT = 1.95 ± 
0.32 m, n =9; KO = 4.93 ± 0.48 m, n = 9, p < 0.001) and increased mean 
velocities (H, WT = 5.82 ± 0.33 m/s, n =9; KO = 15.24 ± 1.44 m/s, n = 9, p < 
0.0001) decreased time in center (I, WT = 1.00± 0.15, n =9; KO = 0.35 ± 0.06, n 
= 9, p < 0.001) in the open field test. *p<0.05, ** p<0.01,***p<0.001,****p<0.0001, 
ns = not significant. 
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Figure 4.4 
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Figure 4.4. Spatial acquisition training and 24 h memory probe in the 
Barnes maze. 
(A) Quantification of the primary latency (s) to find the target hole across all 
training trials (4 trials per day over 4 days) for WT and KO animals. (B) 
Quantification of the types of search strategies used for locating the target hole 
over the 4 training days. (C) The distribution of nose pokes on the board showed 
no difference when probing memory 24 h after training. (D,E) Primary latency to 
the target hole (D, WT = 7 ± 1.6 s, n = 9; KO = 17 ± 3.8 s, n = 9; p < 0.05) and 
total track length (E, WT = 0.11 ± .03 m, n = 9; KO = 0.48 ± .12 m, n = 9; p < 
0.05) were increased in the KO animals probing 24 h after training. *p<0.05. 
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Figure 4.5 
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Figure 4.5. KIDLIA knockout mice show impairments in learning and 
memory 
(A) Traces of track paths in the Barnes spatial memory maze during the 5 d 
memory probe for WT and KO animals. (B) Quantification of the distribution of 
nose pokes across different holes on the board showed a significant decrease for 
the target and adjacent holes in the 5 d memory probe. (C,D) Primary latency to 
the target hole (C, WT = 8 ± 1.7 s, n = 9; KO = 25 ± 7.1 s, n = 9; p < 0.05) and 
total track length (D, WT = 0.11± 0.03 m, n = 9; KO = 0.86 ± 0.30 m, n = 9; p < 
0.01) were increased in the KO animals probing 5 d after training. *p<0.05, ** 
p<0.01. 
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Figure 4.6 
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Figure 4.6. Fear conditioning paradigm 
(A-C) The paradigm used for fear conditioning, contextual and cued memory 
tests. On day 1 after habituation, animals were placed into the box (A1) and 
given three 2 sec foot shocks after playing a 30 sec tone (A2). On day 2, 
contextual memory was tested by placing animals into the same box (B1) with no 
tone played (B2). On day 3, the environment in the box was completely changed 
(C1) and animals were played the tone used during fear conditioning (C2). (D) 
Quantification of freezing time in WT and KO animals during prior to fear 
conditioning showed no freezing behavior. (E) Quantification of freezing time 
during the 30 sec tones played during fear conditioning showed that both WT and 
KO animals learned to associate the tone with the fear stimulus (foot shock). (F) 
Representative motion indices during the contextual memory test for WT and KO 
animals. The conditions during the contextual test are shown above. (G) 
Quantification of the time spent freezing (%) over 10 trial blocks during the 
contextual memory test. (H) Representative motion indices during the cued 
memory test for WT and KO animals. The conditions during the cued test are 
shown above. (I) Quantification of the time spent freezing (%) pre-tone (Baseline) 
and after playing the cue (Tone) during the cued memory test (Baseline: WT = 
2.83 ± 1.32 %, n = 8; KO = 0.88 ± 0.83 %, n = 9, p>0.05; Tone: WT = 14.0 ± 2.51 
%, n= 8; KO = 1.12 ± 1.05 %, n= 9, p<0.001). *p<0.05, ** p<0.01, ***p<0.001 ns 
= not significant.  
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Figure 4.7 
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Figure 4.7. Synaptic deficits after loss of KIDLIA expression in vivo and in 
vitro 
(A) Golgi staining of spines from pyramidal neurons in P90 mouse hippocampus. 
(B) Representative morphologies of the different dendritic protrusion types 
classified. (C) Quantification of protrusion morphologies in WT and KO animals 
showed an increase in immature morphologies (Mushroom: WT = 39.1 ± 2.9 %. 
KO = 32.8 ± 2.4, p>0.05; Stubby: WT = 37.7 ± 3.6 %, KO = 20.0 ± 5.6%, p<0.05; 
Thin: WT = 19.6 ± 5.1 %, KO = 30.6 ± 3.1 %, p<0.05; Filopodia: WT = 3.6 ± 0.9 
%, KO = 17.3 ± 3.2%, p<0.01; n = 14-16 cells). (D,E) Spine density was 
decreased (D, WT = 0.41 ± 0.02 spines/µm, KO = 0.27 ± 0.02 spines/µm, 
p<0.05, n = 14-16 cells) and spine length (E, WT = 1.97± 0.07 µm, KO = 2.64 ± 
0.08 µm, p<0.001, n = 14-16 cells) increased in KO animals. (F) 
Immunohistochemistry in hippocampal brain slices at P0 shows a clear decrease 
in PSD-95, GluA1 and Bassoon. (G) Representative images of 
immunohistochemistry for GluA1 and PSD-95 at DIV15 in rat hippocampal 
cultures after infection with scrambled (SCR shRNA) or KIDLIA shRNA at DIV0. 
(H,I) Quantification of GluA1 immunostaining showed a decrease in puncta 
density (H, WT = 1.0 ± 0.06, KO = 0.55 ± 0.03, p<0.001, n = 10-12 cells) and 
puncta intensity (I, WT = 1.0 ± 0.05, KO = 0.80 ± 0.04, p<0.05, n = 10-12 cells). 
(J,K) Quantification of PSD-95 immunostaining showed a decrease in PSD-95 
density (J, WT = 1.0 ± 0.07, KO = 0.41 ± 0.08, p<0.01, n = 10-12 cells) with no 
176 
 
 
significant change in PSD-95 intensity (n = 10-12 cells, p> 0.05). *p<0.05, ** 
p<0.01, ***p<0.001 ns = not significant. 
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Figure 4.8 
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Figure 4.8. Neurogranin is the top down-regulated synaptic gene in RNAseq 
after loss of KIDLIA expression 
(A) Gene ontology enrichment analysis of top dysregulated cell components and 
biological processes after knockdown of KIDLIA in mouse cortical cultures. (B) 
Percentage of down-regulated (green) and up-regulated (red) signaling genes in 
Ingenuity Pathway Analysis after KIDLIA knockdown. Line represents –log(p-
value). (C) qPCR confirmation of the top down-regulated gene, Nrgn, after 
knockdown of KIDLIA (SCR shRNA = 1.0 ± 0.01, KIDLIA shRNA = 0.28 ± 0.03, n 
= 3 neuron cultures performed in triplicate, p<0.0001). (D,E) Immunostaining 
showed a clear reduction in Nrgn in P0 WT and KO brain slices from cortex (D) 
and hippocampus (E) (Hoescht = nuclear marker). LTP = long-term potentiation; 
PLC = phospholipase C; nNOS = neuronal nitric oxide synthase. ****p<0.0001. 
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Figure 4.9 
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Figure 4.9. Overexpression of neurogranin can rescue synaptic deficits 
after loss of KIDLIA expression in vitro 
(A) Western blot of synaptic-related proteins and confirmation of the top down-
regulated gene, Nrgn, identified in RNAseq from WT and KIDLIA KO 
hippocampus. (B-F) Quantification of western blot data showed a significant 
reduction in Nrgn (B, WT= 1.0 ± 0.08, KO = 0.41 ± 0.09, p<0.01, n = 5 animals), 
reduced GluA1 (C, WT= 1.0 ± 0.07, KO = 0.68 ± 0.06, p<0.05, n = 5 animals), no 
change in PSD-95 (D, p>0.05, n = 5 animals), reduced gephyrin (E, WT= 1.0 ± 
0.05, KO = 0.74 ± 0.05, p<0.05, n = 5 animals) and no change in synapsin 
intensity (F, p>0.05, n = 5 animals). *p<0.05, ** p<0.01,***p<0.001 ns = not 
significant. (G) GluA1 staining (red) after infection with lentiviral scrambled (SCR 
shRNA) or KIDLIA shRNA, together with GFP or Nrgn-GFP, at DIV0. (H,I) Over-
expression of Nrgn was sufficient to rescue GluA1 puncta intensity in vitro (E, 
SCR shRNA+GFP = 1.0 ± 0.05, KIDLIA shRNA+GFP = 0.79 ± 0.05; SCR 
shRNA+Nrgn-GFP = 1.14 ± 0.04, KIDLIA shRNA+Nrgn-GFP = 1.0 ± 0.03, n = 
15-20 cells) and puncta density (F, SCR shRNA+GFP = 1.0 ± 0.05, KIDLIA 
shRNA+GFP = 0.66 ± 0.04; SCR shRNA+Nrgn-GFP = 1.0 ± 0.04, KIDLIA 
shRNA+Nrgn-GFP = 0.90 ± 0.04, n = 15-20 cells). . (J) mEPSC recordings from 
rat hippocampal neurons after infection with lentiviral scrambled (SCR shRNA) or 
KIDLIA shRNA, together with GFP or Nrgn-GFP. (B) Quantification of mEPSC 
recordings showed a significant decrease in amplitude (SCR shRNA+GFP = 14.1 
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± 1.1 pA, KIDLIA shRNA+GFP = 11.0 ± 1.1 pA; SCR shRNA+Nrgn-GFP = 15.9 ± 
1.3 pA, KIDLIA shRNA+Nrgn-GFP = 13.3 ± 1.3 pA, n = 10-12 cells). (C) 
Quantification of mEPSC recordings showed a significant decreae in frequency 
(SCR shRNA+GFP = 1.37 ± 0.17 Hz, KIDLIA shRNA+GFP = 0.62 ± 0.09 Hz; 
SCR shRNA+Nrgn-GFP = 1.80 ± 0.25 Hz, KIDLIA shRNA+Nrgn-GFP = 1.50 ± 
0.24 Hz, n = 10-12 cells). *p<0.05, ** p<0.01, ***p<0.001 ns = not significant.
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Table 4.1 
Gene Fold Change Localization 
NRGN 0.148 Cytoplasm 
NOV 0.150 Extracellular 
CDKL2 0.195 Nucleus 
CDK19 0.219 Nucleus 
WFS1 0.241 Membrane 
CALN1 0.260 Cytoplasm 
NEUROD6 0.282 Nucleus 
PRKG 0.301 Cytoplasm 
PRKG1 0.301 Cytoplasm 
Pcdha3 0.330 Membrane 
Pcdha9 0.332 Membrane 
Pcdha11 0.332 Membrane 
Pcdha2 0.333 Membrane 
Pcdha10 0.333 Membrane 
Pcdha8 0.333 Membrane 
Pcdha5 0.335 Membrane 
Pcdhac1 0.336 Mebrane 
Pcdha7 0.340 Membrane 
Pcdhac2 0.341 Membrane 
Pcdha12 0.341 Membrane 
Pcdha4 0.342 Membrane 
Pcdha6 0.345 Membrane 
CDH12 0.352 Membrane 
SNCA 0.358 Cytoplasm 
SYNDIG1 0.359 Membrane 
CALB2 0.370 Cytoplasm 
CAMK4 0.388 Nucleus 
KCNH3 0.405 Membrane 
KCNH3 0.405 Membrane 
GABRA5 0.409 Membrane 
PRKCG 0.418 Cytoplasm 
GRM7 0.425 Membrane 
GRM1 0.433 Membrane 
CDK5R2 0.437 Nucleus 
MEF2C 0.444 Nucleus 
KCNIP2 0.453 Membrane 
GABRA4 0.460 Membrane 
PRKACB 0.460 Cytoplasm 
NEUROD2 0.460 Nucleus 
CACNA1G 0.461 Membrane 
CDK5R1 0.462 Nucleus 
KCNMB4 0.469 Membrane 
USP14 0.471 Cytoplasm 
PLK2 0.473 Cytoplasm 
PLK2 0.473 Nucleus 
PRKCB 0.474 Cytoplasm 
Kctd16 0.474 Membrane 
NLGN1 0.475 Membrane 
ADD2 0.476 Cytoplasm 
GABRA1 0.477 Membrane 
KCNJ9 0.480 Membrane 
OCLN 0.482 Membrane 
EFNB3 0.488 Membrane 
LRRTM1 0.493 Membrane 
STX7 0.494 Membrane 
Kctd10 0.498 Membrane 
Gria1 0.654 Membrane 
Gria2 0.692 Membrane 
CESLR2 2.002 Membrane 
SLC6A18 2.026 Membrane 
KCNMB1 2.129 Membrane 
CDH3 2.189 Membrane 
KCNJ1 3.049 Membrane 
KCNE3 5.771 Membrane 
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Table 4.1. Top dysregulated synaptic genes identified in RNAseq 
Synaptic genes identified in RNAseq were ranked based on fold change with a 
cutoff of p<0.05. Green = membrane, blue = cytoplasm, orange = nucleus, tan = 
extracellular. 
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CHAPTER FIVE:  
DISCUSSION AND FUTURE PERSPECTIVES  
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5.1 Major findings for the role of KIDLIA in neurodevelopment and brain 
function 
ASD is one of the most heritable neurological disorders. The study of autism-
linked genes provides valuable insight into key neurodevelopmental processes 
involved in brain development and function and offers insight into the major 
neuropathologies underlying developmental disorders. This dissertation is the 
first in-depth study of KIAA2022/KIDLIA, an X-linked gene originally identified in 
humans with ASD and ID, and its role in neural development and brain function. 
 In Chapter 3, I have shown for the first time that KIDLIA protein expression 
is nuclear localized and neuron specific in mouse brain tissue. Additionally, in 
utero electroporation of KIDLIA shRNA produced a redistribution of more 
neurons in the cortical plate at earlier time points and major impairments in apical 
dendrite orientation and growth. In primary rat neurons, shRNA-mediated 
knockdown of KIDLIA impaired neurite outgrowth and branching and increased 
N-cadherin mRNA and total protein levels, with a significant increase in the 
membrane bound fraction of N-cadherin protein. A greater amount of δ-catenin 
became associated with N-cadherin, thereby depleting the cytoplasmic pool of δ-
catenin and increasing RhoA activation. An increase in RhoA activation resulted 
in decreased actin dynamics at the growth cone. Consistently, over-expression of 
δ-catenin or inhibition of RhoA rescued impairments in neurite growth. These 
novel findings shed light on KIDLIA’s role in early brain development and neuron 
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morphogenesis, providing valuable insight into the neurobiological basis for 
KIDLIA-dependent ASD and ID.  
 To investigate KIDLIA-mediated alterations in behavior and the molecular 
alterations in vivo, we generated a KIDLIA KO mouse. In Chapter 4, I report 
findings from the first KIDLIA KO mouse and discovered major deficits in social 
behavior as well as an increase in anxiety and repetitive behaviors with 
significant impairments in learning and memory. The KIDLIA KO mouse also 
displayed seizures that began around 10-12 weeks of age that could sometimes 
be fatal. Taken together, my behavioral studies provide evidence that the KIDLIA 
KO mouse displays many typical ASD phenotypes as well as ID and faithfully 
recapitulates findings observed in humans with loss of function of 
KIDLIA (Cantagrel et al, 2009; Cantagrel et al, 2004; Kuroda et al, 2015; Van 
Maldergem et al, 2013). The major behavioral deficits observed in the KIDLIA KO 
mouse make this model a valuable tool for studies involving ASD, ID, seizures 
and/or anxiety.  
Synaptopathies have emerged as key underlying factors that lead to social 
and cognitive deficits during brain development (Zoghbi et al, 2012). In the 
KIDLIA KO mouse, morphological analyses of dendritic spines using Golgi 
staining revealed significant decreases in spine density as well as a shift to more 
immature spine morphologies. Additionally, I observed reductions in synaptic 
related proteins, including the GluA1 subunit of AMPARs, in western blot and 
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IHC. Using RNAseq after knockdown of KIDLIA in mouse neuronal cultures, I 
observed a dysregulation of developmental signaling cascades, including a major 
enrichment of synapse related genes, and identified Nrgn as a top candidate to 
investigate for the KIDLIA-dependent synaptic dysfunction. Indeed, I was able to 
show that over-expression of Nrgn after knockdown of KIDLIA was sufficient to 
rescue deficits in excitatory synapse function and formation. A summary of the 
developmental effects after loss of KIDLIA are shown in Figure 5.1. These 
findings strongly indicate that some deficits may be reversible in ASD-related 
developmental disorders and provide valuable insight into possible therapeutic 
avenues for future research. 
5.2 The role of KIDLIA in the nucleus 
Despite KIDLIA-dependent major impairments in dendritic growth and synaptic 
function, KIDLIA is localized predominantly in the nucleus with minimal 
distribution in the cytosolic domain or the neurites, if at all. It is interesting to 
postulate that KIDLIA may be a putative transcription factor that regulates the 
expression of key developmental and synaptic genes. Indeed, RNAseq 
confirmed that knockdown of KIDLIA led to a dramatic alteration in the 
expression of a large population of genes especially including those involved in 
cytoskeletal, synaptic and developmentally related signaling cascades. To further 
investigate this hypothesis, chromatin immunoprecipitation sequencing 
(ChIPseq), in which KIDLIA is immunoprecipitated and bound DNA is sequenced, 
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could be cross-referenced to the genes previously identified in RNAseq. If, for 
example, promoter or regulatory regions for Nrgn were found to co-
immunoprecipitate with KIDLIA in ChIPseq, that would suggest that KIDLIA 
directly regulates Nrgn expression levels at the transcriptional level.  
 Although KIDLIA does not display significant homology with other known 
proteins, it is important to note that a BLAST (basic local alignment search tool) 
nucleotide search (Altschul et al, 1990) reveals some overlapping similarity to the 
zeta catalytic subunit of the DNA direct polymerase, REV3L. REV3L is a protein 
coding gene with GO annotations related to nucleic acid binding and 4 iron, 4 
sulfur cluster binding and it is involved in translesion synthesis for DNA 
repair (Gibbs et al, 1998; Morelli et al, 1998). Although the similarity between 
KIDLIA and REV3L may be solely due to their DNA binding capabilities, it could 
also suggest a role for KIDLIA in the repair of DNA damage. 
In terms of KIDLIA and neurodevelopment, it is interesting to suggest that 
highly accessed developmental genes, i.e. synaptic and growth related genes, 
may show higher levels of damage, as suggested with findings of activity-induced 
DNA breaks in neuronal early-response genes required for experienced driven 
synaptic plasticity  (Madabhushi et al, 2015). Therefore, loss of KIDLIA allows 
DNA damage to go un-repaired, thereby disrupting neuronal function and brain 
development. Future studies investigating KIDLIA expression after DNA damage, 
for example after UV exposure, as well as ChIPseq to determine if KIDLIA binds 
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DNA regulatory regions rather than damage sites, would be highly useful in 
determining KIDLIA’s exact function in the nucleus. 
5.3 The timeline of KIDLIA expression and its role in neural development 
The in vitro studies reported in this dissertation used lentiviral shRNA-mediated 
knockdown of KIDLIA at DIV0 and investigated neuron development, growth and 
function at later time points. The rationale for this approach was to mimic the 
human condition in which patients have a loss of function of KIDLIA throughout 
the entire neurodevelopmental period. It would be useful however to knockdown 
KIDLIA at later time points, for instance after the majority of dendritic growth or 
synaptogenesis has occurred. Late-stage knockdown of KIDLIA could investigate 
whether the temporal expression pattern of KIDLIA is critical for proper neuronal 
development, and if persistent KIDLIA expression is required for dendritic or 
synaptic stability. Using a transient transfection of KIDLIA shRNA at DIV15, after 
dendritic growth and synaptogenesis has occurred, one could investigate 
synaptic structure and function at DIV18-20. These studies could elucidate 
whether loss of KIDLIA expression after normal development results in dendritic 
pruning, synapse loss and/or altered neuronal function. 
 Additionally, the generation of a conditional knockout mouse, in which a 
KIDLIA genetic deletion could be achieved with injection of a Cre-recombinase 
virus, would be useful for in vivo studies of KIDLIA’s role in neurodevelopment. 
For instance, Cre-dependent knockout of KIDLIA could be achieved at 1- or 2-
190 
 
 
months of age and behavioral studies conducted to determine if loss of KIDLIA at 
later time points produces the same impairments in learning and memory or 
social behavior. With recent advances in the CRISPR/Cas9 technology, this 
approach could be conducted in a relatively short timeframe and would be a 
valuable tool for elucidating KIDLIA’s role throughout development. 
5.4 KIDLIA’s role in neuronal hyperactivity, excitatory-inhibitory balance 
and seizure activity 
An interesting observation in the KIDLIA KO mice was the occurrence of 
spontaneous seizures starting around 10-12 weeks of age. This is in line with 
reports of febrile seizures in human patients with loss of KIDLIA function, and 
suggests an imbalance in neuronal network activity.  
 From our RNAseq dataset, we identified several potassium channels with 
decreased expression after knockdown of KIDLIA (Table 4.1). This could result in 
neuronal hyperactivity and an depolarized resting membrane potentials, thereby 
making neuronal networks susceptible to aberrant firing that could elicit seizures. 
Current clamp electrophysiological recordings of action potential firing and 
kinetics as well as resting membrane potentials would be useful to investigate 
whether the dysregulation in potassium channel expression results in aberrations 
in neuronal activity. Additionally, biochemical analyses of the expression levels of 
specific channel subtypes would be useful to confirm candidates identified in 
RNAseq. If specific channel blockers are available, treatment with them in vitro 
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for electrophysiological recordings, or administration in vivo, to observe seizure 
activity would be interesting to ascertain the role of potassium channel 
dysregulation in neuronal hyperactivity and seizures after loss of KIDLIA 
expression. 
 An imbalance between excitation-to-inhibition (E/I) in synaptic 
transmission and neural circuits has been implicated in ASD (Gogolla et al, 2009; 
Nelson and Valakh, 2015). Specific factors that contribute to synaptic E/I 
imbalance can include differential excitatory/inhibitory synapse development, 
changes in synaptic transmission and plasticity, homeostatic synaptic plasticity, 
and intrinsic neuronal excitability (Lee et al, 2016). The studies conducted in this 
dissertation focused on excitatory synapse development and function, however 
RNAseq data suggests there may be a down-regulation in GABAergic synapses 
as well. Future work investigating inhibitory synapse development and GABA 
receptor signaling would help elucidate whether an E/I imbalance results after 
loss of KIDLIA and if this contributes to behavioral deficits in the KIDLIA KO 
mouse. Seizure activity in the KO mouse could result from an E/I imbalance if 
inhibitory synaptic development and function is impaired more than excitatory 
synaptic development, thus disinhibiting neuronal networks. Additionally, with a 
down-regulation of potassium channel expression, neuronal network activity 
would presumably be highly dysregulated, leading to seizures as well as broad 
disruptions in brain function and cognitive abilities. 
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5.5 Conclusions 
The results presented in this dissertation represent the first mechanistic 
investigation of the role of the ASD protein KIDLIA in primary neurons and the 
developing mammalian brain. This work elucidates KIDLIA’s role in dendritic 
growth, gene regulation, synaptic development and behavior, suggesting KIDLIA 
expression is pivotal for proper brain growth and maturation. We have 
successfully established and characterized the KIDLIA KO mouse line and found 
multiple behavior phenotypes consistent with ASD and ID. 
A typical downfall with some ASD transgenic mouse models is their 
inability to mimic deficits observed in humans. For example, social impairments 
in Shank3 mouse models have not been consistent, with the only reliable 
behavioral defect being an increase in repetitive grooming, a behavior typical for 
an ASD mouse model but not entirely representative of the human 
condition (Bozdagi et al, 2010; Peca et al, 2011; Wang et al, 2011; Yang et al, 
2012). Additionally, several aspects of cognition, anxiety and social phenotypes 
in FMR1 KO mice are highly variable from different published reports (Auerbach 
et al, 2011; Restivo et al, 2005; Spencer et al, 2005; Van Dam et al, 2000). Many 
of the reported phenotypes in FMR1 KO mice are in opposition to the clinical 
FXS phenotype, such as a lack of major cognitive impairments and reduced 
anxiety in the FMR1 mouse model. The KIDLIA KO mouse recapitulates many of 
the behavioral phenotypes observed in human patients and will be an invaluable 
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tool for further investigation of the role KIDLIA plays in neurodevelopment and 
the study for possible therapeutics for patients with loss of KIDLIA function. 
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Figure 5.1
 
 
Figure 5.1. Summary of deficits in dendritic growth and synapse formation 
after loss of KIDLIA. 
Compared to normal neuronal morphologies (center left), loss of KIDLIA 
significantly decreases dendrite number, length and branching (center right). The 
free cytoplasmic fraction of δ-catenin serves to inhibit RhoA and relieve its 
inhibition on actin (green) dynamics and movement into the growing neurite tip in 
normal cells (bottom left). After loss of KIDLIA, a depletion of the cytoplasmic 
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pool of δ-catenin allows increased RhoA activation and more inhibition on actin 
(green) dynamics and movement into the growing neurite tip (bottom right). 
Loss of KIDLIA also decreases synaptic density and produces more 
immature spine morphologies (center and top). In the spine, decreases in the 
AMPAR and PSD-95 levels are observed after loss of KIDLIA (top right) 
compared to normal cells (top left), and re-expression of neurogranin (Nrgn) is 
sufficient to rescue AMPAR content at the synapse. 
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APPENDIX: β-AMYLOID TRIGGERS ABERRANT OVER-SCALING OF 
HOMEOSTATIC SYNAPTIC PLASTICITY 
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A1.1 Abstract 
The over-production of β-amyloid (Aβ) has been strongly correlated to neuronal 
dysfunction and altered synaptic plasticity in Alzheimer’s disease (AD). 
Accordingly, it has been proposed that disrupted synaptic transmission and 
neuronal network instability underlie memory failure that is evident in the early 
phases of AD. Homeostatic synaptic plasticity (HSP) serves to restrain neuronal 
activity within a physiological range. Therefore a disruption of this mechanism 
may lead to destabilization in synaptic and neural circuit function. Here, we report 
that during HSP by neuronal activity deprivation, application of Aβ results in an 
aberrant over-response of the up-regulation of AMPA receptor (AMPAR)-
mediated synaptic currents and cell-surface AMPAR expression. In the visual 
cortex, in vivo HSP induced by visual deprivation shows a similar over-response 
following an Aβ local injection. Aβ increases the expression of GluA2-lacking, 
calcium permeable AMPARs (CP-AMPARs), which are required for the initiation, 
but not maintenance of HSP. Both GluA2-lacking and GluA2-containing AMPARs 
contribute to the Aβ-mediated over-scaling of HSP. We also find that Aβ induces 
the dissociation of HDAC1 from the miR124 transcription factor EVI1, leading to 
an up-regulation of miR124 expression and increased amount of CP-AMPARs. 
Thus, via aberrant stimulation of miR124 expression and biogenesis of CP-
AMPARs, Aβ is able to induce an over response in HSP. This Aβ-mediated 
dysregulation in homeostatic plasticity may play an important role in the 
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pathogenesis of altered neural function and memory deficits in the early stages of 
AD.  
 
A1.2 Introduction 
Alzheimer’s Disease (AD) is characterized by deficits in learning and memory 
with an eventual loss of higher cognitive functions. Accumulation of β-amyloid 
(Aβ) in the brain is a hallmark of AD and studies have demonstrated that Aβ can 
induce synapse dysregulation and altered neuronal activity (Hsieh et al, 2006; 
Kim et al, 2001; Liu et al, 2010; Tanzi, 2005; Walsh et al, 2002). Emerging 
evidence suggests that soluble Aβ oligomers adversely affect synaptic function, 
which eventually leads to the cognitive failure associated with AD (Li et al, 2009; 
Minano-Molina et al, 2011; Roselli et al, 2005; Walsh et al, 2002). A key 
neuropathobiological hallmark in early AD is the aberrant regulation in synaptic 
function including AMPA receptor (AMPAR) synaptic accumulation and synaptic 
plasticity (Chang et al, 2006; Minano-Molina et al, 2011). In vitro studies 
performed in hippocampal neurons have reported that application of Aβ peptides, 
at concentrations below neurotoxic levels, can inhibit LTP induction without 
affecting basal synaptic transmission  (Chen et al, 2000; Chen et al, 2002; Zhao 
et al, 2004). A similar result was shown in vivo, where cerebral injection of 
naturally secreted Aβ collected from cells expressing amyloid precursor protein 
(APP) prevented the stable maintenance of LTP in the hippocampal CA1 
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region (Walsh et al, 2002). In vivo injection of Aβ is reported to facilitate LTD and 
LTP reversal (depotentiation) in the CA1 region of the hippocampus (Kim et al, 
2001). These studies have provided great insight into Hebbian plasticity in AD, 
however the role of Aβ in homeostatic synaptic plasticity (HSP) remains largely 
unknown (Jang and Chung, 2016). 
 A major function of HSP is to regulate neuronal activity in a negative 
feedback manner, thus maintaining neuronal activity or synaptic function (Fong et 
al, 2015; Hou et al, 2011) within a physiological range after changes in network 
activity (Burrone et al, 2002; Davis and Bezprozvanny, 2001; Turrigiano and 
Nelson, 2004; Turrigiano et al, 1998). Under chronic suppression of neuronal 
activity, HSP is expressed via an increase in synaptic expression of AMPARs 
producing an up-scaling of AMPAR-mediated miniature post-synaptic currents 
(mEPSCs). While most studies show inactivity-induced synaptic scaling in 
cultured neurons (Anggono et al, 2011; Pratt et al, 2011; Shepherd et al, 2006; 
Turrigiano et al, 1998), HSP is also observed in vivo including in the spinal 
cord (Garcia-Bereguiain et al, 2013; Gonzalez-Islas and Wenner, 2006; Knogler 
et al, 2010; Wenner, 2014) and in the visual cortex (Desai et al, 2002; Goel et al, 
2006; Keck et al, 2013; Krahe and Guido, 2011; Maffei and Turrigiano, 2008). 
AMPARs are heterotetrameric ion channels consisting of different compositions 
of the four subunits GluA1-4, and the most common of which are GluA1/GluA2 
and GluA2/GluA3 combinations (Borges and Dingledine, 1998; Dingledine et al, 
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1999). During the early phase of neural inhibition, a change in GluA2 expression 
leads to the formation of GluA2-lacking, calcium permeable AMPARs (CP-
AMPARs). The production and insertion of CP-AMPARs at the synapse is 
required for the initiation of HSP. We have recently shown that the brain-enriched 
microRNA, miR124, causes a selective reduction in GluA2 levels via interaction 
with its 3’-UTR, leading to CP-AMPAR expression and HSP (Hou et al, 2015). 
Here we report that during inactivity-dependent HSP, either in vitro in 
cultured neurons with TTX incubation or in vivo in the visual cortex with visual 
deprivation, application of Aβ results in an aberrant over-scaling of AMPAR-
mediated synaptic currents and surface AMPAR expression. Aβ incubation or 
brain injection produces the expression of additional CP-AMPARs under 
neuronal activity inhibition. The CP-AMPARs are required for the initiation, but 
not maintenance of HSP. Consistent with this, both in vitro in cultured neurons 
with TTX incubation, and in vivo in the visual cortex during visual deprivation, 
application of Aβ leads to increased miR124 expression and the Aβ-mediated 
HSP can be blocked by miR124 suppression. Additionally, we show that Aβ 
induces the dissociation of HDAC1 from the inhibitory miR124 transcription factor 
EVI1, producing an up-regulation of miR124 expression and increased 
generation of CP-AMPARs. Thus, Aβ induces an over-response to inactivity-
dependent HSP via an upregulation of miR124 and CP-AMPAR expression. 
Therefore in the presence of Aβ, neurons adapt their synaptic properties 
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distinctly, which is likely to cause destabilization in neural network operation and 
brain function in AD. 
 
A1.3 Results 
A1.3.1 Aβ causes over-scaling during inactivity-dependent homeostatic 
synaptic plasticity 
To assess the effect of Aβ on HSP during activity deprivation, Aβ oligomers (0.5 
µM) were applied to cultured rat hippocampal neurons, with TTX (1 µM) or 
vehicle (water), for 24 h and AMPAR-mediated mEPSCs were recorded (Fig 
A.1A1). The Aβ [1-42] monomer was allowed to aggregate into oligomeric 
species during preparation and confirmed via western blot (Fig A.2).  In a typical 
HSP response after TTX incubation, we observed a 39% increase in mEPSC 
amplitude. Consistent with previous reports, Aβ treatment led to a modest but 
significant decrease in mEPSC amplitude after 24 h (Chang et al, 2006; Fitzjohn 
et al, 2001). Strikingly, when Aβ was co-applied together with TTX (TTX/Aβ) in 
neurons, we found that mEPSCs were increased to approximately 60% in 
amplitude, a response significantly stronger than a regular HSP response by TTX 
alone (Fig A.1A2-A3). Additionally, using a different paradigm in which HSP was 
induced with the application of TTX and the NMDA receptor antagonist APV (25 
µM), we found that co-application of Aβ produced a 22% greater increase in 
mEPSC amplitude compared to treatment with TTX+APV alone (Fig A.3). 
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Therefore, in the presence of Aβ, activity deprivation induced over-scaling of 
mEPSC during homeostatic regulation. A rightward shift in the cumulative 
distribution of mEPSC amplitudes (Fig A.1B) was not accompanied by any 
changes in inter-event interval (Fig A.1C) or frequency (Fig A.4), suggesting a 
predominant postsynaptic change in AMPA receptor currents.  
A1.3.2 Aβ does not alter the set-point of homeostatic synaptic plasticity 
Homeostatic regulation serves to restrain synaptic activities within a physiological 
range from a certain threshold, or a set-point. It is possible that the Aβ-mediated 
over-scaling of HSP was due to a shift in the homeostatic set-point to a higher 
level. If so, the synaptic strength may not return to basal levels, even after activity 
inhibition. To investigate whether TTX/Aβ-mediated HSP was reversible, we 
removed the treatment medium, washed the neurons and incubated the cells in 
fresh media after HSP for various lengths of time (Fig A.5A1). 24 h following 
TTX/Aβ removal, mEPSC amplitudes showed a significant reduction; after 96 h, 
mEPSC amplitudes of both TTX- and TTX/Aβ-treated neurons returned to basal 
levels (Fig A.5A2). Therefore, the Aβ-mediated over-scaling of HSP was 
reversible and seemed to not affect the homeostatic set-point.  
 To investigate whether Aβ could induce neuronal toxicity during activity 
deprivation, we performed a cell death assay after 24 hr incubation with Aβ, TTX 
or TTX/ Aβ. Live neurons were treated with propidium iodide (PI) to label dying 
cells and Hoescht to label all nuclei, with or without a 30uM glutamate challenge 
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to induce excitotoxicity. Quantification of the ratio of PI-positive to Hoescht 
positive nuclei showed that activity deprivation induced more cell death after a 
glutamate challenge, however cells treated with Aβ did not showed increased 
excitotoxicity (Fig A.6). 
A1.3.2 Calcium permeable-AMPARS regulate the Aβ-mediated over-scaling 
GluA2-lacking CP-AMPARs are produced and required for the expression of 
HSP during activity deprivation (Hou et al, 2008; Ju et al, 2004; Man, 2011; 
Sutton et al, 2006). To examine the role of CP-AMPARs in Aβ-mediated over-
scaling, neurons were treated with TTX or TTX/Aβ with or without the selective 
CP-AMPAR antagonist, philanthotoxin (PhTx), for 24 h (Fig A.5B1). Inhibition of 
CP-AMPARs during neuronal inactivity was sufficient to block both TTX- and 
TTX/Aβ -induced HSP in mEPSCs (Fig A.5B2). Thus, the Aβ-triggered over-
scaling shared the same requirement for CP-AMPARs as regular HSP. Previous 
studies indicate that CP-AMPARs are required for HSP initiation  (Garcia-
Bereguiain et al, 2013; Goel et al, 2006; Hou et al, 2011; Hou et al, 2015) 
however their role in the expression stage (after initiation) of HSP remains 
unclear. We therefore treated neurons with TTX for 12 h (for HSP initiation), 
followed by 12 h incubation with TTX + PhTx  (Fig A.5C1). mEPSC recordings 
from these neurons showed that PhTx application at a later stage did not affect 
synaptic scaling (Fig A.5C2), indicating that CP-AMPARs were necessary only 
for the initiation, but not the maintenance of HSP. To investigate whether Aβ-
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mediated over-scaling was dependent on CP-AMPARs during the later stage of 
HSP expression, we recorded from neurons that were incubated with TTX alone 
for 12 h for normal HSP initiation, then with TTX/Aβ+PhTx for the subsequent 12 
h (Fig A.5C1). Surprisingly, whereas AMPAR mEPSC amplitudes scaled to levels 
similar to TTX-mediated HSP, these neurons failed to produce the Aβ-dependent 
over-scaling of HSP (Fig A.5C2) Additionally, after 24 h treatment with TTX/Aβ, 
mEPSCs showed a faster decay time (90-10%) indicative of the presence of 
GluA2-lacking AMPARs (Fig A.7). Because TTX treatment can induce the 
expression of CP-AMPARs and Aβ may prolong their expression, we examined 
whether treatment of Aβ alone after 12 h incubation with TTX could produce 
over-scaling (Fig A.5C1). However, Aβ treatment after a normal initiation of HSP 
was not sufficient to induce over-scaling similar to 24 hr TTX/ Aβ treatment (Fig 
A.5C2). These findings suggest that CP-AMPARs play a role in the Aβ-mediated 
over-response of the later expression stage of HSP during periods of inactivity. 
A1.3.3 Both GluA2-containing and GluA2-lacking AMPARs contribute to 
Aβ-induced over-scaling 
We next sought to characterize the relative contribution of GluA2-containing, 
normal AMPARs (N-AMPARs) and CP-AMPARs to the mEPSC currents during 
HSP. We have shown that CP-AMPARs are required for HSP initiation in TTX 
and TTX/Aβ treated neurons, but whether the additional currents in over-scaling 
came entirely from CP-AMPARs was not clear. Aβ may facilitate CP-AMPAR 
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expression only transiently during initiation resulting in stronger HSP responses 
by recruiting more N-AMPARs to synapses during the later stage of HSP. 
Alternatively, Aβ could simply trigger continuous expression of CP-AMPARs over 
the entire course, including the early initiation stage and later maintenance stage. 
To investigate these possibilities, neurons were treated with TTX or TTX/Aβ for 8 
or 24 h to allow HSP expression. mEPSC recordings were then conducted either 
in the presence of PhTx to block CP-AMPARs, or without PhTx to record total 
AMPAR currents (N-AMPAR+CP-AMPAR). The difference between the two 
recording conditions would indicate the net contribution of CP-AMPARs. With this 
approach, we were able to compare the relative contribution of N-AMPARs and 
CP-AMPARs during the early initiation (8 h) (Fig A.8A1) and the later (24 h) (Fig 
A.8B1) stages of HSP.  After 8 h treatment with TTX or TTX/Aβ, both conditions 
showed a ~10% increase in mEPSC amplitude over controls, and addition of 
PhTx during recordings reduced amplitudes back to control levels (Fig A.8A2), 
indicating that the small increase in mEPSC amplitude during HSP initiation 
predominantly resulted from addition of CP-AMPARs in both TTX and TTX/Aβ 
treated neurons. Thus, the Aβ-mediated over-scaling was not due to an earlier, 
or stronger, onset during the HSP initiation. In contrast, when neurons were 
treated for 24 h with TTX or TTX/Aβ, addition of PhTx during recordings 
produced a 23% decrease in mEPSC amplitude in TTX/Aβ treated neurons, 
compared to a 12% decrease in neurons treated with TTX alone (Fig A.8B2 and 
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A.8C). TTX/Aβ treatment therefore resulted in larger amounts of CP-AMPAR 
expression during the later stage of HSP (Fig A.8D).  
Analysis of the ratio of CP-AMPAR to total AMPAR currents showed a 
larger contribution of CP-AMPARs after Aβ treatment during activity deprivation 
(Fig A.8E). A comparison of N-AMPAR currents also showed a 20% increase in 
TTX/Aβ-treated neurons over TTX-treated neurons (Fig A.8F). These results 
demonstrate that in addition to a modest increase in CP-AMPARs, more N-
AMPARs were added during the expression stage of Aβ-mediated HSP. The 
increase in CP-AMPARs after 24 h inactivity may suggest an Aβ-dependent 
elongation of the initiation process, which leads to an over-expression of CP-
AMPARs and thus an elevated recruitment of N-AMPARs, resulting in HSP over-
scaling. 
To directly investigate the change in surface AMPAR composition, we 
immunostained neurons for surface synaptic GluA1 and GluA2 after 24h 
incubation with Aβ, TTX or TTX/Aβ (Fig A.8G). Aβ incubation alone produced a 
modest decrease in both surface GluA1 and GluA2 levels (Fig A.8H) with no 
significant change in the ratio of GluA2:GluA1 (Fig A.8I). With the incubation of 
TTX, we observed a significant increase in the amount of surface GluA1 and 
GluA2 compared to control cells (Fig A.8H), as well as a significant decrease in 
the ratio of GluA2:GluA1 (Fig A.8I) suggesting that both CP-AMPARs and N-
AMPARs had been recruited to the synaptic surface. TTX/Aβ treatment led to an 
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increase in both GluA1 and GluA2 levels that were also significantly greater than 
TTX alone (Fig A.8H). Additionally, we observed a significant decrease in the 
GluA2:GluA1 ratio after TTX/Aβ treatment compared to TTX treatment alone (Fig 
A.8I). These findings corroborate our mEPSC recordings and indicate that the 
Aβ-mediated over-scaling of HSP increases the amount of CP-AMPARs and N-
AMPARs at the synaptic surface. 
A1.3.4 Aβ produces over-scaling in vivo in mouse visual cortex after visual 
deprivation that is dependent on calcium permeable-AMPARs 
To determine whether Aβ-mediated over-scaling of HSP could occur in vivo, we 
adopted a mouse model for HSP in the visual cortex with visual deprivation 
(VD)  (Desai et al, 2002; Goel and Lee, 2007). In one month-old mice, Aβ (10 
µg), or vehicle (water), was injected into V1 visual cortex via a cannula, then 
bilateral VD was conducted and the animals were kept in the dark. Following 24 
h VD, brain slices of the visual cortex were prepared for mEPSC recordings to 
examine synaptic scaling (Fig A.9A1). Consistent with previous studies (Goel et 
al, 2007; Keck et al, 2013), VD was able to induce a significant homeostatic 
increase in mEPSC amplitude. We observed a 19% increase in mEPSC 
amplitude in VD animals compared to controls (Fig A.9A2-A3). In line with our 
recordings in cultured neurons, Aβ injection alone decreased mEPSC amplitude 
(Fig A.9A2-A3) and frequency (Fig A.10) compared to vehicle control animals. 
However, VD+Aβ produced an overshoot in the HSP response. Recordings from 
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VD+Aβ treated animals showed a 36% increase in mEPSC amplitude compared 
to control, while VD alone without Aβ showed a 19% increase compared to 
control (Fig A.9A2-A3). Thus, similar to the in vitro findings, Aβ induced an over-
scaling in visual cortical neurons in vivo under activity suppression conditions.  
A1.3.5 Calcium permeable-AMPARs are responsible for Aβ-induced over 
scaling in visual cortex  
To investigate the contribution of CP-AMPARs to Aβ-mediated HSP in vivo, we 
performed visual deprivation for 24 h after injection of Aβ or vehicle into V1 visual 
cortex and recorded mEPSCs from brain slices in the presence of PhTx (Fig 
A.9B1). Strikingly, application of PhTx to brain slices from VD+Aβ animals was 
sufficient to return mEPSC amplitudes to levels similar to control animals without 
VD (Fig A.9B2-B3). Therefore, in visual cortex in vivo, the elevated mEPSC 
amplitude during HSP was constituted predominantly of CP-AMPARs. These 
findings suggest that compared to HSP in cultured neurons, CP-AMPARs are the 
major component for HSP expression in vivo.  
A1.3.6 miR124 is necessary for calcium permeable-AMPAR production and 
Aβ-induced over scaling 
MicroRNA miR124 has been shown to play a key role for the generation of CP-
AMPARs (Ho et al, 2014; Hou et al, 2015). miR124 selectively binds to the 3’-
UTR of GluA2 mRNA suppressing protein expression of GluA2. Probably via 
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calcium signaling gated by calcium permitting CP-AMPARs, an increase in 
miR124, and subsequent formation of CP-AMPARs is required for the 
homeostatic response (Hou et al, 2015). To examine miR124 expression, we 
treated neuronal cultures with TTX, Aβ, or TTX/Aβ for 6h and collected total 
RNA. qPCR revealed that miR124 expression was increased 12% in neurons 
treated with Aβ alone, comparing to a 72% increase in neurons incubated with 
TTX (Fig. A.11A). Surprisingly, co-incubation of TTX with Aβ produced a 97% 
increase in miR124 that was significantly larger than TTX or Aβ alone (Fig 
A.11A). These results indicate that under a condition of activity suppression, Aβ 
is capable of dramatically up-regulating miR124 expression in neurons, which 
presumably leads to the generation of a higher amount of CP-AMPARs for HSP 
expression.  
 To examine the necessity of miR124 in Aβ-mediated HSP, we transfected 
hippocampal neurons with a miR124-binding sponge (BS) construct to neutralize 
endogenous miR124  (Hou et al, 2015). The sponge consisted of two tandem 
repeats of a sequence complementary to miR124, so that when overexpressed, it 
would bind and sequester miR124. The miR124-BS has previously been 
validated to block the initiation of TTX induced HSP (Hou et al, 2015). We found 
that expression of the miR124-BS not only blocked HSP by TTX, but also HSP 
over-scaling induced by TTX/Aβ, indicating that the up-regulation of miR124 was 
required for HSP (Fig A.11B), presumably due to a suppression of CP-AMPAR 
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formation. Additionally, expression of the miR124-BS with Aβ showed an ~10% 
decrease in amplitude, similar to treatment with Aβ + GFP (Fig A.11B). 
A1.3.7 Aβ destabilizes the association between EV1 and HDAC1  
The transcription factor EVI1 has been shown to regulate miR124 expression by 
binding to the regulatory region of the miR124 gene to suppress its 
transcription (Dickstein et al, 2010; Senyuk et al, 2011; Vazquez et al, 2010). 
Association of EVI1 with the histone deacetylase HDAC1 is crucial for 
transcriptional repression via histone deacetylation (Barneda-Zahonero and 
Parra, 2012; Graff and Tsai, 2013). Importantly, a decreased EV1-HDAC1 
interaction has been shown to be controlled by neuronal activity and to control 
miR124 expression (Hou et al, 2015). We hypothesized that treatment with Aβ 
during activity deprivation could further decrease the EVI1-HDAC1 interaction, 
thereby increasing miR124 levels. We therefore immunoprecipitated EVI1 from 
lysates of cultured cortical neurons after treatment with TTX or TTX/Aβ for 24 h 
and probed for HDAC1. Indeed, activity deprivation by TTX caused a reduction in 
the EVI1–HDAC1 interaction, and association was further reduced with the 
TTX/Aβ treatment (Fig A.11C and A.11D), consistent with the idea that a 
destabilization of the EVI1-HDAC1 association by Aβ resulted in elevated 
miR124 expression.  
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A1.3.8 miR124 is required for Aβ-induced over-scaling in vivo 
Next, we wanted to examine whether miR124 was implicated in the aberrant 
over-scaling in vivo. First, we found that following Aβ injection in the visual cortex 
and 24 h VD, qPCR confirmed a 110% increase in miR124 expression compared 
to vehicle controls (Fig A.11E). To confirm the role of miR124 in HSP in vivo, we 
injected miR124 inhibitor virus, or a scrambled control, one month prior to VD 
experiments to allow for viral expression. Mice were then injected with vehicle or 
Aβ, into the visual cortex followed by 24 h VD. mEPSC recordings from visual 
cortical brain slices showed that knockdown of miR124 in vivo blocked VD-
induced HSP in both vehicle and Aβ treated animals (Fig A.11F-G), indicating 
that miR124 expression is necessary for normal and over-scaling of HSP in vivo.   
 
A1.4 Discussion 
For the first time, we provide evidence indicating a role for Aβ in homeostatic 
synaptic regulation, a mechanism counter-balancing Hebbian synaptic plasticity 
and crucial for the stabilization of neuron and neural circuit activity. During 
normal conditions, activity suppression triggers HSP thereby returning synaptic 
activity to a physiological level. However, in the presence of Aβ, neuronal 
inactivity triggered an overshoot in the HSP response, producing an aberrant 
over-scaling of synaptic strength (Fig A.11H). Our findings strongly support a role 
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of altered homeostatic plasticity in AD, a hypothesis that has previously been 
proposed by Small (Small, 2004; Small, 2008). 
The increased synaptic scaling was caused by a larger and more 
prolonged expression of CP-AMPARs during the course of HSP. An increase in 
the generation of CP-AMPARs was observed as a result of an increase in 
miR124 expression after Aβ treatment, both in rat hippocampal neurons in vitro 
and mouse visual cortex in vivo. Although miR124 facilitates the expression of 
HSP, an increase in expression of miR124 alone is not sufficient to induce a 
homeostatic response  (Hou et al, 2015). From our findings, Aβ induces a 
destabilization of the EV1-HDAC1 interaction, thereby allowing for more miR124 
transcription and subsequent generation of CP-AMPARs. This could possibly 
prime the system such that during activity blockade an abnormal overshoot in the 
HSP response can be triggered. In addition to miR124-dependent generation of 
CP-AMPARs, Aβ may remove GluA2-containing AMPARs from synapses 
preferentially thereby promoting the HSP response.  
HSP serves to maintain neuronal networks within a physiological range 
while conserving individual synaptic weights. With an Aβ-mediated over-scaling 
of HSP, the network could destabilize, or individual synaptic responses could 
become saturated, thereby disrupting information processing and contributing to 
memory deficits. Potentially, synaptic over-scaling by Aβ could lead to an 
increase in the overall excitability in a local neural network. Indeed, 
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epidemiological studies have shown that AD confers an increased risk of 
seizures and epilepsy, with about a sevenfold increase in seizure incidences in 
AD patients compared to normal controls (Imfeld et al, 2013). While seizures can 
appear at any stage of the disease, epileptiform activity is highest in younger AD 
patients earlier in the disease progression (Amatniek et al, 2006; Irizarry et al, 
2012). In AD transgenic mice, elevated levels of Aβ correlate with a higher 
incidence of seizures before evidence of neuronal loss (Palop and Mucke, 2009). 
Mechanisms that underlie AD-related seizures remain unclear, but HSP over-
scaling may represent a causal factor. Additionally, since synaptic release of Aβ 
is stimulated by neuronal activity, increased synaptic activity could create a 
positive feedback loop that accelerates AD progression (Noebels, 2011; Small, 
2004; Small, 2008).  
In line with our findings, HSP of excitatory synapses has been shown to 
be impaired in neurons lacking presinilin 1 (PS1 KO) or neurons expressing a 
familial AD-linked mutation (PS1M146V), which was not dependent on g-secretase 
activity and showed impaired phosphatidylinositol 3-kinase (PI3K)/Akt 
signaling (Pratt et al, 2011). These findings suggest that other mechanisms may 
have different effects on HSP in AD and indicate that aberrant synaptic scaling 
may play a role in familial as well as sporadic AD.  
There is a growing body of evidence implicating CP-AMPARs during the 
onset of synaptic pathology in neurological disorders (Grooms et al, 2000; Kwak 
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and Weiss, 2006; Rajasekaran et al, 2012; Whitcomb et al, 2015). Previous 
analyses of hippocampal postsynaptic density fractions from human AD patients 
showed an increase in GluA1 levels compared to healthy controls, whereas no 
changes in NMDAR subunit expression were observed (Marcello et al, 2012), 
suggesting a selective increase in GluA1-containing receptors in the 
hippocampus of AD patients. Consistent with this, aberrant CP-AMPAR 
expression and increased GluA1 phosphorylation have been reported in young 
mice, prior to any neuropathology, in an AD transgenic mouse model (Megill et 
al, 2015). Together, these findings support a mechanism in which increased CP-
AMPAR synaptic insertion during the early stages of AD pathogenesis leads to 
later synaptic pathologies. In addition, given the unique property that CP-
AMPARs have a high permeability to calcium, it is intriguing to postulate an 
additional role of the CP-AMPARs expressed during HSP in neuronal death 
during the later stages of AD. Therefore, the CP-AMPAR as well as the HSP 
regulation cascade could serve as a therapeutic target in the development of new 
treatments in AD. 
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Figure A.1. Aβ triggers an aberrant homeostatic response during neuronal 
activity deprivation  
(A1) Treatment paradigm. Neurons were treated with Aβ alone, TTX alone, or 
TTX and Aβ together (TTX/Aβ) for 24 h prior to mEPSC recordings. (A2) Sample 
mEPSC traces showing Aβ-mediated HSP. (A3) Quantification of mEPSC 
amplitudes (control = 12.9 ± 0.75, n = 9; ; Aβ = 10.9 ± 0.79, n = 9; TTX = 17.7 ± 
0.67, n = 7; TTX/Aβ = 20.6 ± 0.82, n = 8. (B,C) Cumulative probability plots 
showing no change in inter-event interval (B) and a typical multiplicative scaling 
effect on mEPSC amplitude (C) Mann-Whitney U test. *p < 0.05, **p < 0.01, ***p 
< 0.001.  
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Figure A.2 
 
 
 
Figure A.2. Analysis of Aβ oligomers 
Representative western blot of the Aβ 1-42 oligomers used in all experiments. Aβ 
was prepared from monomer as indicated in Methods.  
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Figure A.3 
 
 
 
 
Figure A.3 Aβ causes over-scaling of homeostatic synaptic plasticity 
induced by TTX+APV 
Quantification of mEPSC amplitude after treatment with TTX+APV ± Aβ (control 
= 12.7 ± 0.94, n = 9; TTX = 17.2 ± 1.08, n = 7; TTX/Aβ = 21.05 ± 1.05, n = 8). 
Mann-Whitney U test, * p < 0.05, ** p < 0.01; *** p < 0.001. Values = mean, error 
bars = ± SEM. 
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Figure A.4 
 
 
Figure A.4. mEPSC frequency in vitro 
Quantification of mEPSC frequencies (control = 0.86 ± 0.06, n = 9; Aβ = 0.77 ± 
0.08, n = 9; TTX = 0.89 ± 0.09, n = 7; TTX/Aβ = 0.87 ± 0.08, n = 8). Mann-
Whitney U test, ns = not significant. Values = mean, error bars = ± SEM. 
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Figure A.5 
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Figure A.5. Recovery time course and requirement of calcium permeable-
AMPARs for homeostatic synaptic plasticity  
(A1) Treatment paradigm for HSP recovery. Neurons were incubated in the 
appropriate treatment for 24 h, washed, then allowed to recover in fresh medium 
for various lengths of time. (A2) Normalized mEPSC amplitudes after recovery 
for 24 and 96 h. Both the TTX and TTX/Aβ treatment groups returned to baseline 
after 96 h recovery, indicating a lack of change in the set point of neuronal 
activity during basal conditions (control = 12.7 ± 0.62, n = 9; TTX = 16.9 ± 0.56, n 
= 13; TTX 24 h recovery = 15.8 ± 0.51, n = 9; TTX 96 h recovery = 15.9 ± 1.33, n 
= 8; TTX/Aβ = 19.6 ± 0.54, n = 10; TTX/Aβ 24 h recovery = 17.7 ± 0.59, n = 9; 
TTX/Aβ 96 h recovery = 15.8 ± 1.51, n = 8). (B1) Treatment paradigm of PhTx 
application during HSP. (B2) Graph of normalized mEPSC amplitudes showing 
that blockade of CP-AMPARs was sufficient to occlude HSP in both the TTX and 
TTX/Aβ treatment groups (control = 12.5 ± 0.28, n = 7; TTX = 17.1 ± 0.52, n = 5; 
TTX+PhTx = 13.1 ± 0.42, n = 6; TTX/Aβ = 19.6 ± 0.79, n = 6; TTX/Aβ+PhTx = 
13.5 ± 0.28, n = 6). (C1) Paradigm of PhTX application after the initiation phase 
of HSP. Neurons were allowed to initiate HSP normally in the presence of TTX 
and then treated with PhTx ± Aβ. (C2) Graphs show that blockade of CP-
AMPARs after typical HSP initiation was sufficient to occlude Aβ-induced over-
scaling of HSP (control = 12.4 ± 0.50, n = 7; TTX = 17.1 ± 0.65, n = 6; TTX à 
PhTx = 16.9 ± 0.68, n = 7; TTX/Aβ = 20.1 ± 0.83, n = 6; TTX/Aβ à PhTx = 17.6 ± 
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0.38, n = 8 cells). Mann-Whitney U test, * p < 0.05, ** p < 0.01, *** p < 0.001, ns: 
not significant.   
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Figure A.6 
 
 
Figure A.6. Aβ treatment does not induce toxicity during homeostatic 
synaptic plasticity 
Following the indicated HSP paradigms, neurons were treated with propidium 
iodide (PI) to label dying cells, and Hoescht to label all nuclei. The percentage of 
PI positive to total Hoescht nuclei was calculated (Basal: control = 0.64% ± 0.2%, 
n = 10; Aβ = 0.58 ± 0.19, n = 11; TTX = 1.9 ± 0.4, n = 11; TTX/Aβ = 1.69 ± 0.35, 
n = 12; one-way ANOVA, p <0.01; Glutamate: control = 7.1 ± 1.0, n = 11; Aβ = 
6.5 ± 0.66, n = 12; TTX = 11.5 ± 1.71, n = 10; TTX/Aβ = 12.6 ± 1.65, n = 12). 
Mann-Whitney U test, *p < 0.05, ns: not significant. Values = mean, error bars = 
± SEM. 
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Figure A.7 
 
 
Figure A.7. mEPSC decay time 
Quantification of mEPSC decay values (control = 5.94 ± 0.12, n = 5; Aβ = 5.55 ± 
0.18, n = 5; TTX = 5.33 ± 0.10, n = 5; TTX/Aβ = 4.97 ± 0.14, n = 5). Mann-
Whitney U test, *p < 0.05, **p < 0.01; ns: not significant. 
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Figure A.8 
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Figure A.8. Both calcium permeable-AMPAR and normal-AMPARs 
contribute to the Aβ-mediated over-scaling of homeostatic synaptic 
plasticity 
(A1, B1) Treatment paradigms. mEPSCs were recorded in the presence of PhTx 
after 8 h (A1) and 24 h (B1) of TTX or TTX/Aβ incubation. (A2, B2) Normalized 
mEPSC amplitudes after 8h (A2) (control = 12.5 ± 0.42, n = 10; Con à PhTx = 
12.1 ± 0.51, n = 10; 8h TTX = 13.9 ± 0.58, n = 8; 8h TTX à PhTx = 12.2 ± 0.72, 
n = 8; 8 h TTX/Aβ = 13.9 ± 0.63, n = 9; 8 h TTX/Aβ à PhTx = 12.5 ± 0.66; n = 9) 
and 24 h (B2) HSP (control = 12.1 ± 0.60, n = 9; control à PhTx = 11.7 ± 0.43, n 
=9; TTX = 16.6 ± 0.59, n = 8; TTX à PhTx = 15.1 ± 0.76, n = 8; TTX/Aβ = 19.9 ± 
0.52, n = 9; TTX/Aβ à PhTx = 17.1 ± 0.78; n = 9). PhTx was only applied to the 
extracellular recording solution at the time of the recording. (C) Sample traces of 
mEPSCs after 24 h application of the indicated treatments. (D) Stacked graph of 
the relative contributions of N-AMPARs (mEPSC amplitude after application of 
PhTx) vs. CP-AMPARs (mEPSC amplitude without PhTx − amplitude with PhTx). 
Application of Aβ caused an increase in both CP-AMPAR and N-AMPAR 
components in HSP (control CP-AMPAR = 0.01 ± 0.04, n = 7; control N-AMPAR 
= 0.98 ± 0.05, n = 7; TTX CP-AMPAR = 0.11 ± 0.04, n = 7; TTX N-AMPAR = 
1.28 ± 0.06, n = 7; TTX/Aβ CP-AMPAR = 0.18 ± 0.06, n= 6; TTX/Aβ N-AMPAR = 
1.44 ± 0.04, n = 6). (E) Percentage of the CP-AMPAR component after 8 h and 
24 h HSP. Ratio = (amplitude without PhTx- amplitude with PhTx) / (amplitude 
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without PhTx) (TTX 0 h = 2.27 ± 1.42%, n = 9; TTX 8 h = 12.14 ± 0.82%, n = 9; 
TTX 24 h = 13.09 ± 1.99%, n = 8; TTX/Aβ 0 h = 2.52 ± 1.93%, n = 8; TTX/Aβ 8 h 
= 11.05 ± 2.87%, n = 10; TTX/Aβ 24 h = 18.99 ± 2.13%; n = 10). (F) Changes in 
the N-AMPAR current after 8 h and 24 h HSP (TTX 0 h = 1 ± 0.04, n = 9; TTX 8 h 
= 0.99 ± 0.03, n = 9; TTX 24 h = 1.26 ± 0.03, n = 8; TTX/Aβ 0 h = 1 ± 0.04, n = 
10; TTX/Aβ 8 h = 1.02 ± 0.03, n = 10; TTX/Aβ 24 h = 1.46 ± 0.04; n = 10). (G) 
Immunostainings of surface GluA1 (red) and GluA2 (green) after 24 h incubation 
with the indicated treatments. Scale bar represents 2 µm. (H,I) Quantification of 
changes in surface synaptic intensity of GluA1 and GluA2 (H) and the ratio of 
GluA1:GluA2 (I) (GluA1: control = 1 ± 0.03, n = 11; Aβ = 0.88 ± 0.03, n =10; TTX 
= 1.42 ± 0.03, n = 11; TTX/Aβ = 1.63 ± 0.04, n =11. GluA2: control = 1 ± 0.02, n 
= 10; Aβ = 0.84 ± 0.04, n =10; TTX = 1.29 ± 0.03, n = 10; TTX/Aβ = 1.39 ± 0.04, 
n =10). Mann-Whitney U test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 
0.0001 ns = not significant. 
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Figure A.9 
ns	
0	
2	
4	
6	
8	
10	
12	
14	
16	
18	
20	
No	VD	 A/er	VD	
m
EP
SC
	A
m
pl
itu
de
	(p
A)
	
Control	 Aβ		
0	
2	
4	
6	
8	
10	
12	
14	
No	VD	 A/er	VD	
m
EP
SC
	A
m
pl
itu
de
	(p
A)
	
Control+PhTx	 Aβ+PhTx	
A1	
A2	
24	h	VD+Vehicle	or	VD+Aβ	
	
Record+PhTx	
N
o	
VD
	
A/
er
	V
D	
B1	
A3	
B2	
**	
**	
**	
**	
B3	
24	h	VD+Vehicle	or	VD+Aβ	
Record	
**	
**	 **	
Aβ	
Aβ	
Control	
Control	
N
o	
VD
	
A/
er
	V
D	
20
	p
A	
2s	
Control	
+PhTx	
Control	
+PhTx	
Aβ	
+PhTx	
Aβ	
+PhTx	
20
	p
A	
2s	
229 
 
 
Figure A.9. Aβ-mediated over-scaling in vivo requires calcium permeable-
AMPARs  
(A1) Bilateral VD was performed in one month-old mice by sealing the eyelids 
with black epoxy and the animals were then kept in the dark. Prior to VD, Aβ (10 
µg) or vehicle (water) was injected into V1 visual cortex via a cannula. Following 
24 h VD, brain slices of the visual cortex were prepared for mEPSC recordings to 
examine synaptic scaling. (A2) Sample mEPSC traces from brain slice 
recordings after the treatments shown to A1. (A3) Quantification of the data 
shown in A2 (Control no VD = 12.2 ± 0.23, n = 7; Aβ no VD = 10.2 ± 0.48, n =6; 
Control after VD = 14.5 ± 0..19, n = 6; Aβ after VD = 16.6 ± 0.63, n = 6; 4 mice 
per condition). (B1) Following 24 h VD paradigm, mEPSCs were recorded from 
brain slices with, or without PhTx, to determine the contribution of CP-AMPARs 
to HSP in vivo. (B2) Sample mEPSC traces from brain slice recordings after the 
treatments shown to B1. (B3) Quantification of the data shown in B2 (Control no 
VD+PhTx = 11.5 ± 0.33, n = 5; Aβ no VD+PhTx = 7.68 ± 0.21, n = 5; Control 
after VD+PhTx = 10.9 ± 0.21, n = 6; Aβ after VD+PhTx = 8.2 ± 0.63, n = 5; 4 
mice per condition). Mann-Whitney U test, * p < 0.05, ** p < 0.01, *** p < 0.001, 
ns = not significant. 
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Figure A.10 
 
 
Figure A.10. mEPSC frequency in vivo 
Quantification of mEPSC frequencies (Control no VD = 8.83 ± 1.36, n = 7; Aβ no 
VD = 4.00 ± 1.01, n = 6; Control After VD = 6.90 ± 1.81, n = 6; Aβ After VD = 
9.12 ± 2.58, n = 6). Mann-Whitney U test, *p < 0.05, ns = not significant. Values = 
mean, error bars = ± SEM. 
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Figure A.11 
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Figure A.11. miR124 expression is increased in Aβ-mediated over-scaling 
due to a decreased EVI1-HDAC1 interaction 
A. MicroRNAs were purified from rat hippocampal lysates treated for 24 h with 
the conditions shown and miR124 was quantified by qRT-PCR (Control = 1 ± 
0.02, n = 3; Aβ = 1.12 ± 0.02, n =3; TTX = 1.72 ± 0.03, n = 3; TTX/Aβ = 1.97± 
0.02, n =3). Values normalized to control, error bars = ± SEM. B. Hippocampal 
neurons were transfected with a miR124 BS (containing GFP) or a scrambled 
BS-GFP for 1 day followed by 24 h treatment with the conditions shown. mEPSC 
amplitudes were increased in the scrambled BS controls but not in the miR124 
BS transfected cells (Control + GFP = 12.33 ± 0.86, n = 3; Aβ + GFP = 10.2 ± 
0.97, n =3; TTX + GFP = 16.8 ± 0.62, n = 3; TTX/Aβ + GFP = 19.5 ± 0.74, n =3; 
Control + BS = 12.9 ± 0.74, n =8; Aβ + BS = 9.9 ± 0.83, n =3; TTX + BS = 11.8 ± 
0.86, n =9; TTX/Aβ + BS = 12.9 ± 0.86, n =8; 4 mice per condition). C. Co-
immunoprecipitation of EVI1 and HDAC1. Using lysates from rat cortical neurons 
incubated with the conditions shown for 24 h, EVI1 complexes were isolated by 
immunoprecipitation and probed for HDAC1. EVI1 co-immunoprecipitated with 
HDAC1 and the association was further decreased by incubation with TTX/Aβ. D. 
Quantification of the co-immunoprecipitation data from C (n=4); HDAC1 was 
normalized to the immunoprecipitated EVI1 levels. E. MicroRNAs were purified 
from mouse cortex 24 h after injection of Aβ (10µg) or vehicle control and 
miR124 was quantified by qRT-PCR (Control = 1.01 ± 0.13, n =10; Aβ = 2.12 ± 
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0.25, n = 10). Values normalized to control, error bars = ± SEM. F. Sample 
mEPSC traces from recordings in V1 visual cortex for the treatments shown. G. 
Quantification of the traces shown in E. mEPSC amplitudes were increased in 
the scrambled siRNA controls for VD and VD + Aβ but not in the miR124 siRNA 
infected cells (no VD + scr siRNA = 11.7 ± 0.52, n = 6; VD + scr siRNA = 14.1 ± 
0.23, n =8; VD + Aβ + scr siRNA= 16.1 ± 0..57, n = 5; no VD + miR124 siRNA = 
11.4 ± 0.33, n =6; VD + miR124 siRNA = 10.1 ± .62, n = 5; VD + Aβ + miR124 
siRNA = 10.3 ± .36, n =6; 4 mice per condition). H. Model depicting the disruption 
of HSP by Aβ. During initiation, both TTX and TTX/Aβ show a normal increase in 
CP-AMPARs (solid lines), however in the presence of Aβ, CP-AMPAR 
expression continues to increase subsequently driving a further increase in N-
AMPARs and total AMPARs (dashed lines) during the expression phase of HSP. 
Mann-Whitney U test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.001, ns = 
not significant. Values = mean, error bars = ± SEM. 
 
 
	 234 
JOURNAL ABBREVIATIONS 
 
Acta Neuropathol Acta Neuropathologica 
Adv Exp Med Biol Advances in Experimental Medicine and 
Biology 
Am J Hum Genet American Journal of Human Genetics 
Am J Med Genet A American Journal of Medical Genetics. 
Part A 
Am J Med Genet B  American Journal of Medical Genetics. 
 Neuropsychiatr Genet Part B, Neuropsychiatric Genetics 
Am J Psychiatry American Journal of Psychiatry 
Ann N Y Acad Sci Annals of the New York Academy of 
Sciences 
Ann Neurol Annals of Neurology 
Ann Neurosci Annals of Neurosciences 
Annu Rev Genomics Hum Genet Annual Review of Genomics and Human 
Genetics 
Annu Rev Neurosci Annual Review of Neuroscience 
Annu Rev Pathol Annual Review of Pathology 
Annu Rev Pharmacol Toxicol Annual Review of Pharmacology and 
Toxicology 
Annu Rev Physiol Annual Review of Physiology 
Arch Gen Psychiatry Archives of General Psychiatry 
Arch Neurol Archives of Neurology 
Autism Res Autism Research 
Behav Brain Res Behavioural Brain Research 
Behav Neurosci Behavioral Neuroscience 
Biochem Biophys Res Commun Biochemical and Biophysical Research 
Communications 
Biochem J Biochemical Journal 
Biol Psychiatry Biological Psychiatry 
BMC Cell Biol BMC Cell Biology 
Brain Dev Brain & Development 
Brain Pathol Brain Pathology 
Brain Res Brain Research 
Brain Res Bull Brain Research Bulletin 
Cell Dev Biol Cell & Developmental Biology 
Cell Mol Life Sci Cellular and Molecular Life Sciences 
Cell Rep Cell Reports 
Cereb Cortex Cerebral Cortex 
Child Psychiatry Hum Dev Child Psychiatry and Human 
Development 
Clin Genet Clinical Genetics 
	 235 
Cold Spring Harb Perspect Biol Cold Spring Harbor Perspectives in 
Biology 
Cold Spring Harb Symp Quant Biol Cold Spring Harbor Symposia on 
Quantitative Biology 
Commun Integr Biol Communicative & Integrative Biology 
Curr Alzheimer Res Current Alzheimer Research 
Curr Biol Current Biology: CB 
Curr Mol Med Current Molecular Medicine 
Curr Neurol Neurosci Rep Current Neurology and Neuroscience 
Reports 
Curr Opin Neurobiol Current Opinion in Neurobiology 
Curr Top Dev Biol Current Topics in Developmental Biology 
Cytogenet Cell Genet Cytogenetics and Cell Genetics 
Dev Cell Developmental Cell 
Dev Med Child Neurol Developmental Medicine and Child 
Neurology 
Dev Neurobiol Developmental Neurobiology 
Dialogues Clin Neurosci Dialogues in Clinical Neuroscience 
Dis Model Mech Disease Models & Mechanisms 
EMBO J  EMBO Journal  
Eur J Neurosci European Journal of Neuroscience 
Eur J Pharmacol European Journal of Pharmacology 
Expert Rev Neurother Expert Review of Neurotherapeutics 
FEBS Lett FEBS Letters  
Front Cell Neurosci Frontiers in Cellular Neuroscience 
Front Mol Neurosci Frontiers in Molecular Neuroscience 
Front Neural Circuits Frontiers in Neural Circuits 
Gene Expr Patterns Gene Expression Pattersn 
Genes Brain Behav Genes, Brain, and Behavior 
Genes Dev Genes & Development 
Genet Med Genetics in Medicine 
Genet Test Mol Biomarkers Genetic Testing and Molecular 
Biomarkers 
Hum Genet Human Genetics  
Hum Mol Genet Human Molecular Genetics 
Hum Mutat Human Mutation 
Int J Dev Neurosci International Journal of Developmental 
Neuroscience 
J Alzheimers Dis Journal of Alzheimer's Disease 
J Am Acad Child Adolesc Psychiatry Journal of the American Academy of Child 
and Adolescent Psychiatry 
J Autism Dev Disord Journal of Autism and Developmental 
Disorders 
J Biol Chem Journal of Biological Chemistry 
	 236 
J Cell Biol Journal of Cell Biology 
J Cell Sci Journal of Cell Science 
J Child Adolesc Psychpharmacol Journal of Child and Adolescent 
Psychopharmacology  
J Clin Invest Journal of Clinical Investigation 
J Coll Physicians Surg Pak Journal of the College of Physicians and 
Surgeons--Pakistan 
J Comp Neurol Journal of Comparative Neurology 
J Dev Behav Pediatr Journal of Developmental and Behavioral 
Pediatrics 
J Gen Physiol Journal of General Physiology 
J Genet Journal of Genetics  
J Med Genet Journal of Medical Genetics 
J Mol Biol Journal of Molecular Biology 
J Neural Transm (Vienna) Journal of Neural Transmission 
J Neurobiol Journal of Neurobiology 
J Neurochem Journal of Neurochemistry 
J Neurodev Disord Journal of Neurodevelopmental Disorders 
J Neuropathol Exp Neurol Journal of Neuropathology and 
Experimental Neurology 
J Neurophysiol Journal of Neurophysiology  
J Neurosci Journal of Neuroscience 
J Neurosci Res Journal of Neuroscience Research 
J Physiol Journal of Physiology 
JAMA JAMA: The Journal of the American 
Medical Association 
Learn Mem Learning & Memory 
Mol Autism Molecular Autism 
Mol Cell Molecular Cell 
Mol Cell Biochem Molecular and Cellular Biochemistry 
Mol Cell Biol Molecular and Cellular Biology 
Mol Cell Neurosci Molecular and Cellular Neurosciences 
Mol Oncol Molecular Oncology 
Mol Pharmacol Molecular Pharmacology 
Mol Psychiatry Molecular Psychiatry 
N Engl J Med New England Journal of Medicine 
Nat Cell Biol Nature Cell Biology 
Nat Clin Pract Neurol Nature Clinical Practice. Neurology 
Nat Commun Nature Communications 
Nat Genet Nature Genetics 
Nat Med Nature Medicine 
Nat Methods Nature Methods 
Nat Neurosci Nature Neuroscience 
Nat Rev Genet Nature Reviews. Genetics 
	 237 
Nat Rev Neurosci Nature Reviews. Neuroscience 
Neural Plast Neural Plasticity 
Neurobiol Aging Neurobiology of Aging 
Neurobiol Dis Neurobiology of Disease 
Neurobiol Learn Mem Neurobiology of Learning and Memory 
Neurochem Int Neurochemistry International 
Neuromolecular Med Neuromolecular Medicine 
Neuropsychol Rev Neuropsychology Review 
Neurosci Biobehav Rev Neuroscience and Biobehavioral Reviews 
Neurosci Lett Neuroscience Letters 
Neurosci Res Neuroscience Research 
Nucleic Acids Res Nucleic Acids Res 
Orphanet J Rare Dis Orphanet Journal of Rare Diseases 
Pediatr Neurol Pediatric Neurology 
Pharmacol Rev Pharmacological Reviews 
Philos T R Soc B Philosophical Transactions of the Royal 
Society of London. Series B, Biological 
Sciences 
Philos Trans R Soc Lond B Biol Sci Philosophical Transactions of the Royal 
Society of London. Series B, Biological 
Sciences 
PLoS Biol PLoS Biology 
PLoS Genet PLoS Genetics 
Prenat Diagn Prenatal Diagnosis 
Proc Natl Acad Sci USA Proceedings of the National Academy of 
Sciences of the United States of 
America 
Prog Brain Res Progress in Brain Research 
Prog Neurobiol Progress in Neurobiology 
Psychiatr Genet Psychiatric Genetics 
Res Autism Research in Autism Spectrum Disorders 
Res Dev Disabil Research in Developmental Disabilities 
Sci Rep Scientific Reports 
Sci Signal Science Signaling 
Sci Transl Med Science Translational Medicine 
Semin Cell Dev Biol Seminars in Cell & Developmental Biology 
Transl Psychiatry Translational Psychiatry 
Trends Genet Trends in Genetics 
Trends Mol Med Trends in Molecular Medicine 
Trends Neurosci Trends in Neurosciences 
238 
 
 
REFERENCES 
 
Abraham WC (2003). How long will long-term potentiation last? Philos T R Soc B 
358: 735-744. 
 
Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss LA, et 
al (2013). SFARI Gene 2.0: a community-driven knowledgebase for the autism 
spectrum disorders (ASDs). Molecular Autism 4. 
 
Abu-Elneel K, Ochiishi T, Medina M, Remedi M, Gastaldi L, Caceres A, et al 
(2008). A delta-catenin signaling pathway leading to dendritic protrusions. J Biol 
Chem 283: 32781-32791. 
 
Adams NC, Tomoda T, Cooper M, Dietz G, Hatten ME (2002). Mice that lack 
astrotactin have slowed neuronal migration. Development 129: 965-972. 
 
Akins MR, Berk-Rauch HE, Fallon JR (2009). Presynaptic translation: stepping 
out of the postsynaptic shadow. Front Neural Circuits 3: 17. 
 
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990). Basic local 
alignment search tool. J Mol Biol 215: 403-410. 
 
Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell 
K, et al (2006). Incidence and predictors of seizures in patients with Alzheimer's 
disease. Epilepsia 47: 867-872. 
 
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999). 
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-
CpG-binding protein 2. Nat Genet 23: 185-188. 
 
Anderson SA, Eisenstat DD, Shi L, Rubenstein JL (1997). Interneuron migration 
from basal forebrain to neocortex: dependence on Dlx genes. Science 278: 474-
476. 
 
Angevine JB, Jr., Sidman RL (1961). Autoradiographic study of cell migration 
during histogenesis of cerebral cortex in the mouse. Nature 192: 766-768. 
 
Anggono V, Clem RL, Huganir RL (2011). PICK1 loss of function occludes 
homeostatic synaptic scaling. J Neurosci 31: 2188-2196. 
 
239 
 
 
Arikkath J, Israely I, Tao Y, Mei L, Liu X, Reichardt LF (2008). Erbin controls 
dendritic morphogenesis by regulating localization of delta-catenin. J Neurosci 
28: 7047-7056. 
 
Arikkath J, Peng IF, Ng YG, Israely I, Liu X, Ullian EM, et al (2009). Delta-catenin 
regulates spine and synapse morphogenesis and function in hippocampal 
neurons during development. J Neurosci 29: 5435-5442. 
 
Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM (2006). 
Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of 
Rett syndrome. Neurobiol Dis 21: 217-227. 
 
Auerbach BD, Osterweil EK, Bear MF (2011). Mutations causing syndromic 
autism define an axis of synaptic pathophysiology. Nature 480: 63-68. 
 
Autism Genome Project C, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts 
W, Brian J, et al (2007). Mapping autism risk loci using genetic linkage and 
chromosomal rearrangements. Nat Genet 39: 319-328. 
 
Avino TA, Hutsler JJ (2010). Abnormal cell patterning at the cortical gray-white 
matter boundary in autism spectrum disorders. Brain Res 1360: 138-146. 
 
Ayala R, Shu T, Tsai LH (2007). Trekking across the brain: the journey of 
neuronal migration. Cell 128: 29-43. 
 
Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, et al 
(2009). Equal numbers of neuronal and nonneuronal cells make the human brain 
an isometrically scaled-up primate brain. J Comp Neurol 513: 532-541. 
 
Baas PW, Black MM, Banker GA (1989). Changes in microtubule polarity 
orientation during the development of hippocampal neurons in culture. J Cell Biol 
109: 3085-3094. 
 
Baas PW, Deitch JS, Black MM, Banker GA (1988). Polarity orientation of 
microtubules in hippocampal neurons: uniformity in the axon and nonuniformity in 
the dendrite. Proc Natl Acad Sci U S A 85: 8335-8339. 
 
Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, et al (1998). A 
clinicopathological study of autism. Brain 121 ( Pt 5): 889-905. 
 
Baio J (2014). Prevalence of autism spectrum disorder among children aged 8 
years - autism and developmental disabilities monitoring network, 11 sites, 
240 
 
 
United States, 2010. Morbidity and mortality weekly report Surveillance 
summaries (Washington, DC : 2002) 63: 1-21. 
 
Bakos J, Bacova Z, Grant SG, Castejon AM, Ostatnikova D (2015). Are 
Molecules Involved in Neuritogenesis and Axon Guidance Related to Autism 
Pathogenesis? Neuromolecular Med 17: 297-304. 
 
Balschun D, Manahan-Vaughan D, Wagner T, Behnisch T, Reymann KG, Wetzel 
W (1999). A specific role for group I mGluRs in hippocampal LTP and 
hippocampus-dependent spatial learning. Learn Mem 6: 138-152. 
 
Banerjee-Basu S, Packer A (2010). SFARI Gene: an evolving database for the 
autism research community. Dis Model Mech 3: 133-135. 
 
Bangash MA, Park JM, Melnikova T, Wang D, Jeon SK, Lee D, et al (2011). 
Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of 
autism. Cell 145: 758-772. 
 
Bard L, Boscher C, Lambert M, Mege RM, Choquet D, Thoumine O (2008). A 
molecular clutch between the actin flow and N-cadherin adhesions drives growth 
cone migration. J Neurosci 28: 5879-5890. 
 
Barneda-Zahonero B, Parra M (2012). Histone deacetylases and cancer. Mol 
Oncol 6: 579-589. 
 
Bashir ZI (2003). On long-term depression induced by activation of G-protein 
coupled receptors. Neurosci Res 45: 363-367. 
 
Bashir ZI, Jane DE, Sunter DC, Watkins JC, Collingridge GL (1993). 
Metabotropic glutamate receptors contribute to the induction of long-term 
depression in the CA1 region of the hippocampus. Eur J Pharmacol 239: 265-
266. 
 
Bauman M, Kemper TL (1985). Histoanatomic observations of the brain in early 
infantile autism. Neurology 35: 866-874. 
 
Bear MF, Huber KM, Warren ST (2004). The mGluR theory of fragile X mental 
retardation. Trends Neurosci 27: 370-377. 
 
Bedogni F, Hodge RD, Elsen GE, Nelson BR, Daza RA, Beyer RP, et al (2010). 
Tbr1 regulates regional and laminar identity of postmitotic neurons in developing 
neocortex. Proc Natl Acad Sci U S A 107: 13129-13134. 
241 
 
 
 
Bedogni F, Hodge RD, Nelson BR, Frederick EA, Shiba N, Daza RA, et al 
(2010). Autism susceptibility candidate 2 (Auts2) encodes a nuclear protein 
expressed in developing brain regions implicated in autism neuropathology. 
Gene Expr Patterns 10: 9-15. 
 
Belcaro C, Dipresa S, Morini G, Pecile V, Skabar A, Fabretto A (2015). CTNND2 
deletion and intellectual disability. Gene 565: 146-149. 
 
Belichenko P, Wright E, Belichenko N, Masliah E, Li H, Mobley W, et al (2009). 
Widespread changes in dendritic and axonal morphology in Mecp2-mutant 
mouse models of Rett syndrome: evidence for disruption of neuronal networks. J 
Comp Neurol 514: 240-258. 
 
Bellion A, Baudoin JP, Alvarez C, Bornens M, Metin C (2005). Nucleokinesis in 
tangentially migrating neurons comprises two alternating phases: forward 
migration of the Golgi/centrosome associated with centrosome splitting and 
myosin contraction at the rear. J Neurosci 25: 5691-5699. 
 
Belmonte MK, Allen G (2004). Autism and abnormal development of brain 
connectivity. J Neurosci 24: 9228-9231. 
 
Ben-Itzchak E, Aviva B, Zachor DA (2013). Are special abilities in autism 
spectrum disorder associated with a distinct clinical presentation? Res Autism 
Spec Dis 7: 1122–1128. 
 
Ben-Itzchak E, Ben-Shachar S, Zachor DA (2013). Specific neurological 
phenotypes in autism spectrum disorders are associated with sex representation. 
Autism Res 6: 596-604. 
 
Ben-Itzchak E, Zachor DA (2007). The effects of intellectual functioning and 
autism severity on outcome of early behavioral intervention for children with 
autism. Res Dev Disabil 28: 287-303. 
 
Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, et al (2010). 
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder 
and mental retardation. Nat Genet 42: 489-491. 
 
Berman RF, Murray KD, Arque G, Hunsaker MR, Wenzel HJ (2012). Abnormal 
dendrite and spine morphology in primary visual cortex in the CGG knock-in 
mouse model of the fragile X premutation. Epilepsia 53 Suppl 1: 150-160. 
 
242 
 
 
Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, et al (2014). 
Disruptive CHD8 mutations define a subtype of autism early in development. Cell 
158: 263-276. 
 
Betancur C, Sakurai T, Buxbaum JD (2009). The emerging role of synaptic cell-
adhesion pathways in the pathogenesis of autism spectrum disorders. Trends 
Neurosci 32: 402-412. 
 
Bhakar AL, Dolen G, Bear MF (2012). The pathophysiology of fragile X (and what 
it teaches us about synapses). Annu Rev Neurosci 35: 417-443. 
 
Bian WJ, Miao WY, He SJ, Qiu Z, Yu X (2015). Coordinated Spine Pruning and 
Maturation Mediated by Inter-Spine Competition for Cadherin/Catenin 
Complexes. Cell 162: 808-822. 
 
Bielas SL, Gleeson JG (2004). Cytoskeletal-associated proteins in the migration 
of cortical neurons. J Neurobiol 58: 149-159. 
 
Bilguvar K, Ozturk AK, Louvi A, Kwan KY, Choi M, Tatli B, et al (2010). Whole-
exome sequencing identifies recessive WDR62 mutations in severe brain 
malformations. Nature 467: 207-210. 
 
Bliss TV, Gardner-Medwin AR (1973). Long-lasting potentiation of synaptic 
transmission in the dentate area of the unanaestetized rabbit following 
stimulation of the perforant path. J Physiol 232: 357-374. 
 
Bliss TV, Lomo T (1973). Long-lasting potentiation of synaptic transmission in the 
dentate area of the anaesthetized rabbit following stimulation of the perforant 
path. J Physiol 232: 331-356. 
 
Bloodgood BL, Giessel AJ, Sabatini BL (2009). Biphasic synaptic Ca influx 
arising from compartmentalized electrical signals in dendritic spines. PLoS Biol 7: 
e1000190. 
 
Bloodgood BL, Sabatini BL (2007). Nonlinear regulation of unitary synaptic 
signals by CaV(2.3) voltage-sensitive calcium channels located in dendritic 
spines. Neuron 53: 249-260. 
 
Bond J, Scott S, Hampshire DJ, Springell K, Corry P, Abramowicz MJ, et al 
(2003). Protein-truncating mutations in ASPM cause variable reduction in brain 
size. Am J Hum Genet 73: 1170-1177. 
 
243 
 
 
Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, et al (2003). 
Analysis of reelin as a candidate gene for autism. Mol Psychiatry 8: 885-892. 
 
Borges K, Dingledine R (1998). AMPA receptors: molecular and functional 
diversity. Prog Brain Res 116: 153-170. 
 
Bourgeron T (2007). The possible interplay of synaptic and clock genes in autism 
spectrum disorders. Cold Spring Harb Symp Quant Biol 72: 645-654. 
 
Bourgeron T (2009). A synaptic trek to autism. Curr Opin Neurobiol 19: 231-234. 
 
Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, et al 
(2010). Haploinsufficiency of the autism-associated Shank3 gene leads to deficits 
in synaptic function, social interaction, and social communication. Mol Autism 1: 
15. 
 
Bremer A, Giacobini M, Eriksson M, Gustavsson P, Nordin V, Fernell E, et al 
(2011). Copy number variation characteristics in subpopulations of patients with 
autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 156: 115-
124. 
 
Brigidi GS, Sun Y, Beccano-Kelly D, Pitman K, Mobasser M, Borgland SL, et al 
(2014). Palmitoylation of delta-catenin by DHHC5 mediates activity-induced 
synapse plasticity. Nat Neurosci 17: 522-532. 
 
Brown JA, Diggs-Andrews KA, Gianino SM, Gutmann DH (2012). 
Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a 
cAMP/PKA/ROCK-dependent manner. Mol Cell Neurosci 49: 13-22. 
 
Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI, et al 
(2009). Genome-wide analyses of exonic copy number variants in a family-based 
study point to novel autism susceptibility genes. PLoS Genet 5: e1000536. 
 
Buchman JJ, Durak O, Tsai LH (2011). ASPM regulates Wnt signaling pathway 
activity in the developing brain. Genes Dev 25: 1909-1914. 
 
Burrone J, O'Byrne M, Murthy V (2002). Multiple forms of synaptic plasticity 
triggered by selective suppression of activity in individual neurons. Nature 420: 
414-418. 
 
Burton PR (1988). Dendrites of mitral cell neurons contain microtubules of 
opposite polarity. Brain Res 473: 107-115. 
244 
 
 
 
Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, et al 
(2005). Subset of individuals with autism spectrum disorders and extreme 
macrocephaly associated with germline PTEN tumour suppressor gene 
mutations. J Med Genet 42: 318-321. 
 
Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, et al (2007). 
Mutation screening of the PTEN gene in patients with autism spectrum disorders 
and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 144B: 484-491. 
 
Cahana A, Escamez T, Nowakowski RS, Hayes NL, Giacobini M, von Holst A, et 
al (2001). Targeted mutagenesis of Lis1 disrupts cortical development and LIS1 
homodimerization. Proc Natl Acad Sci U S A 98: 6429-6434. 
 
Cai C, Han L, Ji Z, Chen X, Chen Y (2003). SVM-Prot: Web-based support 
vector machine software for functional classification of a protein from its primary 
sequence. Nucleic Acids Res 31: 3692-3697. 
 
Cantagrel V, Haddad MR, Ciofi P, Andrieu D, Lossi AM, Maldergem L, et al 
(2009). Spatiotemporal expression in mouse brain of Kiaa2022, a gene disrupted 
in two patients with severe mental retardation. Gene Expr Patterns 9: 423-429. 
 
Cantagrel V, Lossi AM, Boulanger S, Depetris D, Mattei MG, Gecz J, et al 
(2004). Disruption of a new X linked gene highly expressed in brain in a family 
with two mentally retarded males. J Med Genet 41: 736-742. 
 
Carper RA, Moses P, Tigue ZD, Courchesne E (2002). Cerebral lobes in autism: 
early hyperplasia and abnormal age effects. Neuroimage 16: 1038-1051. 
 
Casanova EL, Casanova MF (2014). Genetics studies indicate that neural 
induction and early neuronal maturation are disturbed in autism. Front Cell 
Neurosci 8: 397. 
 
Castren M, Tervonen T, Karkkainen V, Heinonen S, Castren E, Larsson K, et al 
(2005). Altered differentiation of neural stem cells in fragile X syndrome. Proc 
Natl Acad Sci U S A 102: 17834-17839. 
 
Caviness VS, Jr., Nowakowski RS, Bhide PG (2009). Neocortical neurogenesis: 
morphogenetic gradients and beyond. Trends Neurosci 32: 443-450. 
 
245 
 
 
Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, et al (2008). MeCP2, a 
key contributor to neurological disease, activates and represses transcription. 
Science 320: 1224-1229. 
 
Chameau P, Inta D, Vitalis T, Monyer H, Wadman WJ, van Hooft JA (2009). The 
N-terminal region of reelin regulates postnatal dendritic maturation of cortical 
pyramidal neurons. Proc Natl Acad Sci U S A 106: 7227-7232. 
 
Chang EH, Savage MJ, Flood DG, Thomas JM, Levy RB, Mahadomrongkul V, et 
al (2006). AMPA receptor downscaling at the onset of Alzheimer's disease 
pathology in double knockin mice. Proc Natl Acad Sci U S A 103: 3410-3415. 
 
Changeux JP, Danchin A (1976). Selective stabilisation of developing synapses 
as a mechanism for the specification of neuronal networks. Nature 264: 705-712. 
 
Chapleau CA, Boggio EM, Calfa G, Percy AK, Giustetto M, Pozzo-Miller L 
(2012). Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a 
dendritic spine phenotype only in the presymptomatic stage. Neural Plast 2012: 
976164. 
 
Charzewska A, Rzonca S, Janeczko M, Nawara M, Smyk M, Bal J, et al (2015). 
A duplication of the whole KIAA2022 gene validates the gene role in the 
pathogenesis of intellectual disability and autism. Clin Genet 88: 297-299. 
 
Chazeau A, Giannone G (2016). Organization and dynamics of the actin 
cytoskeleton during dendritic spine morphological remodeling. Cell Mol Life Sci 
73: 3053-3073. 
 
Chen JA, Penagarikano O, Belgard TG, Swarup V, Geschwind DH (2015). The 
emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev 
Pathol 10: 111-144. 
 
Chen JF, Zhang Y, Wilde J, Hansen KC, Lai F, Niswander L (2014). 
Microcephaly disease gene Wdr62 regulates mitotic progression of embryonic 
neural stem cells and brain size. Nat Commun 5: 3885. 
 
Chen Q, Kagan B, Hirakura Y, Xie C (2000). Impairment of hippocampal long-
term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60: 65-72. 
 
Chen Q-S, Wei W-Z, Shimahara T, Xie C-W (2002). Alzheimer amyloid beta-
peptide inhibits the late phase of long-term potentiation through calcineurin-
246 
 
 
dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 
77: 354-371. 
 
Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001). Deficiency of methyl-CpG 
binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat 
Genet 27: 327-331. 
 
Chen Z, Cobb MH (2001). Regulation of stress-responsive mitogen-activated 
protein (MAP) kinase pathways by TAO2. J Biol Chem 276: 16070-16075. 
 
Chen Z, Raman M, Chen L, Lee SF, Gilman AG, Cobb MH (2003). TAO 
(thousand-and-one amino acid) protein kinases mediate signaling from carbachol 
to p38 mitogen-activated protein kinase and ternary complex factors. J Biol 
Chem 278: 22278-22283. 
 
Cheng TL, Wang Z, Liao Q, Zhu Y, Zhou WH, Xu W, et al (2014). MeCP2 
suppresses nuclear microRNA processing and dendritic growth by regulating the 
DGCR8/Drosha complex. Dev Cell 28: 547-560. 
 
Cheng Y, Quinn JF, Weiss LA (2013). An eQTL mapping approach reveals that 
rare variants in the SEMA5A regulatory network impact autism risk. Hum Mol 
Genet 22: 2960-2972. 
 
Choi YJ, Di Nardo A, Kramvis I, Meikle L, Kwiatkowski DJ, Sahin M, et al (2008). 
Tuberous sclerosis complex proteins control axon formation. Genes Dev 22: 
2485-2495. 
 
Chow DK, Groszer M, Pribadi M, Machniki M, Carmichael ST, Liu X, et al (2009). 
Laminar and compartmental regulation of dendritic growth in mature cortex. Nat 
Neurosci 12: 116-118. 
 
Chuang HC, Huang TN, Hsueh YP (2015). T-Brain-1--A Potential Master 
Regulator in Autism Spectrum Disorders. Autism Res 8: 412-426. 
 
Chubykin AA, Atasoy D, Etherton MR, Brose N, Kavalali ET, Gibson JR, et al 
(2007). Activity-dependent validation of excitatory versus inhibitory synapses by 
neuroligin-1 versus neuroligin-2. Neuron 54: 919-931. 
 
Citri A, Malenka RC (2008). Synaptic plasticity: multiple forms, functions, and 
mechanisms. Neuropsychopharmacology 33: 18-41. 
 
247 
 
 
Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC, et 
al (2005). Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced 
inhibition and epilepsy. Nat Neurosci 8: 1059-1068. 
 
Cody H, Pelphrey K, Piven J (2002). Structural and functional magnetic 
resonance imaging of autism. Int J Dev Neurosci 20: 421-438. 
 
Colasante G, Collombat P, Raimondi V, Bonanomi D, Ferrai C, Maira M, et al 
(2008). Arx is a direct target of Dlx2 and thereby contributes to the tangential 
migration of GABAergic interneurons. J Neurosci 28: 10674-10686. 
 
Colon-Ramos DA (2009). Synapse formation in developing neural circuits. Curr 
Top Dev Biol 87: 53-79. 
 
Comoletti D, De Jaco A, Jennings LL, Flynn RE, Gaietta G, Tsigelny I, et al 
(2004). The Arg451Cys-neuroligin-3 mutation associated with autism reveals a 
defect in protein processing. J Neurosci 24: 4889-4893. 
 
Condro MC, White SA (2014). Distribution of language-related Cntnap2 protein in 
neural circuits critical for vocal learning. J Comp Neurol 522: 169-185. 
 
Coquelle FM, Caspi M, Cordelieres FP, Dompierre JP, Dujardin DL, Koifman C, 
et al (2002). LIS1, CLIP-170's key to the dynein/dynactin pathway. Mol Cell Biol 
22: 3089-3102. 
 
Costa RM, Silva AJ (2003). Mouse models of neurofibromatosis type I: bridging 
the GAP. Trends Mol Med 9: 19-23. 
 
Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, 
Hallet MJ, et al (2011). Neuron number and size in prefrontal cortex of children 
with autism. JAMA 306: 2001-2010. 
 
Courchesne E, Pierce K (2005). Why the frontal cortex in autism might be talking 
only to itself: local over-connectivity but long-distance disconnection. Curr Opin 
Neurobiol 15: 225-230. 
 
Craig AM, Kang Y (2007). Neurexin-neuroligin signaling in synapse development. 
Curr Opin Neurobiol 17: 43-52. 
 
Crawley JN (2007). Mouse behavioral assays relevant to the symptoms of 
autism. Brain Pathol 17: 448-459. 
 
248 
 
 
Crepel A, Steyaert J, De la Marche W, De Wolf V, Fryns JP, Noens I, et al 
(2011). Narrowing the critical deletion region for autism spectrum disorders on 
16p11.2. Am J Med Genet B Neuropsychiatr Genet 156: 243-245. 
 
D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T (1995). A 
protein related to extracellular matrix proteins deleted in the mouse mutant 
reeler. Nature 374: 719-723. 
 
Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, et al 
(2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic 
function and autism. Cell 146: 247-261. 
 
Davis G, Bezprozvanny I (2001). Maintaining the stability of neural function: a 
homeostatic hypothesis. Annu Rev Physiol. 63: 847-869.
 
de Anda FC, Rosario AL, Durak O, Tran T, Graff J, Meletis K, et al (2012). 
Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite 
formation in the neocortex. Nat Neurosci 15: 1022-1031. 
 
de Carlos JA, Lopez-Mascaraque L, Valverde F (1996). Dynamics of cell 
migration from the lateral ganglionic eminence in the rat. J Neurosci 16: 6146-
6156. 
 
de Lange IM, Helbig KL, Weckhuysen S, Moller RS, Velinov M, Dolzhanskaya N, 
et al (2016). De novo mutations of KIAA2022 in females cause intellectual 
disability and intractable epilepsy. J Med Genet. 53(12): 850-858. 
 
De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al 
(2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 
515: 209-215. 
 
De Rubeis S, Pasciuto E, Li KW, Fernandez E, Di Marino D, Buzzi A, et al 
(2013). CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to 
ensure proper dendritic spine formation. Neuron 79: 1169-1182. 
 
Dean C, Dresbach T (2006). Neuroligins and neurexins: linking cell adhesion, 
synapse formation and cognitive function. Trends Neurosci 29: 21-29. 
 
Denaxa M, Chan CH, Schachner M, Parnavelas JG, Karagogeos D (2001). The 
adhesion molecule TAG-1 mediates the migration of cortical interneurons from 
the ganglionic eminence along the corticofugal fiber system. Development 128: 
4635-4644. 
249 
 
 
 
Deriziotis P, O'Roak BJ, Graham SA, Estruch SB, Dimitropoulou D, Bernier RA, 
et al (2014). De novo TBR1 mutations in sporadic autism disrupt protein 
functions. Nat Commun 5: 4954. 
 
Desai NS, Cudmore RH, Nelson SB, Turrigiano GG (2002). Critical periods for 
experience-dependent synaptic scaling in visual cortex. Nat Neurosci 5: 783-789. 
 
DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager S, Schmitz C, 
et al (2006). The developmental neurobiology of autism spectrum disorder. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 26: 
6897-6906. 
 
Dickstein J, Senyuk V, Premanand K, Laricchia-Robbio L, Xu P, Cattaneo F, et al 
(2010). Methylation and silencing of miRNA-124 by EVI1 and self-renewal 
exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. 
Proc Natl Acad Sci U S A 107: 9783-9788. 
 
Dingledine R, Borges K, Bowie D, Traynelis SF (1999). The glutamate receptor 
ion channels. Pharmacol Rev 51: 7-61. 
 
Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, et al (2007). 
Correction of fragile X syndrome in mice. Neuron 56: 955-962. 
 
Dwyer ND, O'Leary DD (2001). Tbr1 conducts the orchestration of early cortical 
development. Neuron 29: 309-311. 
 
Edmondson JC, Liem RK, Kuster JE, Hatten ME (1988). Astrotactin: a novel 
neuronal cell surface antigen that mediates neuron-astroglial interactions in 
cerebellar microcultures. J Cell Biol 106: 505-517. 
 
Egusa SF, Inoue YU, Asami J, Terakawa YW, Hoshino M, Inoue T (2016). 
Classic cadherin expressions balance postnatal neuronal positioning and 
dendrite dynamics to elaborate the specific cytoarchitecture of the mouse cortical 
area. Neurosci Res 105: 49-64. 
 
Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, et al (2008). 
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat 
Med 14: 843-848. 
 
250 
 
 
El Helou J, Belanger-Nelson E, Freyburger M, Dorsaz S, Curie T, La Spada F, et 
al (2013). Neuroligin-1 links neuronal activity to sleep-wake regulation. Proc Natl 
Acad Sci U S A 110: 9974-9979. 
 
Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, et al (2010). Rare 
structural variants found in attention-deficit hyperactivity disorder are 
preferentially associated with neurodevelopmental genes. Mol Psychiatry 15: 
637-646. 
 
Elia L, Yamamoto M, Zang K, Reichardt L (2006). p120 catenin regulates 
dendritic spine and synapse development through Rho-family GTPases and 
cadherins. Neuron 51: 43-56. 
 
Etherton MR, Blaiss CA, Powell CM, Sudhof TC (2009). Mouse neurexin-1alpha 
deletion causes correlated electrophysiological and behavioral changes 
consistent with cognitive impairments. Proc Natl Acad Sci U S A 106: 17998-
18003. 
 
Falconer DS (1951). Two new mutants, 'trembler' and 'reeler', with neurological 
actions in the house mouse (Mus musculus L.). J Genet 50: 192-201. 
 
Farach LS, Northrup H (2016). KIAA2022 nonsense mutation in a symptomatic 
female. Am J Med Genet A 170: 703-706. 
 
Faridar A, Jones-Davis D, Rider E, Li J, Gobius I, Morcom L, et al (2014). 
Mapk/Erk activation in an animal model of social deficits shows a possible link to 
autism. Mol Autism 5: 57. 
 
Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, et al (2011). SYN1 
loss-of-function mutations in autism and partial epilepsy cause impaired synaptic 
function. Hum Mol Genet 20: 2297-2307. 
 
Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, et al 
(2005). Reelin signaling is impaired in autism. Biol Psychiatry 57: 777-787. 
 
Feng J, Schroer R, Yan J, Song W, Yang C, Bockholt A, et al (2006). High 
frequency of neurexin 1beta signal peptide structural variants in patients with 
autism. Neurosci Lett 409: 10-13. 
 
Feng Y, Olson EC, Stukenberg PT, Flanagan LA, Kirschner MW, Walsh CA 
(2000). LIS1 regulates CNS lamination by interacting with mNudE, a central 
component of the centrosome. Neuron 28: 665-679. 
251 
 
 
 
Feyder M, Karlsson RM, Mathur P, Lyman M, Bock R, Momenan R, et al (2010). 
Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene 
variation with phenotypes relevant to autism spectrum disorders and Williams' 
syndrome. Am J Psychiatry 167: 1508-1517. 
 
Filimonenko M, Isakson P, Finley KD, Anderson M, Jeong H, Melia TJ, et al 
(2010). The selective macroautophagic degradation of aggregated proteins 
requires the PI3P-binding protein Alfy. Mol Cell 38: 265-279. 
 
Fish JL, Kosodo Y, Enard W, Paabo S, Huttner WB (2006). Aspm specifically 
maintains symmetric proliferative divisions of neuroepithelial cells. Proc Natl 
Acad Sci U S A 103: 10438-10443. 
 
Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, et al 
(2001). Age-related impairment of synaptic transmission but normal long-term 
potentiation in transgenic mice that overexpress the human APP695SWE mutant 
form of amyloid precursor protein. J Neurosci 21: 4691-4698. 
 
Floricel F, Higaki K, Maki H, Nanba E, Ninomiya H, Ohno K (2007). Antisense 
suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in 
NGF-treated PC12h cells. Brain Dev 29: 502-509. 
 
Folsom TD, Fatemi SH (2013). The involvement of Reelin in neurodevelopmental 
disorders. Neuropharmacology 68: 122-135. 
 
Fombonne E, Roge B, Claverie J, Courty S, Fremolle J (1999). Microcephaly and 
macrocephaly in autism. J Autism Dev Disord 29: 113-119. 
 
Fong MF, Newman JP, Potter SM, Wenner P (2015). Upward synaptic scaling is 
dependent on neurotransmission rather than spiking. Nat Commun 6: 6339. 
 
Fornasiero EF, Raimondi A, Guarnieri FC, Orlando M, Fesce R, Benfenati F, et al 
(2012). Synapsins contribute to the dynamic spatial organization of synaptic 
vesicles in an activity-dependent manner. J Neurosci 32: 12214-12227. 
 
Forster E, Jossin Y, Zhao S, Chai X, Frotscher M, Goffinet AM (2006). Recent 
progress in understanding the role of Reelin in radial neuronal migration, with 
specific emphasis on the dentate gyrus. Eur J Neurosci 23: 901-909. 
 
Frey U, Huang YY, Kandel ER (1993). Effects of cAMP simulate a late stage of 
LTP in hippocampal CA1 neurons. Science 260: 1661-1664. 
252 
 
 
 
Frey U, Krug M, Reymann KG, Matthies H (1988). Anisomycin, an inhibitor of 
protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 
region in vitro. Brain Res 452: 57-65. 
 
Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR (2006). 
Gray and white matter brain chemistry in young children with autism. Arch Gen 
Psychiatry 63: 786-794. 
 
Ganguly K, Poo MM (2013). Activity-dependent neural plasticity from bench to 
bedside. Neuron 80: 729-741. 
 
Gao P, Sultan KT, Zhang XJ, Shi SH (2013). Lineage-dependent circuit 
assembly in the neocortex. Development 140: 2645-2655. 
 
Gao R, Penzes P (2015). Common mechanisms of excitatory and inhibitory 
imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med 15: 
146-167. 
 
Gao Z, Lee P, Stafford JM, von Schimmelmann M, Schaefer A, Reinberg D 
(2014). An AUTS2-Polycomb complex activates gene expression in the CNS. 
Nature 516: 349-354. 
 
Garcia-Bereguiain MA, Gonzalez-Islas C, Lindsly C, Butler E, Hill AW, Wenner P 
(2013). In vivo synaptic scaling is mediated by GluA2-lacking AMPA receptors in 
the embryonic spinal cord. J Neurosci 33: 6791-6799. 
 
Garcia-Castro MI, Vielmetter E, Bronner-Fraser M (2000). N-Cadherin, a cell 
adhesion molecule involved in establishment of embryonic left-right asymmetry. 
Science 288: 1047-1051. 
 
Garcia-Junco-Clemente P, Golshani P (2014). PTEN: A master regulator of 
neuronal structure, function, and plasticity. Commun Integr Biol 7: e28358. 
 
Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, et al (2013). 
Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence 
from a population-based study. Dev Med Child Neurol 55: 139-145. 
 
Garner CC, Wetmore DZ (2012). Synaptic pathology of Down syndrome. Adv 
Exp Med Biol 970: 451-468. 
 
253 
 
 
Gasquoine PG (2014). Contributions of the insula to cognition and emotion. 
Neuropsychol Rev 24: 77-87. 
 
Gerendasy DD, Herron SR, Watson JB, Sutcliffe JG (1994). Mutational and 
biophysical studies suggest RC3/neurogranin regulates calmodulin availability. J 
Biol Chem 269: 22420-22426. 
 
Geschwind D, Levitt P (2007). Autism spectrum disorders: developmental 
disconnection syndromes. Curr Opin Neurobiol 17: 103-111. 
 
Ghanem N, Yu M, Long J, Hatch G, Rubenstein JL, Ekker M (2007). Distinct cis-
regulatory elements from the Dlx1/Dlx2 locus mark different progenitor cell 
populations in the ganglionic eminences and different subtypes of adult cortical 
interneurons. J Neurosci 27: 5012-5022. 
 
Gibbs PE, McGregor WG, Maher VM, Nisson P, Lawrence CW (1998). A human 
homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the 
catalytic subunit of DNA polymerase zeta. Proc Natl Acad Sci U S A 95: 6876-
6880. 
 
Gilbert J, Man HY (2014). Translational Dysregulation in Autism. Cell Dev Biol 3. 
 
Gilbert J, Man HY (2016). The X-Linked Autism Protein KIAA2022/KIDLIA 
Regulates Neurite Outgrowth via N-Cadherin and delta-Catenin Signaling. 
eNeuro 3. 
 
Gilestro GF, Tononi G, Cirelli C (2009). Widespread changes in synaptic markers 
as a function of sleep and wakefulness in Drosophila. Science 324: 109-112. 
 
Gillberg C, de Souza L (2002). Head circumference in autism, Asperger 
syndrome, and ADHD: a comparative study. Dev Med Child Neurol 44: 296-300. 
 
Godfraind JM, Reyniers E, De Boulle K, D'Hooge R, De Deyn PP, Bakker CE, et 
al (1996). Long-term potentiation in the hippocampus of fragile X knockout mice. 
Am J Med Genet 64: 246-251. 
 
Goel A, Jiang B, Xu LW, Song L, Kirkwood A, Lee HK (2006). Cross-modal 
regulation of synaptic AMPA receptors in primary sensory cortices by visual 
experience. Nat Neurosci 9: 1001-1003. 
 
254 
 
 
Goel A, Lee HK (2007). Persistence of experience-induced homeostatic synaptic 
plasticity through adulthood in superficial layers of mouse visual cortex. J 
Neurosci 27: 6692-6700. 
 
Goffin A, Hoefsloot LH, Bosgoed E, Swillen A, Fryns JP (2001). PTEN mutation 
in a family with Cowden syndrome and autism. Am J Med Genet 105: 521-524. 
 
Gogolla N, Leblanc JJ, Quast KB, Sudhof TC, Fagiolini M, Hensch TK (2009). 
Common circuit defect of excitatory-inhibitory balance in mouse models of 
autism. J Neurodev Disord 1: 172-181. 
 
Gonzalez-Islas C, Wenner P (2006). Spontaneous network activity in the 
embryonic spinal cord regulates AMPAergic and GABAergic synaptic strength. 
Neuron 49: 563-575. 
 
Gotts SJ, Simmons WK, Milbury LA, Wallace GL, Cox RW, Martin A (2012). 
Fractionation of social brain circuits in autism spectrum disorders. Brain 135: 
2711-2725. 
 
Graff J, Tsai LH (2013). The potential of HDAC inhibitors as cognitive enhancers. 
Annu Rev Pharmacol Toxicol 53: 311-330. 
 
Greco B, Manago F, Tucci V, Kao HT, Valtorta F, Benfenati F (2013). Autism-
related behavioral abnormalities in synapsin knockout mice. Behav Brain Res 
251: 65-74. 
 
Greer PL, Greenberg ME (2008). From synapse to nucleus: calcium-dependent 
gene transcription in the control of synapse development and function. Neuron 
59: 846-860. 
 
Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, Flavell SW, et 
al (2010). The Angelman Syndrome protein Ube3A regulates synapse 
development by ubiquitinating arc. Cell 140: 704-716. 
 
Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, et al 
(2004). The Microprocessor complex mediates the genesis of microRNAs. 
Nature 432: 235-240. 
 
Grooms SY, Opitz T, Bennett MV, Zukin RS (2000). Status epilepticus decreases 
glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal 
cells before neuronal death. Proc Natl Acad Sci U S A 97: 3631-3636. 
 
255 
 
 
Grosskreutz Y, Betz H, Kneussel M (2003). Rescue of molybdenum cofactor 
biosynthesis in gephyrin-deficient mice by a Cnx1 transgene. Biochem Biophys 
Res Commun 301: 450-455. 
 
Gruber R, Zhou Z, Sukchev M, Joerss T, Frappart PO, Wang ZQ (2011). MCPH1 
regulates the neuroprogenitor division mode by coupling the centrosomal cycle 
with mitotic entry through the Chk1-Cdc25 pathway. Nat Cell Biol 13: 1325-1334. 
 
Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud 
V, et al (2009). Recurrent rearrangements in synaptic and neurodevelopmental 
genes and shared biologic pathways in schizophrenia, autism, and mental 
retardation. Arch Gen Psychiatry 66: 947-956. 
 
Gupta A, Tsai LH, Wynshaw-Boris A (2002). Life is a journey: a genetic look at 
neocortical development. Nat Rev Genet 3: 342-355. 
 
Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007). Reversal of neurological 
defects in a mouse model of Rett syndrome. Science 315: 1143-1147. 
 
Halepoto DM, Bashir S, L ALA (2014). Possible role of brain-derived neurotrophic 
factor (BDNF) in autism spectrum disorder: current status. J Coll Physicians Surg 
Pak 24: 274-278. 
 
Han W, Kwan KY, Shim S, Lam MM, Shin Y, Xu X, et al (2011). TBR1 directly 
represses Fezf2 to control the laminar origin and development of the 
corticospinal tract. Proc Natl Acad Sci U S A 108: 3041-3046. 
 
Happe F, Ronald A, Plomin R (2006). Time to give up on a single explanation for 
autism. Nat Neurosci 9: 1218-1220. 
 
Hatten ME (1999). Central nervous system neuronal migration. Annu Rev 
Neurosci 22: 511-539. 
 
Haws ME, Jaramillo TC, Espinosa F, Widman AJ, Stuber GD, Sparta DR, et al 
(2014). PTEN knockdown alters dendritic spine/protrusion morphology, not 
density. J Comp Neurol 522: 1171-1190. 
 
Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A, et al (2005). 
Magnetic resonance imaging and head circumference study of brain size in 
autism: birth through age 2 years. Arch Gen Psychiatry 62: 1366-1376. 
 
256 
 
 
Hebb DO (1949). The organization of behavior: A neuropsychological theory 
John Wiley & Sons: New York. 
 
Hevner RF, Shi L, Justice N, Hsueh Y, Sheng M, Smiga S, et al (2001). Tbr1 
regulates differentiation of the preplate and layer 6. Neuron 29: 353-366. 
 
Higgins J, Midgley C, Bergh AM, Bell SM, Askham JM, Roberts E, et al (2010). 
Human ASPM participates in spindle organisation, spindle orientation and 
cytokinesis. BMC Cell Biol 11: 85. 
 
Hinton VJ, Brown WT, Wisniewski K, Rudelli RD (1991). Analysis of neocortex in 
three males with the fragile X syndrome. Am J Med Genet 41: 289-294. 
 
Hippenmeyer S, Youn YH, Moon HM, Miyamichi K, Zong H, Wynshaw-Boris A, et 
al (2010). Genetic mosaic dissection of Lis1 and Ndel1 in neuronal migration. 
Neuron 68: 695-709. 
 
Hirotsune S, Takahara T, Sasaki N, Hirose K, Yoshiki A, Ohashi T, et al (1995). 
The reeler gene encodes a protein with an EGF-like motif expressed by pioneer 
neurons. Nat Genet 10: 77-83. 
 
Ho VM, Dallalzadeh LO, Karathanasis N, Keles MF, Vangala S, Grogan T, et al 
(2014). GluA2 mRNA distribution and regulation by miR-124 in hippocampal 
neurons. Mol Cell Neurosci 61: 1-12. 
 
Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, Lee JY, et al (2009). Interaction 
of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 
29: 7459-7473. 
 
Hofmeister W, Nilsson D, Topa A, Anderlid BM, Darki F, Matsson H, et al (2015). 
CTNND2-a candidate gene for reading problems and mild intellectual disability. J 
Med Genet 52: 111-122. 
 
Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, et al 
(2000). Autosomal recessive lissencephaly with cerebellar hypoplasia is 
associated with human RELN mutations. Nat Genet 26: 93-96. 
 
Hori K, Nagai T, Shan W, Sakamoto A, Taya S, Hashimoto R, et al (2014). 
Cytoskeletal regulation by AUTS2 in neuronal migration and neuritogenesis. Cell 
Rep 9: 2166-2179. 
 
257 
 
 
Horton A, Rácz B, Monson E, Lin A, Weinberg R, Ehlers M (2005). Polarized 
secretory trafficking directs cargo for asymmetric dendrite growth and 
morphogenesis. Neuron 48: 757-771. 
 
Horton AC, Ehlers MD (2004). Secretory trafficking in neuronal dendrites. Nat 
Cell Biol 6: 585-591. 
 
Hou Q, Gilbert J, Man HY (2011). Homeostatic regulation of AMPA receptor 
trafficking and degradation by light-controlled single-synaptic activation. Neuron 
72: 806-818. 
 
Hou Q, Ruan H, Gilbert J, Wang G, Ma Q, Yao WD, et al (2015). MicroRNA 
miR124 is required for the expression of homeostatic synaptic plasticity. Nat 
Commun 6: 10045. 
 
Hou Q, Zhang D, Jarzylo L, Huganir RL, Man HY (2008). Homeostatic regulation 
of AMPA receptor expression at single hippocampal synapses. Proc Natl Acad 
Sci U S A 105: 775-780. 
 
Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al (2006). 
AMPAR removal underlies Abeta-induced synaptic depression and dendritic 
spine loss. Neuron 52: 831-843. 
 
Huang EP (1998). Synaptic plasticity: going through phases with LTP. Curr Biol 
8: R350-352. 
 
Huang J, Manning BD (2008). The TSC1-TSC2 complex: a molecular 
switchboard controlling cell growth. Biochem J 412: 179-190. 
 
Huang XL, Zou YS, Maher TA, Newton S, Milunsky JM (2010). A de novo 
balanced translocation breakpoint truncating the autism susceptibility candidate 2 
(AUTS2) gene in a patient with autism. Am J Med Genet A 152A: 2112-2114. 
 
Huang Z (2009). Molecular regulation of neuronal migration during neocortical 
development. Mol Cell Neurosci 42: 11-22. 
 
Huber KM, Gallagher SM, Warren ST, Bear MF (2002). Altered synaptic plasticity 
in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A 99: 
7746-7750. 
 
258 
 
 
Huber KM, Roder JC, Bear MF (2001). Chemical induction of mGluR5- and 
protein synthesis--dependent long-term depression in hippocampal area CA1. J 
Neurophysiol 86: 321-325. 
 
Huber R, Ghilardi MF, Massimini M, Tononi G (2004). Local sleep and learning. 
Nature 430: 78-81. 
 
Huguet G, Ey E, Bourgeron T (2013). The genetic landscapes of autism 
spectrum disorders. Annu Rev Genomics Hum Genet 14: 191-213. 
 
Hussman JP (2001). Suppressed GABAergic inhibition as a common factor in 
suspected etiologies of autism. J Autism Dev Disord 31: 247-248. 
 
Hutsler JJ, Love T, Zhang H (2007). Histological and magnetic resonance 
imaging assessment of cortical layering and thickness in autism spectrum 
disorders. Biol Psychiatry 61: 449-457. 
 
Hutsler JJ, Zhang H (2010). Increased dendritic spine densities on cortical 
projection neurons in autism spectrum disorders. Brain Res 1309: 83-94. 
 
Ifrim MF, Williams KR, Bassell GJ (2015). Single-Molecule Imaging of PSD-95 
mRNA Translation in Dendrites and Its Dysregulation in a Mouse Model of 
Fragile X Syndrome. J Neurosci 35: 7116-7130. 
 
Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR (2013). Seizures in patients 
with Alzheimer's disease or vascular dementia: a population-based nested case-
control analysis. Epilepsia 54: 700-707. 
 
International Mouse Knockout C, Collins FS, Rossant J, Wurst W (2007). A 
mouse for all reasons. Cell 128: 9-13. 
 
International Schizophrenia C (2008). Rare chromosomal deletions and 
duplications increase risk of schizophrenia. Nature 455: 237-241. 
 
Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, et al (2014). 
The contribution of de novo coding mutations to autism spectrum disorder. 
Nature 515: 216-221. 
 
Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al (2012). 
De novo gene disruptions in children on the autistic spectrum. Neuron 74: 285-
299. 
 
259 
 
 
Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, et al (2012). 
Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch 
Neurol 69: 368-372. 
 
Irwin SA, Idupulapati M, Gilbert ME, Harris JB, Chakravarti AB, Rogers EJ, et al 
(2002). Dendritic spine and dendritic field characteristics of layer V pyramidal 
neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet 111: 
140-146. 
 
Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP, et al 
(2001). Abnormal dendritic spine characteristics in the temporal and visual 
cortices of patients with fragile-X syndrome: a quantitative examination. Am J 
Med Genet 98: 161-167. 
 
Ishikawa T, Miyata S, Koyama Y, Yoshikawa K, Hattori T, Kumamoto N, et al 
(2012). Transient expression of Xpn, an XLMR protein related to neurite 
extension, during brain development and participation in neurite outgrowth. 
Neuroscience 214: 181-191. 
 
Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, et al 
(2000). Pharmacological properties of Y-27632, a specific inhibitor of rho-
associated kinases. Mol Pharmacol 57: 976-983. 
 
Ito M, Kano M (1982). Long-lasting depression of parallel fiber-Purkinje cell 
transmission induced by conjunctive stimulation of parallel fibers and climbing 
fibers in the cerebellar cortex. Neurosci Lett 33: 253-258. 
 
Ito M, Sakurai M, Tongroach P (1982). Climbing fibre induced depression of both 
mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. 
J Physiol 324: 113-134. 
 
Jackman C, Horn ND, Molleston JP, Sokol DK (2009). Gene associated with 
seizures, autism, and hepatomegaly in an Amish girl. Pediatr Neurol 40: 310-313. 
 
Jackson AP, Eastwood H, Bell SM, Adu J, Toomes C, Carr IM, et al (2002). 
Identification of microcephalin, a protein implicated in determining the size of the 
human brain. Am J Hum Genet 71: 136-142. 
 
Jackson AP, McHale DP, Campbell DA, Jafri H, Rashid Y, Mannan J, et al 
(1998). Primary autosomal recessive microcephaly (MCPH1) maps to 
chromosome 8p22-pter. Am J Hum Genet 63: 541-546. 
 
260 
 
 
Jahr CE, Stevens CF (1993). Calcium permeability of the N-methyl-D-aspartate 
receptor channel in hippocampal neurons in culture. Proc Natl Acad Sci U S A 
90: 11573-11577. 
 
Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg I, et al (2003). 
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are 
associated with autism. Nat Genet 34: 27-29. 
 
Jan YN, Jan LY (2010). Branching out: mechanisms of dendritic arborization. Nat 
Rev Neurosci 11: 316-328. 
 
Jang SS, Chung HJ (2016). Emerging Link between Alzheimer's Disease and 
Homeostatic Synaptic Plasticity. Neural Plast 2016: 7969272. 
 
Jang SW, Liu X, Pradoldej S, Tosini G, Chang Q, Iuvone PM, et al (2010). N-
acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci 
U S A 107: 3876-3881. 
 
Jiang M, Ash RT, Baker SA, Suter B, Ferguson A, Park J, et al (2013). Dendritic 
arborization and spine dynamics are abnormal in the mouse model of MECP2 
duplication syndrome. J Neurosci 33: 19518-19533. 
 
Jossin Y, Goffinet AM (2007). Reelin signals through phosphatidylinositol 3-
kinase and Akt to control cortical development and through mTor to regulate 
dendritic growth. Mol Cell Biol 27: 7113-7124. 
 
Ju W, Morishita W, Tsui J, Gaietta G, Deerinck TJ, Adams SR, et al (2004). 
Activity-dependent regulation of dendritic synthesis and trafficking of AMPA 
receptors. Nat Neurosci 7: 244-253. 
 
Jugloff DG, Jung BP, Purushotham D, Logan R, Eubanks JH (2005). Increased 
dendritic complexity and axonal length in cultured mouse cortical neurons 
overexpressing methyl-CpG-binding protein MeCP2. Neurobiol Dis 19: 18-27. 
 
Kaindl AM, Passemard S, Kumar P, Kraemer N, Issa L, Zwirner A, et al (2010). 
Many roads lead to primary autosomal recessive microcephaly. Prog Neurobiol 
90: 363-383. 
 
Kalueff AV, Stewart AM, Song C, Berridge KC, Graybiel AM, Fentress JC (2016). 
Neurobiology of rodent self-grooming and its value for translational neuroscience. 
Nat Rev Neurosci 17: 45-59. 
 
261 
 
 
Kang R, Wan J, Arstikaitis P, Takahashi H, Huang K, Bailey AO, et al (2008). 
Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation. Nature 
456: 904-909. 
 
Kapitein LC, Schlager MA, Kuijpers M, Wulf PS, van Spronsen M, MacKintosh 
FC, et al (2010). Mixed microtubules steer dynein-driven cargo transport into 
dendrites. Curr Biol 20: 290-299. 
 
Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H (2003). Structure-
stability-function relationships of dendritic spines. Trends Neurosci 26: 360-368. 
 
Kasarpalkar NJ, Kothari ST, Dave UP (2014). Brain-Derived Neurotrophic Factor 
in children with Autism Spectrum Disorder. Ann Neurosci 21: 129-133. 
 
Katayama Y, Nishiyama M, Shoji H, Ohkawa Y, Kawamura A, Sato T, et al 
(2016). CHD8 haploinsufficiency results in autistic-like phenotypes in mice. 
Nature 537: 675-679. 
 
Katz B, Miledi R (1968). The role of calcium in neuromuscular facilitation. J 
Physiol 195: 481-492. 
 
Keck T, Keller GB, Jacobsen RI, Eysel UT, Bonhoeffer T, Hubener M (2013). 
Synaptic scaling and homeostatic plasticity in the mouse visual cortex in vivo. 
Neuron 80: 327-334. 
 
Kelleher R, Bear M (2008). The autistic neuron: troubled translation? Cell 135: 
401-406. 
 
Ketzef M, Gitler D (2014). Epileptic synapsin triple knockout mice exhibit 
progressive long-term aberrant plasticity in the entorhinal cortex. Cereb Cortex 
24: 996-1008. 
 
Kim H, Oh M, Lu Q, Kim K (2008). E-Cadherin negatively modulates delta-
catenin-induced morphological changes and RhoA activity reduction by 
competing with p190RhoGEF for delta-catenin. Biochem Biophys Res Commun 
377: 636-641. 
 
Kim JH, Anwyl R, Suh YH, Djamgoz MB, Rowan MJ (2001). Use-dependent 
effects of amyloidogenic fragments of (beta)-amyloid precursor protein on 
synaptic plasticity in rat hippocampus in vivo. J Neurosci 21: 1327-1333. 
 
262 
 
 
Kishi N, Macklis JD (2004). MECP2 is progressively expressed in post-migratory 
neurons and is involved in neuronal maturation rather than cell fate decisions. 
Mol Cell Neurosci 27: 306-321. 
 
Kitagawa M, Umezu M, Aoki J, Koizumi H, Arai H, Inoue K (2000). Direct 
association of LIS1, the lissencephaly gene product, with a mammalian 
homologue of a fungal nuclear distribution protein, rNUDE. FEBS Lett 479: 57-
62. 
 
Kneussel M, Brandstatter JH, Laube B, Stahl S, Muller U, Betz H (1999). Loss of 
postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. J Neurosci 
19: 9289-9297. 
 
Knogler LD, Liao M, Drapeau P (2010). Synaptic scaling and the development of 
a motor network. J Neurosci 30: 8871-8881. 
 
Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E, et al (2001). 
A germ-line Tsc1 mutation causes tumor development and embryonic lethality 
that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc 
Natl Acad Sci U S A 98: 8762-8767. 
 
Koekkoek SK, Yamaguchi K, Milojkovic BA, Dortland BR, Ruigrok TJ, Maex R, et 
al (2005). Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, 
enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X 
syndrome. Neuron 47: 339-352. 
 
Kozma R, Sarner S, Ahmed S, Lim L (1997). Rho family GTPases and neuronal 
growth cone remodelling: relationship between increased complexity induced by 
Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and 
lysophosphatidic acid. Mol Cell Biol 17: 1201-1211. 
 
Krahe TE, Guido W (2011). Homeostatic plasticity in the visual thalamus by 
monocular deprivation. J Neurosci 31: 6842-6849. 
 
Krawczun MS, Jenkins EC, Brown WT (1985). Analysis of the fragile-X 
chromosome: localization and detection of the fragile site in high resolution 
preparations. Hum Genet 69: 209-211. 
 
Kriegstein AR, Noctor SC (2004). Patterns of neuronal migration in the 
embryonic cortex. Trends Neurosci 27: 392-399. 
 
263 
 
 
Kuhn M, Wolf E, Maier JG, Mainberger F, Feige B, Schmid H, et al (2016). Sleep 
recalibrates homeostatic and associative synaptic plasticity in the human cortex. 
Nat Commun 7: 12455. 
 
Kuroda Y, Ohashi I, Naruto T, Ida K, Enomoto Y, Saito T, et al (2015). 
Delineation of the KIAA2022 mutation phenotype: two patients with X-linked 
intellectual disability and distinctive features. Am J Med Genet A 167: 1349-1353. 
 
Kwak S, Weiss JH (2006). Calcium-permeable AMPA channels in 
neurodegenerative disease and ischemia. Curr Opin Neurobiol 16: 281-287. 
 
Kwiatkowski DJ, Manning BD (2005). Tuberous sclerosis: a GAP at the 
crossroads of multiple signaling pathways. Hum Mol Genet 14 Spec No. 2: 
R251-258. 
 
Kwon C-H, Luikart B, Powell C, Zhou J, Matheny S, Zhang W, et al (2006). Pten 
regulates neuronal arborization and social interaction in mice. Neuron 50: 377-
388. 
 
Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H, et al (1997). 
Macrocephaly in children and adults with autism. J Am Acad Child Adolesc 
Psychiatry 36: 282-290. 
 
Lanctot AA, Peng CY, Pawlisz AS, Joksimovic M, Feng Y (2013). Spatially 
dependent dynamic MAPK modulation by the Nde1-Lis1-Brap complex patterns 
mammalian CNS. Dev Cell 25: 241-255. 
 
Landa RJ (2008). Diagnosis of autism spectrum disorders in the first 3 years of 
life. Nat Clin Pract Neurol 4: 138-147. 
 
Laplante M, Sabatini DM (2012). mTOR signaling in growth control and disease. 
Cell 149: 274-293. 
 
Larson J, Jessen RE, Kim D, Fine AK, du Hoffmann J (2005). Age-dependent 
and selective impairment of long-term potentiation in the anterior piriform cortex 
of mice lacking the fragile X mental retardation protein. J Neurosci 25: 9460-
9469. 
 
Lauterborn JC, Rex CS, Kramar E, Chen LY, Pandyarajan V, Lynch G, et al 
(2007). Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse 
model of fragile X syndrome. J Neurosci 27: 10685-10694. 
 
264 
 
 
Lavdas AA, Grigoriou M, Pachnis V, Parnavelas JG (1999). The medial 
ganglionic eminence gives rise to a population of early neurons in the developing 
cerebral cortex. J Neurosci 19: 7881-7888. 
 
Lee A, Li W, Xu K, Bogert BA, Su K, Gao FB (2003). Control of dendritic 
development by the Drosophila fragile X-related gene involves the small GTPase 
Rac1. Development 130: 5543-5552. 
 
Lee E, Lee J, Kim E (2017). Excitation/Inhibition Imbalance in Animal Models of 
Autism Spectrum Disorders. Biol Psychiatry. 81(10): 838-847. 
 
Lee T, Winter C, Marticke SS, Lee A, Luo L (2000). Essential roles of Drosophila 
RhoA in the regulation of neuroblast proliferation and dendritic but not axonal 
morphogenesis. Neuron 25: 307-316. 
 
Leeuwen FN, Kain HE, Kammen RA, Michiels F, Kranenburg OW, Collard JG 
(1997). The guanine nucleotide exchange factor Tiam1 affects neuronal 
morphology; opposing roles for the small GTPases Rac and Rho. J Cell Biol 139: 
797-807. 
 
Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT, et al 
(2008). Molecular genetics of adult ADHD: converging evidence from genome-
wide association and extended pedigree linkage studies. J Neural Transm 
(Vienna) 115: 1573-1585. 
 
Letinic K, Zoncu R, Rakic P (2002). Origin of GABAergic neurons in the human 
neocortex. Nature 417: 645-649. 
 
Levitt P, Campbell DB (2009). The genetic and neurobiologic compass points 
toward common signaling dysfunctions in autism spectrum disorders. J Clin 
Invest 119: 747-754. 
 
Li J, Pelletier MR, Perez Velazquez JL, Carlen PL (2002). Reduced cortical 
synaptic plasticity and GluR1 expression associated with fragile X mental 
retardation protein deficiency. Mol Cell Neurosci 19: 138-151. 
 
Li S, Hong S, Shepardson N, Walsh D, Shankar G, Selkoe D (2009). Soluble 
oligomers of amyloid Beta protein facilitate hippocampal long-term depression by 
disrupting neuronal glutamate uptake. Neuron 62: 788-801. 
 
265 
 
 
Li Z, Aelst VL, Cline HT (2000). Rho GTPases regulate distinct aspects of 
dendritic arbor growth in Xenopus central neurons in vivo. Nat Neurosci 3: 217-
225. 
 
Lim S, Naisbitt S, Yoon J, Hwang JI, Suh PG, Sheng M, et al (1999). 
Characterization of the Shank family of synaptic proteins. Multiple genes, 
alternative splicing, and differential expression in brain and development. J Biol 
Chem 274: 29510-29518. 
 
Linden DJ, Dickinson MH, Smeyne M, Connor JA (1991). A long-term depression 
of AMPA currents in cultured cerebellar Purkinje neurons. Neuron 7: 81-89. 
 
Lionel AC, Crosbie J, Barbosa N, Goodale T, Thiruvahindrapuram B, Rickaby J, 
et al (2011). Rare copy number variation discovery and cross-disorder 
comparisons identify risk genes for ADHD. Sci Transl Med 3: 95ra75. 
 
Lionel AC, Tammimies K, Vaags AK, Rosenfeld JA, Ahn JW, Merico D, et al 
(2014). Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males 
for autism spectrum disorders, ADHD and other neurodevelopmental 
phenotypes. Hum Mol Genet 23: 2752-2768. 
 
Lionel AC, Vaags AK, Sato D, Gazzellone MJ, Mitchell EB, Chen HY, et al 
(2013). Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) 
in risk for autism, schizophrenia and seizures. Hum Mol Genet 22: 2055-2066. 
 
Liu SJ, Gasperini R, Foa L, Small DH (2010). Amyloid-beta decreases cell-
surface AMPA receptors by increasing intracellular calcium and phosphorylation 
of GluR2. J Alzheimers Dis 21: 655-666. 
 
Liu Y, Zhao D, Dong R, Yang X, Zhang Y, Tammimies K, et al (2015). De novo 
exon 1 deletion of AUTS2 gene in a patient with autism spectrum disorder and 
developmental delay: a case report and a brief literature review. Am J Med Genet 
A 167: 1381-1385. 
 
Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, et al (1989). 
Autism diagnostic observation schedule: a standardized observation of 
communicative and social behavior. J Autism Dev Disord 19: 185-212. 
 
Lu Q, Paredes M, Medina M, Zhou J (1999). Δ-Catenin, an adhesive junction–
associated protein which promotes cell scattering. The Journal of Cell Biology 
 144(3): 519-532.
266 
 
 
Lu Y, Wang F, Li Y, Ferris J, Lee JA, Gao FB (2009). The Drosophila homologue 
of the Angelman syndrome ubiquitin ligase regulates the formation of terminal 
dendritic branches. Hum Mol Genet 18: 454-462. 
 
Mabb AM, Judson MC, Zylka MJ, Philpot BD (2011). Angelman syndrome: 
insights into genomic imprinting and neurodevelopmental phenotypes. Trends 
Neurosci 34: 293-303. 
 
MacLaurin SA, Krucker T, Fish KN (2007). Hippocampal dendritic arbor growth in 
vitro: regulation by Reelin-Disabled-1 signaling. Brain Res 1172: 1-9. 
 
Madabhushi R, Gao F, Pfenning AR, Pan L, Yamakawa S, Seo J, et al (2015). 
Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-
Response Genes. Cell 161: 1592-1605. 
 
Maffei A, Turrigiano GG (2008). Multiple modes of network homeostasis in visual 
cortical layer 2/3. J Neurosci 28: 4377-4384. 
 
Magome T, Hattori T, Taniguchi M, Ishikawa T, Miyata S, Yamada K, et al 
(2013). XLMR protein related to neurite extension (Xpn/KIAA2022) regulates cell-
cell and cell-matrix adhesion and migration. Neurochem Int 63: 561-569. 
 
Major MB, Roberts BS, Berndt JD, Marine S, Anastas J, Chung N, et al (2008). 
New regulators of Wnt/beta-catenin signaling revealed by integrative molecular 
screening. Sci Signal 1: ra12. 
 
Malenka RC (1994). Synaptic plasticity in the hippocampus: LTP and LTD. Cell 
78: 535-538. 
 
Malenka RC, Bear MF (2004). LTP and LTD: an embarrassment of riches. 
Neuron 44: 5-21. 
 
Man HY (2011). GluA2-lacking, calcium-permeable AMPA receptors--inducers of 
plasticity? Curr Opin Neurobiol 21: 291-298. 
 
Marcello E, Epis R, Saraceno C, Gardoni F, Borroni B, Cattabeni F, et al (2012). 
SAP97-mediated local trafficking is altered in Alzheimer disease patients' 
hippocampus. Neurobiol Aging 33: 422 e421-410. 
 
Marin O, Rubenstein JL (2001). A long, remarkable journey: tangential migration 
in the telencephalon. Nat Rev Neurosci 2: 780-790. 
 
267 
 
 
Martinez M, Ochiishi T, Majewski M, Kosik KS (2003). Dual regulation of 
neuronal morphogenesis by a delta-catenin-cortactin complex and Rho. J Cell 
Biol 162: 99-111. 
 
Matsuki T, Matthews RT, Cooper JA, van der Brug MP, Cookson MR, Hardy JA, 
et al (2010). Reelin and stk25 have opposing roles in neuronal polarization and 
dendritic Golgi deployment. Cell 143: 826-836. 
 
Maximo JO, Cadena EJ, Kana RK (2014). The implications of brain connectivity 
in the neuropsychology of autism. Neuropsychol Rev 24: 16-31. 
 
McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, et al 
(2009). Microduplications of 16p11.2 are associated with schizophrenia. Nat 
Genet 41: 1223-1227. 
 
McKenney RJ, Vershinin M, Kunwar A, Vallee RB, Gross SP (2010). LIS1 and 
NudE induce a persistent dynein force-producing state. Cell 141: 304-314. 
 
McKinney BC, Grossman AW, Elisseou NM, Greenough WT (2005). Dendritic 
spine abnormalities in the occipital cortex of C57BL/6 Fmr1 knockout mice. Am J 
Med Genet B Neuropsychiatr Genet 136B: 98-102. 
 
Meberg PJ, Bamburg JR (2000). Increase in neurite outgrowth mediated by 
overexpression of actin depolymerizing factor. J Neurosci 20: 2459-2469. 
 
Medina M, Marinescu RC, Overhauser J, Kosik KS (2000). Hemizygosity of δ-
catenin (CTNND2) is associated with severe mental retardation in cri-du-chat 
syndrome. Genomics 63: 157-164. 
 
Mefford HC, Muhle H, Ostertag P, von Spiczak S, Buysse K, Baker C, et al 
(2010). Genome-wide copy number variation in epilepsy: novel susceptibility loci 
in idiopathic generalized and focal epilepsies. PLoS Genet 6: e1000962. 
 
Megill A, Tran T, Eldred K, Lee NJ, Wong PC, Hoe HS, et al (2015). Defective 
Age-Dependent Metaplasticity in a Mouse Model of Alzheimer's Disease. J 
Neurosci 35: 11346-11357. 
 
Miao S, Chen R, Ye J, Tan GH, Li S, Zhang J, et al (2013). The Angelman 
syndrome protein Ube3a is required for polarized dendrite morphogenesis in 
pyramidal neurons. J Neurosci 33: 327-333. 
 
268 
 
 
Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, et al 
(2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. 
Neuron 74: 49-56. 
 
Miles JH, Takahashi TN, Bagby S, Sahota PK, Vaslow DF, Wang CH, et al 
(2005). Essential versus complex autism: definition of fundamental prognostic 
subtypes. Am J Med Genet A 135: 171-180. 
 
Minano-Molina AJ, Espana J, Martin E, Barneda-Zahonero B, Fado R, Sole M, et 
al (2011). Soluble oligomers of amyloid-beta peptide disrupt membrane 
trafficking of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor 
contributing to early synapse dysfunction. J Biol Chem 286: 27311-27321. 
 
Ming GL, Song H (2005). Adult neurogenesis in the mammalian central nervous 
system. Annu Rev Neurosci 28: 223-250. 
 
Missler M, Sudhof TC, Biederer T (2012). Synaptic cell adhesion. Cold Spring 
Harb Perspect Biol 4: a005694. 
 
Missler M, Zhang W, Rohlmann A, Kattenstroth G, Hammer RE, Gottmann K, et 
al (2003). Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. 
Nature 423: 939-948. 
 
Morelli C, Mungall AJ, Negrini M, Barbanti-Brodano G, Croce CM (1998). 
Alternative splicing, genomic structure, and fine chromosome localization of 
REV3L. Cytogenet Cell Genet 83: 18-20. 
 
Morgan JT, Barger N, Amaral DG, Schumann CM (2014). Stereological study of 
amygdala glial populations in adolescents and adults with autism spectrum 
disorder. PLoS One 9: e110356. 
 
Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, et al (2008). Identifying 
autism loci and genes by tracing recent shared ancestry. Science 321: 218-223. 
 
Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, Murphy DL, et al 
(2009). Social approach in genetically engineered mouse lines relevant to 
autism. Genes Brain Behav 8: 129-142. 
 
Nadarajah B, Parnavelas JG (2002). Modes of neuronal migration in the 
developing cerebral cortex. Nat Rev Neurosci 3: 423-432. 
 
269 
 
 
Nakayama AY, Harms MB, Luo L (2000). Small GTPases Rac and Rho in the 
maintenance of dendritic spines and branches in hippocampal pyramidal 
neurons. J Neurosci 20: 5329-5338. 
 
Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, et al (2012). Patterns 
and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 
242-245. 
 
Nelson SB, Valakh V (2015). Excitatory/Inhibitory Balance and Circuit 
Homeostasis in Autism Spectrum Disorders. Neuron 87: 684-698. 
 
Nery S, Fishell G, Corbin JG (2002). The caudal ganglionic eminence is a source 
of distinct cortical and subcortical cell populations. Nat Neurosci 5: 1279-1287. 
 
Neumann H, Schweigreiter R (2002). Tumor necrosis factor inhibits neurite 
outgrowth and branching of hippocampal neurons by a rho-dependent 
mechanism. J Neurosci 22: 854-862. 
 
Newey SE, Velamoor V, Govek EE (2005). Rho GTPases, dendritic structure, 
and mental retardation. Dev Neurobiol 64: 58-74. 
 
Nguyen D, Disteche C (2006). High expression of the mammalian X 
chromosome in brain. Brain Res 1126: 46-49. 
 
Nichols AJ, Olson EC (2010). Reelin promotes neuronal orientation and 
dendritogenesis during preplate splitting. Cereb Cortex 20: 2213-2223. 
 
Nicholson-Dykstra S, Higgs HN, Harris ES (2005). Actin dynamics: growth from 
dendritic branches. Curr Biol 15: R346-357. 
 
Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, et al (2000). NUDEL 
is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. 
Neuron 28: 697-711. 
 
Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G (2004). Reelin 
promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 
pathway. Neuron 41: 71-84. 
 
Noebels J (2011). A perfect storm: Converging paths of epilepsy and Alzheimer's 
dementia intersect in the hippocampal formation. Epilepsia 52 Suppl 1: 39-46. 
 
270 
 
 
Noor A, Dupuis L, Mittal K, Lionel AC, Marshall CR, Scherer SW, et al (2015). 
15q11.2 Duplication Encompassing Only the UBE3A Gene Is Associated with 
Developmental Delay and Neuropsychiatric Phenotypes. Hum Mutat 36: 689-
693. 
 
Nowicki ST, Tassone F, Ono MY, Ferranti J, Croquette MF, Goodlin-Jones B, et 
al (2007). The Prader-Willi phenotype of fragile X syndrome. J Dev Behav 
Pediatr 28: 133-138. 
 
Ogawa S, Kwon CH, Zhou J, Koovakkattu D, Parada LF, Sinton CM (2007). A 
seizure-prone phenotype is associated with altered free-running rhythm in Pten 
mutant mice. Brain Res 1168: 112-123. 
 
Oliet SH, Malenka RC, Nicoll RA (1997). Two distinct forms of long-term 
depression coexist in CA1 hippocampal pyramidal cells. Neuron 18: 969-982. 
 
Orloff MS, He X, Peterson C, Chen F, Chen JL, Mester JL, et al (2013). Germline 
PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes. Am J 
Hum Genet 92: 76-80. 
 
Orosco LA, Ross AP, Cates SL, Scott SE, Wu D, Sohn J, et al (2014). Loss of 
Wdfy3 in mice alters cerebral cortical neurogenesis reflecting aspects of the 
autism pathology. Nat Commun 5: 4692. 
 
Osterweil EK, Krueger DD, Reinhold K, Bear MF (2010). Hypersensitivity to 
mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of 
a mouse model of fragile X syndrome. J Neurosci 30: 15616-15627. 
 
Ouyang Q, Lizarraga SB, Schmidt M, Yang U, Gong J, Ellisor D, et al (2013). 
Christianson syndrome protein NHE6 modulates TrkB endosomal signaling 
required for neuronal circuit development. Neuron 80: 97-112. 
 
Ozgen HM, van Daalen E, Bolton PF, Maloney VK, Huang S, Cresswell L, et al 
(2009). Copy number changes of the microcephalin 1 gene (MCPH1) in patients 
with autism spectrum disorders. Clin Genet 76: 348-356. 
 
Pagan C, Delorme R, Callebert J, Goubran-Botros H, Amsellem F, Drouot X, et 
al (2014). The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for 
autism spectrum disorders. Transl Psychiatry 4: e479. 
 
Palop JJ, Mucke L (2009). Epilepsy and cognitive impairments in Alzheimer 
disease. Arch Neurol 66: 435-440. 
271 
 
 
 
Panganiban G, Rubenstein JL (2002). Developmental functions of the Distal-
less/Dlx homeobox genes. Development 129: 4371-4386. 
 
Pardo CA, Eberhart CG (2007). The neurobiology of autism. Brain Pathol 17: 
434-447. 
 
Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, et al (2013). 
Integrative functional genomic analyses implicate specific molecular pathways 
and circuits in autism. Cell 155: 1008-1021. 
 
Passemard S, Titomanlio L, Elmaleh M, Afenjar A, Alessandri JL, Andria G, et al 
(2009). Expanding the clinical and neuroradiologic phenotype of primary 
microcephaly due to ASPM mutations. Neurology 73: 962-969. 
 
Passemard S, Verloes A, Billette de Villemeur T, Boespflug-Tanguy O, 
Hernandez K, Laurent M, et al (2016). Abnormal spindle-like microcephaly-
associated (ASPM) mutations strongly disrupt neocortical structure but spare the 
hippocampus and long-term memory. Cortex 74: 158-176. 
 
Pathania M, Davenport EC, Muir J, Sheehan DF, Lopez-Domenech G, Kittler JT 
(2014). The autism and schizophrenia associated gene CYFIP1 is critical for the 
maintenance of dendritic complexity and the stabilization of mature spines. 
Transl Psychiatry 4: e374. 
 
Pawlisz AS, Feng Y (2011). Three-dimensional regulation of radial glial functions 
by Lis1-Nde1 and dystrophin glycoprotein complexes. PLoS Biol 9: e1001172. 
 
Pawlisz AS, Mutch C, Wynshaw-Boris A, Chenn A, Walsh CA, Feng Y (2008). 
Lis1-Nde1-dependent neuronal fate control determines cerebral cortical size and 
lamination. Hum Mol Genet 17: 2441-2455. 
 
Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, et al (2011). 
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. 
Nature 472: 437-442. 
 
Peça J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, et al (2011). 
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. 
Nature 472: 437-442. 
 
Pelphrey KA, Carter EJ (2008). Brain mechanisms for social perception: lessons 
from autism and typical development. Ann N Y Acad Sci 1145: 283-299. 
272 
 
 
 
Penagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, 
et al (2011). Absence of CNTNAP2 leads to epilepsy, neuronal migration 
abnormalities, and core autism-related deficits. Cell 147: 235-246. 
 
Persico A, Bourgeron T (2006). Searching for ways out of the autism maze: 
genetic, epigenetic and environmental clues. Trends Neurosci 29: 349-358. 
 
Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, et al 
(2001). Reelin gene alleles and haplotypes as a factor predisposing to autistic 
disorder. Mol Psychiatry 6: 150-159. 
 
Pescosolido MF, Yang U, Sabbagh M, Morrow EM (2012). Lighting a path: 
genetic studies pinpoint neurodevelopmental mechanisms in autism and related 
disorders. Dialogues Clin Neurosci 14: 239-252. 
 
Peters SU, Beaudet AL, Madduri N, Bacino CA (2004). Autism in Angelman 
syndrome: implications for autism research. Clin Genet 66: 530-536. 
 
Petersen A, Gerges NZ (2015). Neurogranin regulates CaM dynamics at 
dendritic spines. Sci Rep 5: 11135. 
 
Pettitt SJ, Liang Q, Rairdan XY, Moran JL, Prosser HM, Beier DR, et al (2009). 
Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat 
Methods 6: 493-495. 
 
Pfeiffer B, Zang T, Wilkerson J, Taniguchi M, Maksimova M, Smith L, et al 
(2010). Fragile X mental retardation protein is required for synapse elimination by 
the activity-dependent transcription factor MEF2. Neuron 66: 191-197. 
 
Phelan MC (2008). Deletion 22q13.3 syndrome. Orphanet J Rare Dis 3: 14. 
 
Phillips M, Pozzo-Miller L (2015). Dendritic spine dysgenesis in autism related 
disorders. Neurosci Lett 601: 30-40. 
 
Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al (2010). 
Functional impact of global rare copy number variation in autism spectrum 
disorders. Nature 466: 368-372. 
 
Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, et al (1999). 
Caspr2, a new member of the neurexin superfamily, is localized at the 
273 
 
 
juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 
24: 1037-1047. 
 
Polleux F, Whitford KL, Dijkhuizen PA, Vitalis T, Ghosh A (2002). Control of 
cortical interneuron migration by neurotrophins and PI3-kinase signaling. 
Development 129: 3147-3160. 
 
Poluch S, Juliano SL (2007). A normal radial glial scaffold is necessary for 
migration of interneurons during neocortical development. Glia 55: 822-830. 
 
Poulopoulos A, Aramuni G, Meyer G, Soykan T, Hoon M, Papadopoulos T, et al 
(2009). Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory 
synapses through gephyrin and collybistin. Neuron 63: 628-642. 
 
Pozo K, Goda Y (2010). Unraveling mechanisms of homeostatic synaptic 
plasticity. Neuron 66: 337-351. 
 
Pratt KG, Zimmerman EC, Cook DG, Sullivan JM (2011). Presenilin 1 regulates 
homeostatic synaptic scaling through Akt signaling. Nat Neurosci 14: 1112-1114. 
 
Pulvers JN, Bryk J, Fish JL, Wilsch-Brauninger M, Arai Y, Schreier D, et al 
(2010). Mutations in mouse Aspm (abnormal spindle-like microcephaly 
associated) cause not only microcephaly but also major defects in the germline. 
Proc Natl Acad Sci U S A 107: 16595-16600. 
 
Qiu Z, Sylwestrak EL, Lieberman DN, Zhang Y, Liu XY, Ghosh A (2012). The 
Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci 32: 989-
994. 
 
Rajasekaran K, Todorovic M, Kapur J (2012). Calcium-permeable AMPA 
receptors are expressed in a rodent model of status epilepticus. Ann Neurol 72: 
91-102. 
 
Rakic P (1972). Mode of cell migration to the superficial layers of fetal monkey 
neocortex. J Comp Neurol 145: 61-83. 
 
Rakic S, Zecevic N (2000). Programmed cell death in the developing human 
telencephalon. Eur J Neurosci 12: 2721-2734. 
 
Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, et al 
(2010). Proceedings from the 2009 genetic syndromes of the Ras/MAPK 
pathway: From bedside to bench and back. Am J Med Genet A 152A: 4-24. 
274 
 
 
 
Redcay E (2008). The superior temporal sulcus performs a common function for 
social and speech perception: implications for the emergence of autism. Neurosci 
Biobehav Rev 32: 123-142. 
 
Redies C, Hertel N, Hubner CA (2012). Cadherins and neuropsychiatric 
disorders. Brain Res 1470: 130-144. 
 
Redmond L, Kashani AH, Ghosh A (2002). Calcium regulation of dendritic growth 
via CaM kinase IV and CREB-mediated transcription. Neuron 34: 999-1010. 
 
Reiersen AM, Todd RD (2008). Co-occurrence of ADHD and autism spectrum 
disorders: phenomenology and treatment. Expert Rev Neurother 8: 657-669. 
 
Reiner O (2000). LIS1. let's interact sometimes... (part 1). Neuron 28: 633-636. 
 
Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, et al 
(1993). Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-
subunit-like repeats. Nature 364: 717-721. 
 
Reiner O, Karzbrun E, Kshirsagar A, Kaibuchi K (2016). Regulation of neuronal 
migration, an emerging topic in autism spectrum disorders. J Neurochem 136: 
440-456. 
 
Restivo L, Ferrari F, Passino E, Sgobio C, Bock J, Oostra BA, et al (2005). 
Enriched environment promotes behavioral and morphological recovery in a 
mouse model for the fragile X syndrome. Proc Natl Acad Sci U S A 102: 11557-
11562. 
 
Reynolds AB, Carnahan RH (2004). Regulation of cadherin stability and turnover 
by p120ctn: implications in disease and cancer. Semin Cell Dev Biol 15: 657-663. 
 
Ricciardi S, Ungaro F, Hambrock M, Rademacher N, Stefanelli G, Brambilla D, et 
al (2012). CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-
PSD95 interaction in the postsynaptic compartment and is impaired in patient 
iPSC-derived neurons. Nat Cell Biol 14: 911-923. 
 
Richards MW, Leung JW, Roe SM, Li K, Chen J, Bayliss R (2010). A pocket on 
the surface of the N-terminal BRCT domain of Mcph1 is required to prevent 
abnormal chromosome condensation. J Mol Biol 395: 908-915. 
 
275 
 
 
Roberts E, Hampshire DJ, Pattison L, Springell K, Jafri H, Corry P, et al (2002). 
Autosomal recessive primary microcephaly: an analysis of locus heterogeneity 
and phenotypic variation. J Med Genet 39: 718-721. 
 
Rochefort NL, Konnerth A (2012). Dendritic spines: from structure to in vivo 
function. EMBO Rep???? 13: 699-708. 
 
Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, et al (1995). 
Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 
375: 488-493. 
 
Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, et al (2005). Soluble 
beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic 
density-95 at glutamatergic synapses. J Neurosci 25: 11061-11070. 
 
Rosser TL, Packer RJ (2003). Neurocognitive dysfunction in children with 
neurofibromatosis type 1. Curr Neurol Neurosci Rep 3: 129-136. 
 
Rubenstein JL, Merzenich MM (2003). Model of autism: increased ratio of 
excitation/inhibition in key neural systems. Genes Brain Behav 2: 255-267. 
 
Rudelli RD, Brown WT, Wisniewski K, Jenkins EC, Laure-Kamionowska M, 
Connell F, et al (1985). Adult fragile X syndrome. Clinico-neuropathologic 
findings. Acta Neuropathol 67: 289-295. 
 
Ryoo K, Hwang SG, Kim KJ, Choi EJ (2015). RC3/neurogranin negatively 
regulates extracellular signal-regulated kinase pathway through its interaction 
with Ras. Mol Cell Biochem 402: 33-40. 
 
Sacco R, Militerni R, Frolli A, Bravaccio C, Gritti A, Elia M, et al (2007). Clinical, 
morphological, and biochemical correlates of head circumference in autism. Biol 
Psychiatry 62: 1038-1047. 
 
Salinger WL, Ladrow P, Wheeler C (2003). Behavioral phenotype of the reeler 
mutant mouse: effects of RELN gene dosage and social isolation. Behav 
Neurosci 117: 1257-1275. 
 
Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, 
et al (2011). Multiple recurrent de novo CNVs, including duplications of the 
7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 
70: 863-885. 
 
276 
 
 
Saneyoshi T, Wayman G, Fortin D, Davare M, Hoshi N, Nozaki N, et al (2008). 
Activity-dependent synaptogenesis: regulation by a CaM-kinase kinase/CaM-
kinase I/betaPIX signaling complex. Neuron 57: 94-107. 
 
Santoro MR, Bray SM, Warren ST (2012). Molecular mechanisms of fragile X 
syndrome: a twenty-year perspective. Annu Rev Pathol 7: 219-245. 
 
Sasaki S, Shionoya A, Ishida M, Gambello MJ, Yingling J, Wynshaw-Boris A, et 
al (2000). A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the 
developing and adult nervous system. Neuron 28: 681-696. 
 
Schnell E, Bensen AL, Washburn EK, Westbrook GL (2012). Neuroligin-1 
overexpression in newborn granule cells in vivo. PLoS One 7: e48045. 
 
Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, 
et al (2010). Longitudinal magnetic resonance imaging study of cortical 
development through early childhood in autism. J Neurosci 30: 4419-4427. 
 
Sekine K, Kubo K, Nakajima K (2014). How does Reelin control neuronal 
migration and layer formation in the developing mammalian neocortex? Neurosci 
Res 86: 50-58. 
 
Senyuk V, Premanand K, Xu P, Qian Z, Nucifora G (2011). The oncoprotein EVI1 
and the DNA methyltransferase Dnmt3 co-operate in binding and de novo 
methylation of target DNA. PLoS One 6: e20793. 
 
Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, et al 
(2002). Mice with truncated MeCP2 recapitulate many Rett syndrome features 
and display hyperacetylation of histone H3. Neuron 35: 243-254. 
 
Sheng M, Kim E (2000). The Shank family of scaffold proteins. J Cell Sci 113 ( Pt 
11): 1851-1856. 
 
Shepherd GM, Katz DM (2011). Synaptic microcircuit dysfunction in genetic 
models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr Opin 
Neurobiol 21: 827-833. 
 
Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, et al (2006). 
Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 
52: 475-484. 
 
277 
 
 
Shigemoto R, Abe T, Nomura S, Nakanishi S, Hirano T (1994). Antibodies 
inactivating mGluR1 metabotropic glutamate receptor block long-term depression 
in cultured Purkinje cells. Neuron 12: 1245-1255. 
 
Shim SY, Wang J, Asada N, Neumayer G, Tran HC, Ishiguro K, et al (2008). 
Protein 600 is a microtubule/endoplasmic reticulum-associated protein in CNS 
neurons. J Neurosci 28: 3604-3614. 
 
Silverman JL, Yang M, Lord C, Crawley JN (2010). Behavioural phenotyping 
assays for mouse models of autism. Nat Rev Neurosci 11: 490-502. 
 
Sivaramakrishnan S, Brodwick MS, Bittner GD (1991). Presynaptic facilitation at 
the crayfish neuromuscular junction. Role of calcium-activated potassium 
conductance. J Gen Physiol 98: 1181-1196. 
 
Skalecka A, Liszewska E, Bilinski R, Gkogkas C, Khoutorsky A, Malik AR, et al 
(2016). mTOR kinase is needed for the development and stabilization of dendritic 
arbors in newly born olfactory bulb neurons. Dev Neurobiol 76: 1308-1327. 
 
Skuse D (2005). X-linked genes and mental functioning. Hum Mol Genet 14 
Spec No 1: 32. 
 
Small D (2004). Mechanisms of synaptic homeostasis in Alzheimer's disease. 
Curr Alzheimer Res 1: 27-32. 
 
Small DH (2008). Network dysfunction in Alzheimer's disease: does synaptic 
scaling drive disease progression? Trends Mol Med 14: 103-108. 
 
Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP (2011). 
Increased gene dosage of Ube3a results in autism traits and decreased 
glutamate synaptic transmission in mice. Sci Transl Med 3: 103ra197. 
 
Soden ME, Chen L (2010). Fragile X protein FMRP is required for homeostatic 
plasticity and regulation of synaptic strength by retinoic acid. J Neurosci 30: 
16910-16921. 
 
Spencer CM, Alekseyenko O, Serysheva E, Yuva-Paylor LA, Paylor R (2005). 
Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model 
of fragile X syndrome. Genes Brain Behav 4: 420-430. 
 
Srinivasan K, Leone DP, Bateson RK, Dobreva G, Kohwi Y, Kohwi-Shigematsu 
T, et al (2012). A network of genetic repression and derepression specifies 
278 
 
 
projection fates in the developing neocortex. Proc Natl Acad Sci U S A 109: 
19071-19078. 
 
Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M (1996). Autism in 
Angelman syndrome: a population-based study. Pediatr Neurol 14: 131-136. 
 
Stiles J, Jernigan TL (2010). The basics of brain development. Neuropsychol Rev 
20: 327-348. 
 
Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S, et al (2014). 
Patches of disorganization in the neocortex of children with autism. N Engl J Med 
370: 1209-1219. 
 
Storch EA, Arnold EB, Jones AM, Ale CM, Wood JJ, Ehrenreich-May J, et al 
(2012). The role of co-occurring disruptive behavior in the clinical presentation of 
children and adolescents with anxiety in the context of autism spectrum 
disorders. Child Psychiatry Hum Dev 43: 734-746. 
 
Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, Parod JM, 
et al (2006). Recessive symptomatic focal epilepsy and mutant contactin-
associated protein-like 2. N Engl J Med 354: 1370-1377. 
 
Stromme P, Mangelsdorf ME, Scheffer IE, Gecz J (2002). Infantile spasms, 
dystonia, and other X-linked phenotypes caused by mutations in Aristaless 
related homeobox gene, ARX. Brain Dev 24: 266-268. 
 
Stuss DP, Boyd JD, Levin DB, Delaney KR (2012). MeCP2 mutation results in 
compartment-specific reductions in dendritic branching and spine density in layer 
5 motor cortical neurons of YFP-H mice. PLoS One 7: e31896. 
 
Sultana R, Yu CE, Yu J, Munson J, Chen D, Hua W, et al (2002). Identification of 
a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in 
a pair of autistic twins. Genomics 80: 129-134. 
 
Sundaram SK, Huq AM, Wilson BJ, Chugani HT (2010). Tourette syndrome is 
associated with recurrent exonic copy number variants. Neurology 74: 1583-
1590. 
 
Sutton MA, Ito HT, Cressy P, Kempf C, Woo JC, Schuman EM (2006). Miniature 
neurotransmission stabilizes synaptic function via tonic suppression of local 
dendritic protein synthesis. Cell 125: 785-799. 
 
279 
 
 
Suvrathan A, Hoeffer CA, Wong H, Klann E, Chattarji S (2010). Characterization 
and reversal of synaptic defects in the amygdala in a mouse model of fragile X 
syndrome. Proc Natl Acad Sci U S A 107: 11591-11596. 
 
Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, et al (2007). 
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic 
transmission in mice. Science 318: 71-76. 
 
Tahirovic S, Bradke F (2009). Neuronal polarity. Cold Spring Harb Perspect Biol 
1: a001644. 
 
Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A, et 
al (2012). Sequencing chromosomal abnormalities reveals neurodevelopmental 
loci that confer risk across diagnostic boundaries. Cell 149: 525-537. 
 
Tan Z-JJ, Peng Y, Song H-LL, Zheng J-JJ, Yu X (2010). N-cadherin-dependent 
neuron-neuron interaction is required for the maintenance of activity-induced 
dendrite growth. Proc Natl Acad Sci U S A 107: 9873-9878. 
 
Tan ZJ, Peng Y, Song HL, Zheng JJ, Yu X (2010). N-cadherin-dependent 
neuron-neuron interaction is required for the maintenance of activity-induced 
dendrite growth. Proc Natl Acad Sci U S A 107: 9873-9878. 
 
Tanzi RE (2005). The synaptic Abeta hypothesis of Alzheimer disease. Nat 
Neurosci 8: 977-979. 
 
Tau GZ, Peterson BS (2010). Normal development of brain circuits. 
Neuropsychopharmacology 35: 147-168. 
 
Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL (2005). 
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 
and Tsc2. Nat Neurosci 8: 1727-1734. 
 
Thomanetz V, Angliker N, Cloetta D, Lustenberger RM, Schweighauser M, 
Oliveri F, et al (2013). Ablation of the mTORC2 component rictor in brain or 
Purkinje cells affects size and neuron morphology. J Cell Biol 201: 293-308. 
 
Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R (2009). Marble 
burying reflects a repetitive and perseverative behavior more than novelty-
induced anxiety. Psychopharmacology (Berl) 204: 361-373. 
 
280 
 
 
Thornton GK, Woods CG (2009). Primary microcephaly: do all roads lead to 
Rome? Trends Genet 25: 501-510. 
 
Toma C, Hervas A, Torrico B, Balmana N, Salgado M, Maristany M, et al (2013). 
Analysis of two language-related genes in autism: a case-control association 
study of FOXP2 and CNTNAP2. Psychiatr Genet 23: 82-85. 
 
Tononi G, Cirelli C (2003). Sleep and synaptic homeostasis: a hypothesis. Brain 
Res Bull 62: 143-150. 
 
Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, et al 
(2010). Key role for gene dosage and synaptic homeostasis in autism spectrum 
disorders. Trends Genet 26: 363-372. 
 
Towbin KE, Pradella A, Gorrindo T, Pine DS, Leibenluft E (2005). Autism 
spectrum traits in children with mood and anxiety disorders. J Child Adolesc 
Psychopharmacol 15: 452-464. 
 
Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, Welker E, et al 
(2002). Long-term in vivo imaging of experience-dependent synaptic plasticity in 
adult cortex. Nature 420: 788-794. 
 
Tsai JW, Bremner KH, Vallee RB (2007). Dual subcellular roles for LIS1 and 
dynein in radial neuronal migration in live brain tissue. Nat Neurosci 10: 970-979. 
 
Tsai NP, Wilkerson JR, Guo W, Maksimova MA, DeMartino GN, Cowan CW, et 
al (2012). Multiple autism-linked genes mediate synapse elimination via 
proteasomal degradation of a synaptic scaffold PSD-95. Cell 151: 1581-1594. 
 
Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM, et al (2012). 
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant 
mice. Nature 488: 647-651. 
 
Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, et al (1999). 
Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of 
postsynaptic density proteins. Neuron 23: 583-592. 
 
Tunca Y, Vurucu S, Parma J, Akin R, Desir J, Baser I, et al (2006). Prenatal 
diagnosis of primary microcephaly in two consanguineous families by 
confrontation of morphometry with DNA data. Prenat Diagn 26: 449-453. 
 
281 
 
 
Turner G, Partington M, Kerr B, Mangelsdorf M, Gecz J (2002). Variable 
expression of mental retardation, autism, seizures, and dystonic hand 
movements in two families with an identical ARX gene mutation. Am J Med 
Genet 112: 405-411. 
 
Turner TN, Sharma K, Oh EC, Liu YP, Collins RL, Sosa MX, et al (2015). Loss of 
delta-catenin function in severe autism. Nature 520: 51-56. 
 
Turrigiano G, Nelson S (2004). Homeostatic plasticity in the developing nervous 
system. Nat Rev Neurosci. 5(2): 97-107.
 
Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB (1998). Activity-
dependent scaling of quantal amplitude in neocortical neurons. Nature 391: 892-
896. 
 
Uchino S, Wada H, Honda S, Nakamura Y, Ondo Y, Uchiyama T, et al (2006). 
Direct interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing 
synaptic molecule Shank3 with GluR1 alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid receptor. J Neurochem 97: 1203-1214. 
 
Uppal N, Wicinski B, Buxbaum JD, Heinsen H, Schmitz C, Hof PR (2014). 
Neuropathology of the anterior midcingulate cortex in young children with autism. 
J Neuropathol Exp Neurol 73: 891-902. 
 
Valiente M, Marin O (2010). Neuronal migration mechanisms in development and 
disease. Curr Opin Neurobiol 20: 68-78. 
 
Van Dam D, D'Hooge R, Hauben E, Reyniers E, Gantois I, Bakker CE, et al 
(2000). Spatial learning, contextual fear conditioning and conditioned emotional 
response in Fmr1 knockout mice. Behav Brain Res 117: 127-136. 
 
van Kooten IA, Palmen SJ, von Cappeln P, Steinbusch HW, Korr H, Heinsen H, 
et al (2008). Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 
131: 987-999. 
 
Van Maldergem L, Hou Q, Kalscheuer VM, Rio M, Doco-Fenzy M, Medeira A, et 
al (2013). Loss of function of KIAA2022 causes mild to severe intellectual 
disability with an autism spectrum disorder and impairs neurite outgrowth. Hum 
Mol Genet 22: 3306-3314. 
 
van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R, et 
al (2007). Rescue of neurological deficits in a mouse model for Angelman 
282 
 
 
syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci 
10: 280-282. 
 
Varea O, Martin-de-Saavedra MD, Kopeikina KJ, Schurmann B, Fleming HJ, 
Fawcett-Patel JM, et al (2015). Synaptic abnormalities and cytoplasmic 
glutamate receptor aggregates in contactin associated protein-like 2/Caspr2 
knockout neurons. Proc Natl Acad Sci U S A 112: 6176-6181. 
 
Varga EA, Pastore M, Prior T, Herman GE, McBride KL (2009). The prevalence 
of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, 
developmental delay, and macrocephaly. Genet Med 11: 111-117. 
 
Vazquez I, Maicas M, Marcotegui N, Conchillo A, Guruceaga E, Roman-Gomez 
J, et al (2010). Silencing of hsa-miR-124 by EVI1 in cell lines and patients with 
acute myeloid leukemia. Proc Natl Acad Sci U S A 107: E167-168; author reply 
E169-170. 
 
Volders K, Nuytens K, Creemers JW (2011). The autism candidate gene 
Neurobeachin encodes a scaffolding protein implicated in membrane trafficking 
and signaling. Curr Mol Med 11: 204-217. 
 
von der Brelie C, Waltereit R, Zhang L, Beck H, Kirschstein T (2006). Impaired 
synaptic plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23: 686-
692. 
 
Waites CL, Craig AM, Garner CC (2005). Mechanisms of vertebrate 
synaptogenesis. Annu Rev Neurosci 28: 251-274. 
 
Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al (2002). 
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal 
long-term potentiation in vivo. Nature 416: 535-539. 
 
Wang G, Gilbert J, Man HY (2012). AMPA receptor trafficking in homeostatic 
synaptic plasticity: functional molecules and signaling cascades. Neural Plast 
2012: 825364. 
 
Wang H, Ardiles AO, Yang S, Tran T, Posada-Duque R, Valdivia G, et al (2016). 
Metabotropic Glutamate Receptors Induce a Form of LTP Controlled by 
Translation and Arc Signaling in the Hippocampus. J Neurosci 36: 1723-1729. 
 
283 
 
 
Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al (2009). 
Common genetic variants on 5p14.1 associate with autism spectrum disorders. 
Nature 459: 528-533. 
 
Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, et al (2011). 
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of 
Shank3. Hum Mol Genet 20: 3093-3108. 
 
Webster R, Cho MT, Retterer K, Millan F, Nowak C, Douglas J, et al (2017). De 
novo Loss of function Mutations in KIAA2022 Are Associated with Epilepsy and 
Neurodevelopmental Delay in Females. Clin Genet. 91(5): 756-763.
 
Weeber EJ, Jiang YH, Elgersma Y, Varga AW, Carrasquillo Y, Brown SE, et al 
(2003). Derangements of hippocampal calcium/calmodulin-dependent protein 
kinase II in a mouse model for Angelman mental retardation syndrome. J 
Neurosci 23: 2634-2644. 
 
Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Marchi E, et al (2010). The 
neuropathology of autism: defects of neurogenesis and neuronal migration, and 
dysplastic changes. Acta Neuropathol 119: 755-770. 
 
Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, et al (2008). 
Association between microdeletion and microduplication at 16p11.2 and autism. 
N Engl J Med 358: 667-675. 
 
Weng SM, McLeod F, Bailey ME, Cobb SR (2011). Synaptic plasticity deficits in 
an experimental model of rett syndrome: long-term potentiation saturation and its 
pharmacological reversal. Neurosc????? 180: 314-321. 
 
Wenner P (2014). Homeostatic synaptic plasticity in developing spinal networks 
driven by excitatory GABAergic currents. Neuropharmacology 78: 55-62. 
 
Weston MC, Chen H, Swann JW (2014). Loss of mTOR repressors Tsc1 or Pten 
has divergent effects on excitatory and inhibitory synaptic transmission in single 
hippocampal neuron cultures. Front Mol Neurosci 7: 1. 
 
Whalley HC, O'Connell G, Sussmann JE, Peel A, Stanfield AC, Hayiou-Thomas 
ME, et al (2011). Genetic variation in CNTNAP2 alters brain function during 
linguistic processing in healthy individuals. Am J Med Genet B Neuropsychiatr 
Genet 156B: 941-948. 
 
284 
 
 
Whitcomb DJ, Hogg EL, Regan P, Piers T, Narayan P, Whitehead G, et al 
(2015). Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of 
AMPA receptor in the hippocampus. Sci Rep 5: 10934. 
 
Wichterle H, Turnbull DH, Nery S, Fishell G, Alvarez-Buylla A (2001). In utero 
fate mapping reveals distinct migratory pathways and fates of neurons born in 
the mammalian basal forebrain. Development 128: 3759-3771. 
 
Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al 
(2006). Angelman syndrome 2005: updated consensus for diagnostic criteria. Am 
J Med Genet A 140: 413-418. 
 
Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al (2013). 
Coexpression networks implicate human midfetal deep cortical projection 
neurons in the pathogenesis of autism. Cell 155: 997-1007. 
 
Wilson BM, Cox CL (2007). Absence of metabotropic glutamate receptor-
mediated plasticity in the neocortex of fragile X mice. Proc Natl Acad Sci U S A 
104: 2454-2459. 
 
Wilson PM, Fryer RH, Fang Y, Hatten ME (2010). Astn2, a novel member of the 
astrotactin gene family, regulates the trafficking of ASTN1 during glial-guided 
neuronal migration. J Neurosci 30: 8529-8540. 
 
Witte H, Bradke F (2008). The role of the cytoskeleton during neuronal 
polarization. Curr Opin Neurobiol 18: 479-487. 
 
Wong WT, Faulkner-Jones BE, Sanes JR (2000). Rapid dendritic remodeling in 
the developing retina: dependence on neurotransmission and reciprocal 
regulation by Rac and Rho. J Neurosci 20: 5024-5036. 
 
Yang M, Bozdagi O, Scattoni ML, Wohr M, Roullet FI, Katz AM, et al (2012). 
Reduced excitatory neurotransmission and mild autism-relevant phenotypes in 
adolescent Shank3 null mutant mice. J Neurosci 32: 6525-6541. 
 
Yangngam S, Plong-On O, Sripo T, Roongpraiwan R, Hansakunachai T, 
Wirojanan J, et al (2014). Mutation screening of the neurexin 1 gene in thai 
patients with intellectual disability and autism spectrum disorder. Genet Test Mol 
Biomarkers 18: 510-515. 
 
285 
 
 
Yip J, Soghomonian JJ, Blatt GJ (2007). Decreased GAD67 mRNA levels in 
cerebellar Purkinje cells in autism: pathophysiological implications. Acta 
Neuropathol 113: 559-568. 
 
Yoo J, Bakes J, Bradley C, Collingridge GL, Kaang BK (2014). Shank mutant 
mice as an animal model of autism. Philos Trans R Soc Lond B Biol Sci 369: 
20130143. 
 
Yu L, Goda Y (2009). Dendritic signalling and homeostatic adaptation. Curr Opin 
Neurobiol 19: 327-335. 
 
Yu TW, Mochida GH, Tischfield DJ, Sgaier SK, Flores-Sarnat L, Sergi CM, et al 
(2010). Mutations in WDR62, encoding a centrosome-associated protein, cause 
microcephaly with simplified gyri and abnormal cortical architecture. Nat Genet 
42: 1015-1020. 
 
Yu X, Malenka RC (2003). Beta-catenin is critical for dendritic morphogenesis. 
Nat Neurosci 6: 1169-1177. 
 
Yuan L, Seong E, Beuscher JL, Arikkath J (2015). delta-Catenin Regulates Spine 
Architecture via Cadherin and PDZ-dependent Interactions. J Biol Chem 290: 
10947-10957. 
 
Zafeiriou DI, Ververi A, Vargiami E (2007). Childhood autism and associated 
comorbidities. Brain Dev 29: 257-272. 
 
Zhang D, Cheng L, Qian Y, Alliey-Rodriguez N, Kelsoe JR, Greenwood T, et al 
(2009). Singleton deletions throughout the genome increase risk of bipolar 
disorder. Mol Psychiatry 14: 376-380. 
 
Zhang ZW (2004). Maturation of layer V pyramidal neurons in the rat prefrontal 
cortex: intrinsic properties and synaptic function. J Neurophysiol 91: 1171-1182. 
 
Zhao C, Deng W, Gage FH (2008). Mechanisms and functional implications of 
adult neurogenesis. Cell 132: 645-660. 
 
Zhao D, Watson J, Xie C-W (2004). Amyloid beta prevents activation of 
calcium/calmodulin-dependent protein kinase II and AMPA receptor 
phosphorylation during hippocampal long-term potentiation. J Neurophysiol 92: 
2853-2858. 
 
286 
 
 
Zhao H, Dupont J, Yakar S, Karas M, LeRoith D (2004). PTEN inhibits cell 
proliferation and induces apoptosis by downregulating cell surface IGF-IR 
expression in prostate cancer cells. Oncogene 23: 786-794. 
 
Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M (2005). Deficits in trace 
fear memory and long-term potentiation in a mouse model for fragile X 
syndrome. J Neurosci 25: 7385-7392. 
 
Zheng C, Heintz N, Hatten ME (1996). CNS gene encoding astrotactin, which 
supports neuronal migration along glial fibers. Science 272: 417-419. 
 
Zhong L, Cherry T, Bies CE, Florence MA, Gerges NZ (2009). Neurogranin 
enhances synaptic strength through its interaction with calmodulin. EMBO J 28: 
3027-3039. 
 
Zhong L, Gerges NZ (2010). Neurogranin and synaptic plasticity balance. 
Commun Integr Biol 3: 340-342. 
 
Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, et al (2006). Brain-
specific phosphorylation of MeCP2 regulates activity-dependent Bdnf 
transcription, dendritic growth, and spine maturation. Neuron 52: 255-269. 
 
Zikopoulos B, Barbas H (2010). Changes in prefrontal axons may disrupt the 
network in autism. J Neurosci 30: 14595-14609. 
 
Zoghbi H (2003). Postnatal neurodevelopmental disorders: meeting at the 
synapse? Science (New York, NY) 302: 826-830. 
 
Zoghbi HY, Bear MF (2012). Synaptic dysfunction in neurodevelopmental 
disorders associated with autism and intellectual disabilities. Cold Spring Harb 
Perspect Biol 4. 
 
Zucker RS, Regehr WG (2002). Short-term synaptic plasticity. Annu Rev Physiol 
64: 355-405. 
 
287 
 
CURICULUM VITAE 
288 
 
289 
 
290 
 
 
 
291 
 
